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Abstract 
The development of a database and bioinformatics applications for 
the investigation of immune genes 
 
Faviel Francisco Gonzalez Galarza 
 
The extensive allelic variability observed in several genes related to the immune 
response and its significance in transplantation, disease association studies and diversity 
in human populations has led the scientific community to analyse these variants among 
individuals.       
 
This thesis is focussed on the development of a database and software applications for 
the investigation of several immune genes and the frequencies of their corresponding 
alleles in worldwide human populations. The approach presented in this thesis includes 
the design of a relational database, a web interface, the design of models for data 
exchange and the development of online searching mechanisms for the analysis of allele, 
haplotype and genotype frequencies. 
 
At present, the database contains data from more than 1000 populations covering more 
than four million unrelated individuals. The repertory of datasets available in the 
database encompasses different polymorphic regions such as Human Leukocyte 
Antigens (HLA), Killer-cell Immunoglobulin-like Receptors (KIR), Major 
histocompatibility complex Class I chain-related (MIC) genes and a number of cytokine 
gene polymorphisms. 
 
The work presented in this document has been shown to be a valuable resource for the 
medical and scientific societies. Acting as a primary source for the consultation of 
immune gene frequencies in worldwide populations, the database has been widely used 
in a variety of contexts by scientists, including histocompatibility, immunology, 
epidemiology, pharmacogenetics and population genetics among many others. In the 
last year (August 2010 to August 2011), the website was accessed by 15,784 distinct 
users from 2,758 cities in 136 countries and has been cited in 168 peer-reviewed 
publications demonstrating its wide international use. 
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Thesis overview 
 
In recent years, technologies and computational techniques have been applied to the 
fields of medicine and biological sciences. A large number of algorithms and methods 
have been implemented in these areas to assist scientists in the analysis of large datasets 
generated after experiments. This information needs to be stored in electronic 
repositories to allow individuals to submit their own information, consult the data 
available and participate in the curation of other datasets where possible.  
 
This thesis describes the design of a database, the Allele Frequency Net Database 
(AFND), containing information on several polymorphic regions, genes and their 
corresponding alleles involved in the immune response. A set of computational 
notations used in the construction of the database and formats for data exchange are 
also described in this work. The schemas presented in this thesis can be used by other 
database developers for the implementation of other related polymorphic regions or 
datasets with a similar structure. Additionally, the thesis describes a set of web-based 
applications which were designed for the consultation of information available. 
 
AFND has assisted a number of different scientific groups from a diverse range of 
disciplines. The website has been extensively used in the investigation of the presence of 
alleles in worldwide human populations. 
 
The content of this thesis is divided into eight related chapters which describe the 
design and implementation of the database and the analysis of the different frequencies 
of the polymorphic regions available. 
 
Chapter 1 presents an introduction to the basis of immunology and immunogenetic 
databases. The chapter is intended to allow both informaticians and biologists to 
familiarise themselves with the basics of immunogenetics, the importance of public 
databases and the use of bioinformatics applications as a method to disseminate 
biological datasets. The polymorphisms covered in this work include the Human 
Leukocyte Antigens (HLA), Killer-cell Immunoglobulin-like Receptors (KIR), Major 
histocompatibility complex Class I chain-related (MIC) genes and a number of cytokine 
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gene polymorphisms. A review of other useful databases and bioinformatics 
applications commonly used for the analysis of immune genes is also presented in 
Chapter 1. 
 
Chapters 2 and 3 describe the informatics approaches developed in this research. The 
computational methods and techniques are described in these two chapters. Chapter 2 is 
focussed on the definition of the structure and content of the different datasets and 
computational techniques that were used in the construction of AFND. This chapter 
describes the implementation of a database schema to define the relationships among 
the existing datasets. Chapter 3 describes the development of the AFND website as an 
electronic interface to explore the frequency data of the different populations. This 
chapter presents some examples of searching tools available on the AFND website 
including searches by allele, haplotype, genotype and amino acid frequencies. 
 
Chapters 4, 5, 6 and 7 present a summary of the different analyses that were performed 
for each polymorphic region available in AFND. The aim of these chapters is to 
examine the allele, haplotype and genotype frequencies in different populations and 
illustrate their variability by presenting a collection of overlaid maps and breakdowns.  
 
Chapter 4 focuses on the analysis of the frequency distribution of HLA genes at allele 
and haplotype level. The chapter includes the description of different software 
applications implemented for the analysis of frequencies. Additionally, several overlaid 
maps are presented to illustrate the variability of specific alleles in worldwide 
populations.  
 
Taking into account that many of the existing HLA alleles have only been reported on 
one occasion, Chapter 5 presents an extensive worldwide analysis of the rarity of HLA 
alleles. The analysis is based on the number of confirmations of these alleles by different 
scientific groups and international organisations.  
 
Chapter 6 presents a summary of the distribution of KIR genes at allele and genotype 
level. The chapter includes a section to describe the content and structure of the KIR 
genotype database. The compilation of KIR genotypes presented in this chapter 
encompasses the largest KIR genotype collection in worldwide populations.  
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Chapter 7 comprises a summary of breakdowns of the frequencies of MIC genes and 
frequencies on associations with some of the HLA loci. Additionally, frequencies of 
several cytokine gene polymorphisms in worldwide populations are also presented in 
this chapter.  
 
Finally, Chapter 8 summarises the findings and includes a set of topics for discussion. 
Additionally, the section describes also a number of future projects which may be 
generated from the current work. 
 
As complementary material, two appendices are included at the end of this thesis to 
further describe the methods and parameters used in the implementation of the 
database: Appendix A describes the schemas used in the construction of the database 
and Appendix B defines the metadata and data dictionary of the schemas. 
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Chapter 1  
Investigation of  immune genes 
 
1.1 Introduction 
 
In recent decades, the field of bioinformatics has played a significant role in the 
investigation of the genetics and genomics of human beings. The completion of the 
human genome project (HGP) (Lander et al. 2001; Venter et al. 2001) has led 
individuals to further extend the number of analyses and experiments with the aim of 
understanding the functioning of this biological complex.  
 
One of the topics that has gained the attention of medical and biological researchers is 
to explore the relationship between the immune system and hereditary factors in 
individuals. Since 1936, when the term immunogenetics was initially introduced to describe 
this association, many studies have been performed by scientific groups to investigate 
the function of several genes which are involved in the immune system response in 
humans (Alper & Larsen 2004; Bontrop, Kasahara & Watkins 1999; Irwin 1976).  
 
For many years, researchers have tended to combine experimental biology with 
analytical methods including algorithms and, more recently, computational models to 
assist scientific communities in the interpretation of their experiments and results. Thus, 
the role of programmers in the field of biology, known as bioinformatics, has become an 
important part of contemporary research by providing scientists with specialised 
software and databases to host and analyse an extensive number of biological datasets. 
 
In the last fifty years, a vast number of studies on genes involved in the immune system 
response have been reported in the literature and in proceedings from International 
Histocompatibility Workshops (IHWSs) amassing an extremely large volume of information 
[For reviews of IHWSs see (Terasaki 2007; Thorsby 2009)]. One of the main outcomes 
from these IHWSs has been the massive number of DNA variants that have been found 
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in these immune genes among individuals in different worldwide populations. The 
variability present in the sequences of these genes has been demonstrated to have a 
significant impact in many fields of immunology and genetics research, i.e. explaining 
the basis of tissue rejection in transplantation, associations to infectious and 
autoimmune diseases, diversity in populations, etc. (See Section 1.4.4 for a wider review 
of applications of immune genes).  
 
With the advances in technology and the use of novel molecular methods, data reported 
in journals becomes out of date rapidly. Therefore, the need to provide a public and up-
to-date electronic resource to contain frequency datasets in populations has been an 
essential requirement for the scientific and medical societies.  
 
In the past two decades, the introduction of public databases has fostered the interest of 
individuals from different research groups to interact with online repositories that can 
be freely accessed through the world wide web (WWW) (Varmus 2003).  However, the 
design of biological databases encompasses a series of important factors that need to be 
considered during the implementation process such as (i) the standardisation of datasets, 
(ii) the definition of controlled vocabularies and (iii) integration with other databases 
(Stein 2003). Considering these essential factors, this research was focussed on the 
development of a database which can serve as a warehouse for the storage of immune 
gene frequencies along with an online repository to satisfy the demands of investigators 
who are interested in examining the occurrence of these genes.  
 
The aim of this chapter is to present a concise review of the functioning of the immune 
system and some of the genes involved in the immune response, and introduce the 
reader to the basis of population genetics, immunogenetics databases and software 
applications which can be useful to perform population genetics analysis. The 
polymorphisms covered in this research include four polymorphic regions: the Human 
Leukocyte Antigens (HLA), Killer-cell Immunoglobulin-like Receptors (KIR), Major 
histocompatibility complex Class I chain-related (MIC) genes and a number of cytokine 
gene polymorphisms. 
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1.2 The immune system 
 
The immune system in humans is a set of biological processes that protects individuals 
against infectious agents and tumour cells. These processes are based on the 
identification of non-self molecules in the body which are subsequently eliminated. The 
immune response is divided into two components, the innate and adaptive immune 
systems. The innate immune system provides individuals with an immediate response by 
recruiting immune cells, predominantly phagocytes (neutrophils, monocytes and 
macrophages), to the region infected, which have the capacity to distinguish host cells 
from pathogens (Delves & Roitt 2000a). 
 
Usually, individuals acquire immunity during their lives due to the adaptive immune system, 
which can recognise an indefinite number of cells and act rapidly on re-exposure to the 
same infection.  
 
Some aspects of the immune system have hereditary factors that vary among groups of 
individuals leading to the importance of investigating these genetic traits in different 
populations.  
 
1.3 The Major Histocompatibility Complex 
 
The Major Histocompatibility Complex (MHC) is a genomic region that encodes a set of 
proteins located on the surface of cells which permit T cells (known also as T 
lymphocytes) to identify and target infected cells (Delves & Roitt 2000b). The MHC is 
situated on the short arm of chromosome 6 at position 6p21.3 and is considered to be 
the most polymorphic region in the human genome. This site contains more than two 
hundred expressed genes of which approximately 40% are estimated to have 
immunological functions (Horton et al. 2004; The MHC sequencing consortium 1999).  
 
The MHC region is approximately 7.6 mega base pairs (Mb) in length and many of the 
genes exhibit extensive polymorphism (Horton et al. 2004).  The MHC is divided into 
three main regions referred as Class I, II and III (Figure 1.1). However, MHC Class III 
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presents different functions from those of Class I and II and only the first two classes 
are investigated in this thesis. 
 
 
Figure 1.1: Location and organisation of the HLA complex. 
(Klein & Sato 2000a) 
 
1.4 Human Leukocyte Antigens 
 
In humans, one of the most important components of the MHC is the Human Leukocyte 
Antigen (HLA) System. The principal role of the HLA system is in defence against 
microorganisms by presenting peptides (short sequences of amino acids) of the pathogen 
to T cells for recognition.  
 
The HLA system is divided into two classes: Class I and Class II, which differ in 
molecular structure and function. HLA Class I molecules are found on almost all 
somatic cells, whereas HLA Class II molecules are specifically present on immune 
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system cells (e.g. B and T lymphocytes, macrophages and dendritic cells) (Klein & Sato 
2000a).  
 
The main function of the HLA Class I molecule is to present antigens to cytotoxic T 
lymphocytes (CD8+ T cells) which can eradicate cells typically infected by viruses. In 
contrast, HLA Class II molecules present peptides to T helper cells (CD4+ T cells) 
which, although they cannot directly eliminate infected cells, play an important role in 
the activation of other immune cells.  
 
Based on the molecular structure, the HLA Class I molecule is formed by two 
polypeptides chains (α and β) containing a total of five domains: two peptide-binding 
domains (α1 and α2), one immunoglobulin-like domain (α3), a lateral β2-microglobulin 
gene (β2m), the transmembrane region (TM) and the cytoplasmic tail (Figure 1.2). The 
structure of the class II is composed of two mirror peptides with four domains each: a 
peptide-binding domain (α1 or β1), the immunoglobulin-like domain (α2 or β2), the 
transmembrane region and the cytoplasmic tail in each of the chains.  
 
 
Figure 1.2: Structure of the HLA Class I and Class II molecules. 
(Klein & Sato 2000a) 
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1.4.1 Genes and alleles in the HLA system 
 
The HLA region is composed of more than twenty genes which are officially named by 
the World Health Organisation (WHO) Nomenclature Committee. Some of these genes 
are regularly tested for and thus called classical HLA genes (HLA-A, -B and -C for Class I; 
and HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 for Class II). Other genes or loci1 
have also been identified in the HLA region; however, the majority of them probably do 
not function as peptide presenters and are not regularly tested for. Consequently, these 
loci have received the name of non-classical HLA genes.  
 
Each locus of the HLA region presents a significant number of variants in their amino 
acid sequences. Variants in the DNA sequence of a gene are called alleles. The presence 
of HLA alleles differ considerably among populations and their corresponding 
frequencies are vastly supportive in investigating the function of HLA genes and genetic 
differences among individuals (See Section 1.4.4).  
 
In the beginnings of the study of HLA, antigens2 were identified using antisera (blood 
serum containing antibodies) in which the number of variants were encoded using a 
serological nomenclature [See review (McCluskey, Kanaan & Diviney 2003)]. However, 
with the advent of molecular techniques applied to the HLA typing since the mid 1980s, 
a massive number of alleles have been reported splitting the serological nomenclature 
into hundreds of alleles. At present, the officially recognised HLA loci and 
corresponding alleles are defined by the Nomenclature Committee for Factors of the 
HLA System (Marsh et al. 2010). 
 
The number of alleles that have been recognised by molecular methods is constantly 
increasing. More than 6,000 HLA alleles have been reported as of January 2011 at 
release 3.3.0 on the IMGT/HLA Database (Robinson et al. 2003). The high number of 
alleles observed gives an indication of the extensive polymorphism that is found in this 
genomic region, except in non-classical genes in which the polymorphism is low (Table 
1.1). Despite the elevated polymorphism observable in the HLA system, the variability is 
                                                 
1 Locus (plural loci) is a term commonly used to specify the location of the gene on the chromosome. 
2 Antigens are molecules which activate the production of antibodies in the immune system response. 
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mainly presented in a short region of nucleotides located principally at exons 2 and 3 for 
HLA Class I molecules and at exon 2 for the HLA Class II molecule (Little & Parham 
1999; Williams 2001). These two exons are known for encoding the peptide binding 
region.  
 
Table 1.1: Genes and number of alleles in the HLA region  
HLA locus Alleles HLA locus Alleles 
A 1,518 DRB4 14 
B 2,068 DRB5 19 
C 1,016 DRB6 3 
DMA 4 DRB7 2 
DMB 7 DRB8 1 
DOA 12 DRB9 1 
DOB 9 E 10 
DPA1 28 F 22 
DPB1 145 G 46 
DQA1 35 H 12 
DQB1 144 J 9 
DRA 3 K 6 
DRB1 873 L 5 
DRB2 1 P 4 
DRB3 52 V 3 
Number of HLA alleles as of January 2011 from release 3.3.0 available in the IMGT/HLA database (Robinson et al. 
2003). Classical loci are shown in bold. 
 
1.4.2 HLA nomenclature 
 
Since 1968, when the nomenclature to designate the name of HLA alleles was 
introduced initially, the Committee for factors of the HLA system has produced a series 
of nomenclature reports (http://hla.alleles.org/nomenclature/nomenc_reports.html) to 
meet the principles of HLA specificities [For a review of HLA specificities see (Park & 
Terasaki 2000)]. The current notation used to designate HLA alleles is composed of  
alphanumeric characters and symbols which are divided into two main components: (i) 
the name of the locus (e.g. HLA-A, -B, -C, etc.), followed by an asterisk (*), and (ii) the 
DNA sequence variant (Figure 1.3). 
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Figure 1.3: Structure of the nomenclature for HLA alleles. 
(Reprinted with permission of S.G.E. Marsh) 
Source: http://hla.alleles.org/nomenclature/naming.html 
 
The notation used to define the DNA sequence variant consists of 2-4 levels (Fields) 
which are separated by a colon (:) as shown in Figure 1.3. Level 1 (Field 1) encodes the 
HLA allele family which usually corresponds to the antigen group (e.g. A*02), level 2 
(Field 2) defines the DNA sequence variant at protein level which is typically given in a 
consecutive numerical order (e.g. A*02:101), level 3 (Field 3) is used to describe a 
synonymous DNA substitution3 within the coding region (i.e. A*02:101:01 and A*02:101:02 
alleles both encode for Arginine at codon 163 which is located in exon 3 in the 
sequence, however, nucleotide sequences of these two alleles correspond to CGG and 
AGG respectively) and level 4 (Field 4) is used for those alleles that present a difference 
in the non-coding region4 of the sequence (e.g. A*02:101:01:02) [For more details on HLA 
allele nomenclature see (Marsh et al. 2010)].  
 
Additionally, several suffixes are used in the HLA nomenclature to indicate special 
characteristics of the allele indicating whether the allele is not expressed (N), whether 
the allele has shown a low expression on the surface of the cell (L), whether the 
                                                 
3 A synonymous substitution is the replacement of one nucleotide in which the change does not affect the 
amino acid produced. E.g. CGG and AGG both encode the amino acid Arginine. 
4 The non-coding region is the part of the DNA sequence that does not encode for protein sequences. 
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specification of proteins is expressed as secreted molecule (S), if the allele is present in the 
cytoplasm (C), if it corresponds to an aberrant allele (A) or if the allele is questionable 
regarding its level of expression (Q). These special suffixes are only present in a few 
alleles (~ 3.4% of the total of HLA alleles) and only in some loci (Table 1.2). 
 
Table 1.2: HLA alleles with a special expression status 
HLA locus N L S C A Q Total 
A 72 3    5 80 
B 62 1 1   6 70 
C 24     9 33 
DOA 1      1 
DPB1 3      3 
DQA1 1      1 
DQB1 1      1 
DRB1 10      10 
DRB4 3      3 
DRB5 2      2 
G 2      2 
Total 181 4 1 0 0 20 206 
Number of HLA alleles with suffixes as of January 2011 from release 3.3.0 available in the IMGT/HLA database 
(Robinson et al. 2003). N=Not expressed, L=Low expression, S=Secreted molecule, C=Cytoplasm, A=Aberrant, 
Q=Questionable. 
 
Allele detection and groups 
 
HLA alleles can be identified in laboratories using different typing methods based on 
the use of molecular techniques incorporating the Polymerase Chain Reaction (PCR) [See 
review of PCR in (Bartlett & Stirling 2003)]. The amplification of DNA sequence using 
PCR protocols has underpinned the improvements of allele detection which were 
originally identified by antisera [See reviews in (Erlich, Opelz & Hansen 2001; 
Middelton 2005)]. PCR methods performed in HLA typing include Restriction fragment 
length polymorphism (PCR-RFLP), Sequence-Specific Primer (PCR-SSP), Sequence-Specific 
Oligonucleotide Probe (PCR-SSOP), Single-Strand Conformation Polymorphism (PCR-SSCP), 
Reference Strand Conformation Analysis (PCR-RSCA) and Sequence Based Typing (PCR-SBT). 
The PCR-RFLP method is used to distinguish two alleles differing by the presence of a 
restriction enzyme site. The main problem of this method is that a failure to get 
complete cleavage may lead a homozygote to be considered as a heterozygote. Also, it 
may be difficult to find appropriate restriction sites in all of the alleles in certain loci. In 
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the PCR-SSP method, primers are designed to target only a specific set of alleles or a 
single allele. These unique sequences are usually located at the 3' end of the primer. 
However, this method is not suitable for large number of samples or for automation. 
The PCR-SSOP technique involves the use of single stranded DNA sequence which is 
used to complement a target sequence (~18 nucleotides). There are many alternatives of 
SSOP methods which mainly differ on the length and sequence of oligonucleotide 
probes. This method has been proved to be reliable, robust and accurate, although is 
not suitable for analysing individual alleles or small numbers. In the case of PCR-SSCP, 
PCR-amplified DNA is denatured and electrophoresed on a polyacrylamide gel. Each 
single strand moves at a position related to its conformation as determined by its 
sequence. This method could be useful in comparing the alleles of two individuals; 
however, this technique is not widely used due to the results may be difficult to 
interpret. The PCR-RSCA is a conformational technique which uses a fluorescien-
labelled reference (FLR) in which pairs are formed between the PCR product of the 
locus of interest and a locus-specific FLR strand. RSCA is a rapid method for high 
resolution typing of large numbers of samples but limited to proprietary RSCA typing 
kits. Finally, PCR-SBT is based on the amplification of HLA alleles which are sequenced 
directly to identify the alleles carried by the individual. A sequence-specific sequencing 
primer is used to produce the sequence of a single allele from a PCR reaction containing 
both alleles at a locus. In this method, a software program is employed to identify the 
alleles based on their sequence. [For a review of typing methods see (Little 2007)]. 
 
Some of the HLA alleles share identical amino acid/nucleotide sequences over exons 2 
and 3 for Class I and exon 2 for Class II. As mentioned in Section 1.4.1, these exons 
encompass the peptide binding domain. The WHO Nomenclature Committee classifies 
identical alleles at these exons in two main groups. One group corresponds to those 
alleles that encode the same protein (at exons 2 and 3 for HLA Class I and exon 2 for HLA 
Class II alleles) and which are grouped using the allele code designation at level 2 
followed by the suffix P (e.g. A*02:03P) (Figure 1.4). The second group corresponds to 
those alleles that have identical nucleotide sequences (at exons 2 and 3 for HLA Class I and 
exon 2 for HLA Class II alleles) and which can be grouped using the allele code 
designation at level 3 followed by the suffix G (e.g. A*02:03:01G) (Figure 1.4). In the 
example shown in Figure 1.4, all six alleles (A*02:03:01, A*02:03:02, A*02:03:03, 
A*02:03:04, A*02:253 and A*02:264) have identical protein sequence over exons 2 and 
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3 (Group A*02:03P). However, only A*02:03:01, A*02:253 and A*02:264 have identical 
nucleotide sequences over these two exons (Group A*02:03:01G). 
 
                                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Example of identical HLA alleles over exons 2 and 3. 
Symbols: (-) Identical sequence to first allele, (*) not sequenced, (?) incomplete sequence. 
 
1.4.3 Genetics of the HLA system 
 
In the HLA system, as elsewhere, individuals inherit two copies of DNA from their 
parents following the Mendelian law of segregation. Two blocks of alleles called 
haplotypes, are inherited together, one from the mother and one from the father. The set 
of alleles contained in the two haplotypes constitute the genotype of an individual. Figure 
1.5 illustrates the total number of combinations of four different haplotypes (a, b, c and 
d) inherited from parents. Sibling I is shown to inherit haplotype „a‟ (A*24:02-B*35:01-
A*02:03:01G 
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ACG  
---  
---  
--T  
---  
---  
 
 
 
 
 
 
 
 
Positions where 
nucleotides differ 
          |Exon1                Exon1|Exon2                      Exon2 
Position   -24        -14        -4   1       10         20         30         40 
A*02:03:01 MAVMAPRTLV LLLSGALALT QTWA GSHSMRYFFT SVSRPGRGEP RFIAVGYVDD TQFVRFDSDA 
A*02:03:02 ********** ********** **** ?--------- ---------- ---------- ---------- 
A*02:03:03 ---------- ---------- ---- ---------- ---------- ---------- ---------- 
A*02:03:04 ********** ********** **** ?--------- ---------- ---------- ---------- 
A*02:253   ---------- ---------- ---- ---------- ---------- ---------- ---------- 
A*02:264   ---------- ---------- ---- ---------- ---------- ---------- ---------- 
 
           Exon2                                            Exon2|Exon3 
Position           50         60         70         80         90        100 
A*02:03:01 ASQRMEPRAP WIEQEGPEYW DGETRKVKAH SQTHRVDLGT LRGYYNQSEA GSHTVQRMYG 
A*02:03:02 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:03:03 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:03:04 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:253   ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:264   ---------- ---------- ---------- ---------- ---------- ---------- 
 
           Exon3                                                       Exon3 
Position           110       120        130        140        150        160 
A*02:03:01 CDVGSDWRFL RGYHQYAYDG KDYIALKEDL RSWTAADMAA QTTKHKWETA HEAEQWRAYL  
A*02:03:02 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:03:03 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:03:04 ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:253   ---------- ---------- ---------- ---------- ---------- ---------- 
A*02:264   ---------- ---------- ---------- ---------- ---------- ---------- 
 
           Exon3              Exon3|Exon4                               Exon4 
Position          170        180         190        200        210        220 
A*02:03:01 EGTCVEWLRR YLENGKETLQ RT DAPKTHMT HHAVSDHEAT LRCWALSFYP AEITLTWQRD 
A*02:03:02 ---------- ---------- -- -------- ---------- ---------- ---------- 
A*02:03:03 ---------- ---------- -- -------- ---------- ---------- ---------- 
A*02:03:04 ---------- ---------- -- ?******* ********** ********** ********** 
A*02:253   ---------- ---------- -- -------- ---------- ---------- ---------- 
A*02:264   ---------- ---------- -- -------- ----P----- ---------- ---------- 
 
           Exon4                                                 Exon4|Exon5    
Position          230        240        250        260        270         280 
A*02:03:01 GEDQTQDTEL VETRPAGDGT FQKWAAVVVP SGQEQRYTCH VQHEGLPKPL TLRW EPSSQP  
A*02:03:02 ---------- ---------- ---------- ---------- ---------- ---- ?***** 
A*02:03:03 ---------- ---------- ---------- ---------- ---------- ---- ------ 
A*02:03:04 ********** ********** ********** ********** ********** **** ****** 
A*02:253   ---------- ---------- ---------- -----S---- ---------- ---- ------ 
A*02:264   ---------- ---------- ---------- ---------- ---------- ---- ------ 
 
           Exon5                          Exon5|Exon6       |Exon7       Exon7| | 
Position          290        300        310         320         330        340 
A*02:03:01 TIPIVGIIAG LVLFGAVITG AVVAAVMWRR KSS DRKGGSY SQAA SSDSAQ GSDVSLTACK V 
A*02:03:02 ********** ********** ********** *** ******* **** ****** ********** * 
A*02:03:03 ---------- ---------- ---------- --- ------- ---- ------ ---------- - 
A*02:03:04 ********** ********** ********** *** ******* **** ****** ********** * 
A*02:253   ---------- ---------- ---------- --- ------- ---- ------ ---------- - 
A*02:264   ---------- ---------- ---------- --- ------- ---- ------ ---------- - 
A*02:03P 
Amino acids 
Differences 
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C*03:02-DRB1*04:03-DQA1*03:01-DQB1-03:01) from the father and haplotype „c‟ 
(A*02:01-B*39:02-C*03:04-DRB1*04:11-DQA1*04:01-DQB1*03:01) from the mother. 
 
Individuals who present the same allele in each of the two copies in a particular locus 
are called homozygous, and heterozygous if the alleles are different. For example, in Figure 
1.5, Sibling I is homozygous for the locus DQB1 by presenting the same allele 
(DQB1*03:01) and heterozygous for the rest of the loci whereas the other siblings are 
heterozygous at DQB1 locus. The inherited HLA alleles are co-dominant, which 
indicates that both alleles are equally expressed on the cell surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Example of inheritance of HLA alleles.  
 
 
As shown in Figure 1.5, the chance of finding an identical genotype among siblings 
from the same family is one in four whereas the chance of sharing one of the haplotypes 
is 50%. Because this information is exceptionally significant for examining common 
diseases and potential donors in clinical transplantation (Crawford & Nickerson 2005), 
these data have been investigated by several groups such as the MHC Haplotype 
Consortium (Horton et al. 2008).  
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Taking into account the elevated number of existing alleles, the total number of 
haplotypic combinations may be immense. However, this number of combinations can 
be reduced as some loci and alleles are in linkage disequilibrium (LD) which, contrary to 
basic Mendelian genetics, states that those combinations have frequencies considerable 
higher than the frequencies theoretically expected knowing the individual allele 
frequency [See review of LD in (Slatkin 2008)]. The patterns of LD have been found to 
vary between populations and are of great interest for immune-related disease and 
population studies (Begovich et al. 1992; Evseeva et al. 2010; Sanchez-Mazas et al. 
2000). 
 
1.4.4 Applications of the HLA system 
 
HLA and transplantation 
 
The major applications of the HLA system have been in the field of tissue and organ 
transplantation. Originally the MHC was discovered as the region of the human genome 
which was the determinant for the histocompatibility between donor and recipient in tissue 
and organ graft. Since then, many studies and methods have been performed to examine 
the chances of survival after the transplant (Chinen & Buckley 2010; Sheldon & Poulton 
2006; Terasaki & Cai 2008).  
 
In some cases, a mismatch on the HLA genotype of the donor and recipient may cause 
the immune system of the donor to reject the transplanted organ or tissue. Recent 
studies have concluded that the matching of some loci is more important than others. 
For example, antigen matches of HLA-A, -B, -C and -DR loci are believed to be more 
crucial than mismatches in other loci (Sheldon & Poulton 2006). In the case of Bone 
Marrow Transplantation (BMT), the incompatibility not only affects the rejection but also 
may lead to a Graft-Versus-Host-Disease (GVHD) in which the recipient is attacked by the 
grafted bone marrow (Shlomchik 2007). In this case, complete HLA matching is 
normally needed. 
 
As mentioned in the previous section, the chance of finding an identical HLA genotype 
among individuals from the same family is one in four. However, it is believed that only 
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less than a third part of the individuals who need a transplant have an HLA identical 
sibling (Petersdorf 2008). At present, computational matching algorithms and searching 
mechanisms are performed in Cord Blood and Bone Marrow Registries which contain 
large number of volunteer unrelated potential donors (Eberhard et al. 2010). One of the 
facts to consider is that if a match in two loci (e.g. HLA-DRB1, HLA-B) is found the 
chances for matching a third locus (e.g. HLA-C) are high, based on the LD that some of 
these loci present. 
 
HLA in autoimmune and infectious diseases 
 
Infectious diseases 
 
The HLA system has also been recognised by its capability to offer some resistance to a 
wide number of infectious diseases (Blackwell, Jamieson & Burgner 2009). It is believed 
that human beings have acquired protection to diseases due to an evolutionary process 
called pathogen-driven balancing selection (Prugnolle et al. 2005). The HLA system has 
thus worked in conjunction with environmental factors to develop this defence through 
the adaptive and innate response (Traherne 2008).   
 
One of the most common practices performed by researchers in infectious disease 
associations is to compare frequencies and/or genetic linkage of HLA alleles in patients 
against the corresponding frequencies in controls. For instance, carrying a particular 
combination of HLA variants may lead an individual to have a greater susceptibility to a 
given infection, e.g. malaria which has been associated with the absence of the HLA-
B*53 allele, suggesting that the presence of this allele may reduce the risk of severe 
malaria by 40% (Hill et al. 1991). These association analyses are usually followed by a set 
of guidelines which involve the identification of an appropriate selection of individuals 
(controls) such as matching for ethnic background of individuals, selection of an 
optimal population/sample size, etc. (Balding 2006; Hattersley & McCarthy 2005). Thus, 
the selection of suitable parameters is essential in the quality control of information in 
disease associations. 
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Autoimmune diseases 
 
On some occasions, individuals may present some alleles or haplotypes which may be 
linked to a particular disease (Klein & Sato 2000b). Although other factors such as 
environmental conditions and/or involvement of other non-HLA genes are clearly 
important, some HLA alleles have a significant correlation with some specific 
autoimmune diseases, for example, Type 1 Diabetes (T1D) in which some studies have 
shown a major predisposing factor in HLA genes and alleles implicated in the disorder 
[See reviews in (Bluestone, Herold & Eisenbarth 2010; Thorsby & Lie 2005)]. 
 
HLA and diversity 
 
Despite the short length of the HLA system (~2.5 × 10-3 percent of the total length of 
the human genome), this genomic region is the most polymorphic among individuals 
and thus has captured the attention of anthropologists due to the extensive diversity 
presented among populations (Sanchez-Mazas 2007; Shiina et al. 2009).  
 
Anthropology studies have focussed on the analysis of allele frequencies and haplotypic 
variations in different geographic regions to predict and trace historical human 
migration. As allele and haplotype frequencies differ between groups of individuals, the 
HLA system has been extensively used in the characterisation of different ethnic groups 
[See examples in (Arnaiz-Villena et al. 2005; Begovich et al. 2001; Hollenbach et al. 
2001; Yuliwulandari et al. 2009)]. The analyses performed in these populations include 
the comparison of genetic distance among populations, the representation of 
hierarchical structures by the creation of dendrograms5 and phylogenetic trees6, principal 
component analysis7 (PCA) for human genetic clustering8, among many others.  
 
In recent years, the genetic variation of human beings has been analysed at different 
levels: within individuals from the same population, among populations within the same 
                                                 
5 Dendrograms are diagrams used to illustrate the genetic distance from populations. 
6 Phylogenetic trees are diagrams to infer evolutionary relationships among species. 
7 Principal component analysis is a statistical technique to identify correlations between different groups. 
For instance, in HLA, PCA are used to analyse correlations between populations. 
8 Human genetic clustering refers to the similarity between individuals to infer population structures. 
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continent, and among different continents. The outcomes of HLA population analyses 
have assisted researchers in the confirmation of previous analyses performed using 
other DNA markers. In the case of HLA, approximately 84-92% of the variability 
(depending on the HLA locus examined) is presented by individuals from the same 
population, 4-6% among populations from the same continent and 3-9% among 
populations from different continents (Sanchez-Mazas 2007). 
 
1.5 Killer-cell Immunoglobulin-like Receptors 
 
The Killer-cell Immunoglobulin-like Receptors (KIR) constitute a group of proteins which are 
present on the cell surface of Natural Killer (NK) cells and in some T cells (Parham 
2005a). The main task of these receptors is to participate in the regulation of the killing 
function against infections and malignancy by interacting with MHC Class I molecules 
(Kumar & McNerney 2005; Parham 2005b).  
 
1.5.1 Genes and alleles in the KIR family 
 
The KIR family consists of fifteen genes and two pseudogenes9 clustered on the 
Leukocyte Receptor Complex (LRC) residing on the long arm of chromosome 19 at position 
19q13.4 (Wende et al. 1999). These receptors may be activating (KIR2DS1, KIR2DS2, 
KIR2DS3, KIR2DS4, KIR2DS5 and KIR3DS1) or inhibitory (KIR2DL1, KIR2DL2, 
KIR2DL3, KIR2DL5A, KIR2DL5B, KIR3DL1, KIR3DL2 and KIR3DL3) based on the 
activating role on the function of the NK cell, except KIR2DL4 which appear to have 
both functions (Middleton, Curran & Maxwell 2002).  
 
KIR genes are also inherited as blocks of genes. According to recent studies, each 
individual may carry from seven to eleven different genes (Middleton, Meenagh & 
Gourraud 2007; Shilling et al. 2002; Uhrberg, Parham & Wernet 2002). Because of the 
high variability in the gene content and the allelic polymorphism found in this genomic 
region, individuals rarely present identical KIR genotypes (presence or absence of the 
KIR genes in an individual).  
                                                 
9 Pseudogenes are genes that lack expression in the cell. 
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The KIR family also presents a high level of polymorphism derived from presence or 
absence of genes, although not at the same level as the HLA region. A total of 601 KIR 
alleles have been reported as of release 2.4.0 April 2011 in the IPD-KIR database 
(Robinson et al. 2005). KIR3DL1, KIR3DL2 and KIR3DL3 are the most polymorphic 
genes with 70, 84 and 101 alleles respectively (Table 1.3). 
 
Table 1.3: Genes and number of alleles in the KIR family 
KIR locus Alleles KIR locus Alleles 
KIR2DL1 43 KIR2DS1 15 
KIR2DL2 27 KIR2DS2 22 
KIR2DL3 32 KIR2DS3 13 
KIR2DL4 47 KIR2DS4 30 
KIR2DL5A 15 KIR2DS5 16 
KIR2DL5B 25 KIR3DS1 16 
KIR3DL1 70 KIR2DP1 22 
KIR3DL2 84 KIR3DP1 23 
KIR3DL3 101   
Number of KIR alleles as of April 2011 from release 2.4.0 available in the IPD-KIR Database (Robinson et al. 2005).  
 
1.5.2 Organisation of the KIR genes 
 
In the last decade, many studies have been performed to analyse the organisation of the 
KIR genes. Researchers have classified genes in two main groups „A‟ and „B‟ according 
to the haplotype content, originally based on the presence or absence of a 24kb HindIII 
restriction enzyme fragment (Uhrberg et al. 1997). The basis of each haplotype group 
consists of four genes KIR3DL3 and KIR3DP1 located at the centromeric10 side and 
KIR2DL4 and KIR3DL2 at the telomeric11 side, which are considered to be framework 
genes and always present (Figure 1.6). Group A consists of the presence of KIR3DL1, 
KIR2DL1, KIR2DL3 and KIR2DS4 genes whereas group B is composed of the presence 
of one or more of the following genes: KIR2DL2, KIR2DL5, KIR3DS1, KIR2DS1, 
                                                 
10 Centromere is the region of DNA situated near the middle of the chromosome and which is involved 
in cell division. 
11 Telomere is the region of DNA located at the end of the chromosome and which protects from 
deterioration or fusion with other chromosomes. 
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KIR2DS2, KIR2DS3 and KIR2DS5 [For KIR haplotypes see review in (Middleton & 
Gonzalez 2010)].  
 
According to the A and B haplotype classification, the resulting haplotype groups can be 
categorised as AA or Bx (in which x can be either A or B) as defined by McQueen and 
colleagues due to the difficulty of distinguishing the other A or B haplotype without 
familial data (McQueen et al. 2007). The terms AA and Bx will be used throughout this 
thesis for referencing KIR haplotype groups. 
 
 
Figure 1.6: Organisation of the KIR genes. 
In this figure, KIR genes are classified by centromeric and telomeric side. Two examples of haplotypes are shown in 
the figure. Framework genes are shown in brown. Genes specific to B haplotypes are shown in blue. Genes that are 
present in both groups are shown in yellow (Parham 2005b). 
 
Based on the number of genes in each group (as shown in Figure 1.6), the number of 
haplotype combinations containing B genes is expected to be greater than A subsets 
(Hsu et al. 2002a). In recent studies, more than twenty different haplotypes have been 
identified by family studies. With these haplotypes, a high number of genotypes can be 
generated by haplotype permutations (Hsu et al. 2002b).  
 
1.5.3 KIR nomenclature 
 
The KIR nomenclature guidelines are defined by the Human Genome Organisation 
(HUGO) via the Genome Nomenclature Committee (Marsh et al. 2003). Following a 
similar notation as used for HLA allele designations, the KIR nomenclature is 
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composed of two main components: (i) the gene name and (ii) the code for the allele 
variant which are separated by an asterisk (*) (Figure 1.7).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Structure of the nomenclature for KIR alleles. 
(Reprinted with permission of S.G.E. Marsh)  
Source: http://www.ebi.ac.uk/ipd/kir/alleles.html 
 
The gene name is formed by the acronym of the polymorphic region (KIR) and the 
name of the corresponding gene (e.g. 2DL1, 2DL2, etc.). The name of the gene is 
composed of four to five alphanumeric characters which define the characteristics of 
the gene. The first character represents the number of immunoglobulin-like domains (2 
or 3 domains), the second denotes the prefix of the word domain (D), the third 
character indicates whether the gene has a long (L) or short (S) cytoplasmic tail, or if it is 
a pseudogene (P). Long tail codes are commonly associated with inhibitory genes and 
short tail codes with activating genes, except KIR2DL4 which appear to have both 
functions as mentioned in Section 1.5.1. The fourth character describes the number of 
the gene in consecutive numerical order which is assigned by the GenBank database 
(Benson et al. 2008) and a suffix „A‟ or „B‟ is added to distinguish genes that present 
similar structures and sequences, e.g. 2DL5A and 2DL5B (Marsh et al. 2003).  
 
Finally, the KIR allele variant is composed of three to seven digits. The first three digits 
represent the sequence that encodes a specific protein (e.g. KIR2DL1*003), the next two 
digits are used to distinguished differences (synonymous nucleotide substitutions) within 
the coding region (e.g. KIR2DL1*00302), and the last two digits are used to denote 
differences which are located in the non-coding region (e.g. KIR2DL1*0030202).  
Differs from other KIR2DL1*00302 
alleles by a DNA substitution within 
a non-coding region. 
KIR2DL1*0030202 
First 2DL protein described 
Long cytoplasmic tail 
Two lg-like domains 
Acronym 
Separator 
Member of the third series of KIR2DL1 proteins 
Differs from other KIR2DL1*003 
proteins by a synonymous DNA 
substitution within the coding region. 
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1.5.4 KIR and HLA ligands 
 
The products of certain HLA Class I loci (principally HLA-B and -C) and the products 
of some KIR genes present specific interactions and have been studied by 
immunologists in recent years.  
 
The epitope Bw4 in the HLA-B locus is believed to function as a ligand with the 
KIR3DL1 gene (Trowsdale 2001). In the case of the HLA-C locus, the subsets are 
divided into C1 and C2 epitopes whose differences are found at positions 77-80 in the 
amino acid sequence.  KIR2DL1 interacts with the C2 epitope (covering alleles under 
the C*02, *04, *05, *06 allele families) and KIR2DL2/3 with the C1 epitope (for C*01, 
*03, *07, *08 allele families) (Trowsdale 2001).  
 
These interactions are suggested to influence resistance to infections, susceptibility to 
autoimmune diseases, pregnancy and success in haematopoietic stem cell transplantation 
(Parham 2005b). 
 
1.5.5 Applications of the KIR family 
 
The investigation of the genes of this genomic region and their organisation has assisted 
scientists in the understanding of the functioning of these genes and their interaction 
with other molecules such as the HLA system.  
 
From these studies a number of important topics have been under investigation by 
researchers. For example, the presence of activating KIR genes in individuals is believed 
to protect against infections, but has also been linked to the susceptibility to certain 
autoimmune diseases (Single et al. 2007a).  In contrast, the presence of inhibitory KIR 
genes is believed to protect against inflammatory diseases (Single et al. 2007a).   
 
In population genetics, the diversity present in the genes of the KIR family has been 
studied by anthropologists to understand theories of human migration (Rajalingam et al. 
2008). The analysis of KIR gene/allele frequencies and the correlation of KIR and HLA 
ligands in different populations have provided evidence for coevolution of these 
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genomic regions (Norman et al. 2007; Single et al. 2007a). The number of different 
analyses has also been extended to include a range of populations among regions and 
continents (Middleton et al. 2008).  
 
1.6 Other immune genes 
1.6.1 Major histocompatibility Class I chain-related genes 
 
The Major histocompatibility complex Class I chain-related (MIC) genes code for a set of 
proteins expressed on the surface of tissue cells (epithelial and endothelial) and 
fibroblasts (Bahram 2000). The MIC genomic region comprises seven loci located on 
chromosome 6 at position 6p21.33 in which MICA and MICB are the only genes that 
encode for proteins (Bahram 2000). MICA and MICB are composed of six exons 
encoding three extracellular domains (α1-α3), a transmembrane region and a 
cytoplasmic tail (Bahram 2000). MIC proteins are known for presenting ligands to the 
Natural Killer activating receptor NKG2D and their interactions are believed to play an 
important role in the immune response to infectious agents [See review in (Collins 
2004)]. MICA and MICB loci are located 46 and 141kb respectively from the HLA-B 
locus. Thus, MICA gene has been associated to some diseases and tissue rejection in 
transplantation possibly only as a result of its proximity and high linkage disequilibrium 
with the HLA-B locus (Collins 2004).  
 
MICA and MICB loci also present a considerable number of allelic variants although 
much lower than those described in the HLA and KIR systems. Similarly to HLA, 
MICA and MICB alleles are officially named by the WHO Nomenclature Committee 
and sequences are deposited in the IMGT/HLA database (Robinson et al. 2003). As of 
release 3.3.0 (January 2011), 73 MICA and 31 MICB alleles had been reported in the 
IMGT/HLA database. The nomenclature used for allele designations of MIC genes 
follows a similar fashion as the HLA nomenclature. The code is divided into several 
components to describe the characteristics of the allele (e.g. MICA*002:01). 
 
Prior to the official nomenclature of MICA, alleles were classified into eight variants 
(A4, A5, A5.1, A6, A7, A9, A9.1, A10) based on the number of Alanine repeats (GCT) 
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between codons 291-304 located at exon 5, which encodes for the transmembrane 
domain [See review in (Collins 2004)]. A5.1 and A9.1 alleles, which correspond to 
mutational variants, represent an insertion after the second Alanine repeat and a 
deletion at the start of exon 5 respectively. The presence of these eight allelic variants, 
also known as MICA microsatellites12 or short tandem repeats (STRs), has been shown 
to vary among populations leading the interests of investigators to examine their 
frequencies among different ethnic groups. 
 
The possibility that the diversity present in the MICA gene may be involved in the 
increase in graft survival after transplantation has been under investigation by 
researchers in recent years (Zou & Stastny 2009). The analysis of several diseases has 
also been extended to investigate the relationships between MICA and HLA-B  due to 
the proximity of these two loci in the chromosome [See review in (Stephens 2001)].  
 
1.6.2 Cytokine gene polymorphisms 
 
Cytokines are a set of proteins which participate in the immune response against 
pathogens by modulating the activities of target cells. These proteins are released by 
several types of cells such as neutrophils, lymphocytes, monocytes, macrophages, NK 
cells, etc. by different means (Bidwell et al. 1999). Several cytokines have been 
demonstrated to present genetic polymorphism in specific regions of their DNA 
sequences [See review in (Bidwell et al. 1999)]. The variation, which is mainly presented 
in single nucleotide polymorphisms (SNPs) or in microsatellites, may affect the gene 
transcription and cause variations in cytokine production. For many years, investigators 
have studied the relationships between cytokine gene polymorphisms and their role in 
transplantation, autoimmune diseases and tumours [See review in (Dinarello 2007)].  
 
Unlike HLA, KIR and MIC, the nomenclature of cytokines is not regulated by official 
bodies or online databases. In the last decade, a series of updates to list current 
cytokines were reported in an online database (Bidwell et al. 1999, 2001; Haukim et al. 
2002; Hollegaard & Bidwell 2006). This online resource consisted of an extensive review 
                                                 
12 Microsatellites are DNA repeat sequences of 1 to 6 base pairs which are used as biological markers in 
genetic studies. 
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of bibliographic references featuring the relationships between cytokine gene 
polymorphisms, cytokine gene expression and the susceptibility to several diseases. 
However, the online database which merely provided a list of references has been 
discontinued in recent years. The notation commonly used by individuals to describe 
cytokine gene polymorphisms is primarily composed of the gene name and the specific 
location of the gene that participates in the regulation. For example, „IGF-1/-383‟ 
represents the nucleotide position on the Insulin-like Growth Factor 1 (IGF-1) gene 
that presents the polymorphism.  
 
As the level of expression and frequencies of certain cytokines may lead to different 
diseases, allele and genotype frequencies in different populations have been under 
investigation by immunologists (Larcombe et al. 2005). The study of cytokine gene 
polymorphisms has been also extended to populations from different continents 
(Middleton et al. 2002).  
 
1.7 Bioinformatics and immunogenetics databases 
1.7.1 Evolution of biological databases 
 
Since the introduction of the term bioinformatics by Hogeweg and colleagues to describe 
simulations of biological systems (Hogeweg 1978), the massive number of software 
applications in biological research has facilitated scientific analysis and retrieval of 
information (Ouzounis & Valencia 2003).  
 
The branch of bioinformatics encompasses a wide number of different areas involving 
not only computational simulations and statistical methods but also the development of 
sophisticated databases and searching algorithms for the retrieval of information from 
biological datasets (Maier et al. 2009).   
 
Biological databases are a set of electronic documents (e.g. raw text files, dictionaries, 
libraries, etc.) which contain information of experiments or computational simulations 
performed by scientists from a different range of areas such as genetics, genomics, 
proteomics, etc. The number of different biological repositories reported in different 
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sources is immense. For example, the Database issue of the Nucleic Acid Research 
journal contains more than 1,300 databases reported as of December 2010 and this only 
represents a small portion of all repositories available (Galperin & Cochrane 2011). The 
list of repositories includes data on a diverse number of types and formats. For instance, 
the GenBank (Benson et al. 2011), the EMBL Nucleotide Sequence database (Kulikova 
et al. 2007) and the DNA Data Bank of Japan (Tateno et al. 2002) were designed for the 
storage of sequences; UniProt (Apweiler & Consortium 2010) for the hosting of protein 
sequences and annotations; the Protein Data Bank (Rose et al. 2011) to examine three 
dimensional protein structures, among many others. 
 
The creation of biological databases involves a series of processes including the design 
of an adequate structure for the storage of the data (Birney & Clamp 2004). Generally, 
these databases are developed with additional applications to execute specific analyses 
and utilities for querying data. The combination of databases and software applications 
are the fundamentals of the biological repositories which are becoming more popular and 
more frequently accessed by researchers. 
 
The need to store biological datasets has encouraged bioinformaticians to create 
electronic repositories as a tool to assist researchers in the understanding of biological 
processes, gene structures and molecular interactions. However, in recent years, 
bioinformaticians have had to deal with large volumes of data, reaching in many cases 
dimensions of terabytes (TB = 240) and petabytes (PB =250). As the growth in storage is 
constantly increasing, systems must be designed in such a way that new and 
heterogeneous data can be easily incorporated (Shah et al. 2008). 
 
1.7.2 Architecture of databases 
 
Based on its architecture, databases are generally composed of three main layers: 
internal, external and conceptual levels. These layers will help the reader in the 
understanding of the design of the database and the techniques and methods to access 
the information. In a database, the external level describes the organisation of the data and 
controls the visualisation of specific sections in a set of interfaces called views. Usually 
this information is presented to end users. The conceptual level depicts the relationships 
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and directions (flow of information) among datasets. This layer defines constraints and 
rules which are applied to the datasets. The internal level is used to define how the 
information is physically stored and processed on the computer. In this level, a 
description of type of data, path, directories, etc., are defined by the database designer. 
 
1.7.3 Database modelling 
 
In database development, informaticians are assisted by automated software applications 
which provide useful support in the design and maintenance of the database. The 
software used to perform the maintenance is called the Database Management System 
(DBMS). Nowadays, DBMS applications can support a variety of databases models of 
which the most commonly used by programmers are relational and object-oriented 
models. Some examples of DBMSs available are Microsoft Access, Microsoft SQL 
Server (MSSQL), Oracle, MySQL and PostgreSQL, the last two under the General 
Public License (GPL) and MIT-style license respectively. 
 
Relational databases 
 
Relational databases (RDBs) are models which consist of a collection of entities (tables) and 
their corresponding relationships that are used to define the organisation and flow of 
information among different tables based on a relational model (RM) (Figure 1.8). The RM 
is generally preceded by the design of a conceptual representation called the Entity-
Relationship Diagram (ERD). ERDs are created to specify the relationship between 
different entities using an abstract model.  Each table in an ERD contains a set of 
attributes (columns) which describe the characteristics of the entity. Tables represent the 
core of the RM structure and generally contain many tuples (rows) which share the same 
attributes. Tuples, commonly known by programmers as records, can be distinguished by 
one or several attributes denominated keys. Therefore, keys have the capability to 
uniquely identify a record within a table.  
 
For example, in Figure 1.8, the table locus contains information of the loci available in 
the polymorphic region HLA (HLA-A, -B, -C, etc.). In the example, the attributes 
loc_region and loc_name are used to differentiate each record; therefore, these 
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constitute the key of the table. Chapter 2 will describe the list of tables, relationships and 
attributes that were generated to define the AFND. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Example of a relational model. 
 
Object oriented databases 
 
Object oriented databases (OODBs) are models which follow a different concept of those 
used in RDB designs. An OODB consists of a collection of objects which, in the majority 
of cases, describe an object of the real world (Figure 1.9). OODBs, which were 
introduced since the early 1980s, are very well known by the use of concepts based on 
software reusability. These databases were originally created to facilitate the interaction 
with Object-Oriented Programming (OOP). In OOP, objects sharing similar 
characteristics are classified in classes and can contain a set of attributes and methods. 
Attributes listed in each class are used to describe different features of the object. 
Methods are subroutines which contain a set of instructions for the object. For instance, 
in Figure 1.9, loc_name and loc_chrom_position are attributes of the class locus. 
This class can contain a set of methods to access the information or perform specific 
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operations. In the example, setLoc_name() is used to allocate the name of the locus 
and getLoc_name()to access the value. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Example of an object-oriented model. 
 
Since the inception of OODBs, a broad number of notations to define the relationships 
and flow of information among objects have been described in the literature. One of the 
notations most commonly used by software designers is the Unified Modelling 
Language (UML) which is widely used in industrial and scientific software development. 
 
1.7.4 Information retrieval 
 
The Structured Query Language (SQL) in biological databases 
 
Nearly all DBMS systems provide utilities for information retrieval, giving the facility to 
programmers to perform both simple and complex queries by using a standard notation 
called the Structured Query Language (SQL). SQL is a syntactic-semantic computational 
notation which was designed to facilitate the maintenance of the information within a 
public class locus { 
    private String loc_name; 
    private String loc_chrom_position; 
     
    public void setLoc_name(String loc_name) 
{ 
        this.loc_name = loc_name; 
    }  
    public String getLoc_name() { 
        return loc_name; 
    } 
 }     
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database. The fundamentals of SQL are based on relational algebra using Boolean logic 
(logical operations) to allow individuals to manipulate specific sections of information 
by the use of predefined reserved word or instructions (e.g. SELECT, UPDATE, 
INSERT, DELETE, etc.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: Example of Boolean algebra using AND, OR and NOT operators. 
 
Figure 1.10 illustrates three different set of records that are retrieved after querying the 
table alleles using Boolean logic (AND, OR and NOT operators): (a) selects those alleles 
which belong to the KIR polymorphic region in locus 2DL1 only, (b) shows all alleles 
from the HLA, KIR and MIC polymorphic regions, and (c) lists all alleles of the existing 
polymorphisms except HLA alleles. With the use of relational algebra, programmers can 
easily add, remove or alter records in a database and retrieve a set of records that match 
the given criteria. 
 
1.7.5 Web applications and technologies 
 
AND 
NOT OR 
A B 
A B A B 
SELECT * FROM alleles  
WHERE all_region not like 'HLA' 
SELECT * FROM alleles  
WHERE (all_region = 'HLA'  
or all_region = 'KIR' 
or all_region = 'MIC') 
SELECT * FROM alleles  
WHERE all_region = 'KIR'  
and all_locus = '2DL1' 
a) 
b) c) 
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In the last decade, bioinformaticians have been required to produce applications that 
can be accessed by a wider audience of researchers across diverse disciplines from 
different geographic locations. To do this, programmers have designed applications 
which can be accessed through the World Wide Web (WWW). Web applications can be 
accessed via a private (intranet) or public (internet) network with the use of a software 
interface installed on a client machine. Usually, this interface is provided by web browsers 
which have the capability of operating in a variety of different platforms, i.e. operating 
systems, system architecture, etc., without the need to install additional software for 
each application. 
 
In biological research, websites can contain a number of different components including 
databases, electronic documents (e.g. text files), web pages, etc., which are accessed by 
different protocols such as the Hypertext Transfer Protocol (HTTP), the Simple Object Access 
Protocol (SOAP) and the File Transfer Protocol (FTP). The access to a particular website is 
given by entering the Uniform Resource Locator (URL) in a web browser which can locate 
the specific server in the worldwide network. Web pages can be classified according to 
their content in two categories: „dynamic‟ and „static‟. Static websites are typically used to 
display information whose content is considered to be fixed over time. On the contrary, 
dynamic websites provide users with the capabilities of performing queries and interacting 
with datasets on the hosting machine. Dynamic pages are generally supported by one or 
several programming languages running on the server. 
 
1.7.6 Programming languages in bioinformatics 
 
Since the beginnings of software development in biological research, bioinformaticians 
have used a massive number of different programming languages to produce their 
applications. Normally, programmers select a particular language based on the needs of 
the application, i.e. specific platform (operating system), time response, scalability, 
capabilities of software and hardware, interoperability, etc. (Dudley & Butte 2009). For 
example, applications written in C++ are considered to be the fastest programs due to 
an optimal use of Random-Access Memory (RAM) (Fourment & Gillings 2008). 
However, other languages such as Python, Perl and Java are commonly used in 
bioinformatics applications. 
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As of May 2011, the list of different programming languages encompassed more than 
2,500 (Kinnersley 2011) covering a wide range of diverse methodologies (i.e. procedural, 
structured, object oriented, etc.). In web development some of the most common 
languages used are Perl, PHP, Java and Active Server Pages (ASP) which are generally 
compiled and executed on the hosting machine.  
 
Web programming languages interact with other technologies and/or scripting 
languages such as JavaScript to provide end users with complementary tools to improve 
performance and user interaction. JavaScript is included in all modern browsers (e.g. 
Internet Explorer 8 ©, Firefox 3 ©, Google Chrome 7 ©, Opera 10 ©, Safari 5 ©, etc.) 
and is found in the majority of the current biological databases.  
 
Since the introduction of dynamic websites, web developments have involved the 
combination of different technologies on both client and server sides. For instance, 
technologies such as the Asynchronous JavaScript and XML language (AJAX) have been 
used on the client-side to provide a dynamic interface between databases and the client 
machine without interfering in the display of the information of a given page. These 
technologies have also been used in conjunction with other electronic documents for 
standardisation, for example XML for data exchange and implementation of specific 
applications.  
 
1.7.7 Data exchange and formats 
 
One of the most important issues to consider in the development of biological 
repositories is the design of layers for data exchange which allow interoperability among 
different electronic resources. The majority of the databases are composed of diverse 
type of files for data transportation such as tab-separated values (TSV), comma-
separated values (CSV) text files, Microsoft Excel spreadsheets (XLS), and in recent 
years, the Extensible Markup Language (XML). XML has been adopted by programmers 
as a standard for data exchange (Achard, Vaysseix & Barillot 2001) following the 
specifications provided by the World Wide Web Consortium (W3C). The XML syntax 
consists of a representation of a set of nodes called elements which are defined in a 
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hierarchical structure (Figure 1.11). Each node can contain a series of attributes and 
other nested elements.  
 
Although the XML syntax can be considered as a verbose format, it is considered as the 
most optimal solution to validate the content of exchange documents. The validation is 
performed by the used of the Document Type Definition (DTD) and XML Schemas. In 
recent years, XML has been used in different software applications and technologies 
including SOAP, Really Simple Syndication (RSS) and web services.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Example of XML document. 
 
The use of XML formats has facilitated the standardisation of complex datasets. One 
example of the application of these documents has been in the field of Proteomics. The 
Human Proteomics Organisation (HUPO) has adopted this syntax as a technique to 
implement their standards which have been developed by the Proteomics Standard 
Initiative (HUPO-PSI) (Orchard, Hermjakob & Apweiler 2003).  
 
1.7.8 Curation of biological datasets 
 
The development of biological databases involves not only the compilation and display 
of the information but also the inclusion of mechanisms to ensure that the quality of the 
Elements 
Nested elements 
Attributes 
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information provided can be continuously maintained. This is probably one of the most 
crucial steps in the designs of the biological databases. Thus, the importance of data 
curation has led developers to generate applications that can be easily validated by 
database administrators and end users.  
 
Usually, data validation is performed by biocurators whose main roles are (i) to ensure 
that data is correctly extracted from different sources (e.g. peer-reviewed publications, 
external databases, etc.), (ii) validate the correct use of controlled vocabulary and (iii) 
provide facilities to interact with other researchers in the review process (Howe et al. 
2008).  
 
1.7.9 Immune gene databases and bioinformatics resources 
 
In recent years, a considerable number of databases and bioinformatics applications for 
the investigation of the functions of immune genes have been published in the literature 
and set up online (Galperin & Cochrane 2011). The repositories available provide 
capabilities for a wide range of analyses as mentioned in Section 1.7.1. In the case of 
immunogenetics, the different resources include the IMGT/HLA (Robinson et al. 2009) 
and IPD-KIR databases (Robinson et al. 2010) for the definition of official 
nomenclatures for immune genes (HLA, KIR and MIC) and alleles in humans, the IPD-
MHC database (Robinson et al. 2010) which encompasses the definition of sequences 
for non-humans species; NetMHCpan (Hoof et al. 2009; Nielsen et al. 2007), 
NetMHCIIpan (Nielsen et al. 2008) for peptide biding predictions of MHC Class I and 
Class II respectively; the SYFPEITHI database (Rammensee et al. 1999) for prediction 
of T-cell epitopes and MHC ligands; the dbMHC database (Helmberg, Dunivin & Feolo 
2004) and ALFRED (Rajeevan et al. 2003)  which encompass data of several 
polymorphisms in worldwide populations, among many others. Table 1.4 and Table 1.5 
present a list of different useful resources available which can be used as a reference for 
the investigation of several immune genes including methods and techniques for peptide 
binding predictions and population genetic analyses.  
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Table 1.4: Useful databases for the investigation of immune genes 
Database Description URL References 
ALFRED Public database for the storage of Allele 
Frequency in different populations and 
DNA polymorphisms. 
http://alfred.med.yale.edu/ (Cheung et al. 2000; 
Osier et al. 2001; 
Rajeevan et al. 2003) 
dbMHC                               Public database and online applications 
for the analysis of HLA and related genes 
including microsatellites.  
http://www.ncbi.nlm.nih.gov/projects/mhc/  (Helmberg & Feolo 
2007) 
IMGT Integrated repository specialised in 
immunoglobulins, T cell receptors, MHC 
and related proteins of the immune 
system in humans and other vertebrates. 
http://www.imgt.cines.fr/  (Lefranc 2004) 
IMGT/HLA Public database for the storage of 
sequences of the HLA system including 
the official nomenclature for genes and 
alleles. 
http://www.ebi.ac.uk/imgt/hla/ (Robinson et al. 2009; 
Robinson et al. 2003) 
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Table 1.4: Useful databases for the investigation of immune genes (Continued) 
Database Description URL References 
IPD-KIR Public repository for the storage of 
sequences of the KIR polymorphic region 
including the official nomenclature for 
genes and alleles. 
http://www.ebi.ac.uk/ipd/kir/ (Robinson et al. 2010; 
Robinson et al. 2005) 
SYFPEITHI Public database for MHC ligands, peptide 
motifs and T-cell epitope prediction. 
http://www.syfpeithi.de/ (Rammensee et al. 
1999; Schuler, Nastke 
& Stevanovikc 2007) 
The Immune Epitope 
Database (IEDB) 
Public repository for the representation of 
the molecular structures recognised by 
adaptive immune receptors. 
http://www.iedb.org/ (Beaver, Bourne & 
Ponomarenko 2007; 
Vita et al. 2010) 
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Table 1.5: Useful applications for immunogenetics and population genetics analyses                  
Application Description URL References 
Arlequin Software for the analysis of population 
genetics including the estimation of 
haplotype and allele frequencies, linkage 
disequilibrium, test of neutrality, among 
others. 
http://cmpg.unibe.ch/software/arlequi
n3/ 
(Excoffier, Laval & Schneider 
2005) 
ClustalW,  
ClustalX 
Software for multiple alignments of 
nucleotide and amino acid sequences. 
http://www.ebi.ac.uk/Tools/msa/clust
alw2/  
http://www.clustal.org/ 
(Chenna et al. 2003; Larkin et 
al. 2007; Thompson, Gibson 
& Higgins 2002) 
Gene[RATE] Online tools for the analysis of ambiguities 
in HLA datasets. 
http://geneva.unige.ch/generate/  (Nunes 2007) 
HLA Completion Online tool for resolving HLA ambiguities 
in low and intermediate resolution types. 
http://atom.research.microsoft.com/H
LACompletion/ 
(Listgarten et al. 2008) 
HLA Matchmaker Computational algorithm for the analysis of 
HLA molecule and amino acids mismatches. 
http://www.hlamatchmaker.net (Duquesnoy 2002; Duquesnoy 
& Askar 2007; Duquesnoy, 
Howe & Takemoto 2003; 
Duquesnoy & Marrari 2002; 
Duquesnoy et al. 2003) 
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Table 1.5: Useful applications for immunogenetics and population genetics analyses (Continued) 
Application Description URL References 
MEGA Molecular Evolutionary Genetics Analysis 
Software for sequence alignments, inferring 
phylogenetic trees and molecular evolution. 
http://www.megasoftware.net/ (Kumar et al. 2008; Tamura et 
al. 2007) 
NetMHCpan 
NetMHCIIpan 
Online software to analyse the function and 
interaction of HLA Class I and Class II 
molecules. 
http://www.cbs.dtu.dk/services/NetM
HCpan 
(Buus et al. 2003; Hoof et al. 
2009; Nielsen et al. 2007; 
Nielsen et al. 2008) 
PHYLIP Software package for inferring evolutionary 
trees. 
http://evolution.genetics.washington.ed
u/phylip.html 
(Retief 2000) 
PyPop Open-source software package for the 
analysis of populations at large scale and 
multiple loci. 
http://pypop.org/ (Lancaster et al. 2003; 
Lancaster et al. 2007) 
SKDM Software for HLA and disease association 
analysis examining strong associations, 
amino acids and linkage disequilibrium 
between patients and controls. 
http://sourceforge.net/projects/skdm/ (Kanterakis et al. 2008) 
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1.8 Aim of the thesis 
 
The objective of this research was to develop a web-based repository containing data on 
frequencies of several immune genes and their corresponding alleles along with a set of 
online bioinformatics tools to ascertain the occurrence of these variants in worldwide 
human populations.  
 
Giving the number of applications which could benefit by the use of frequency data of 
these immune genes and alleles, the research work was dived into three main cases of 
study: 
 
a) Compilation of immune gene frequency data and design of a database 
 
As mentioned in Section 1.1, the number of reports of allele, haplotype and 
genotype frequencies of different polymorphic regions in human populations has 
increased considerably in recent years. This information has been reported in 
different peer-reviewed journals in non-standardised formats leading to the difficulty 
to perform meta-analysis of these datasets. Thus, the first goal of the research was 
to provide a database to collect and curate publications and individual reports 
through an online submission system which could validate the different 
characteristic of the data, i.e. the official gene and allele names, demographic data of 
the population, etc., and the capability to incorporate other immune related genes. 
This work is summarised in Chapter 2 which comprises the description of 
population datasets and the schemas used in the construction of the database. 
 
b) Analysis of immune gene frequency data in worldwide populations 
 
The investigation of immune genes and their frequency distribution among 
worldwide human populations involves the analysis of data at different levels: allele, 
haplotype and genotype frequencies. Therefore, software applications must have the 
flexibility to summarise frequency data at different levels and provide searching 
mechanisms for the analysis of specific datasets, i.e. a specific population, 
geographic region, set of alleles, source of data (published or unpublished data), type 
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of populations (e.g. anthropological studies, individuals used as controls in disease 
association studies, etc.), level of resolution in allele typing (low and high-resolution), 
etc. Searching mechanisms implemented for the investigation of immune genes will 
be discussed in detail in Chapter 3. 
 
As frequencies vary among populations, one interest was focussed in describing the 
variability presented by the different genes in specific geographic locations. For 
HLA, KIR, MIC and cytokine gene polymorphisms a scenario was formulated in 
which specific alleles would be clearly representative of a particular geographic 
region. In the case of the KIR polymorphism, the interest was extended to the 
investigation of the organisation of KIR genotypes by analysing which populations 
may present specific genes according to the genes being inhibitory or activating. The 
set of analysis carried out and software tools implemented for these four different 
polymorphic regions are presented in Chapters 4, 6 and 7. 
 
c) Ascertaining of the rarity of HLA alleles  
 
Regardless of the high number of alleles that have been reported in latest releases in 
the IMGT/HLA database, many HLA alleles have only been found once, suggesting 
that these alleles may have been wrongly sequenced or the methods used in the past 
were not optimal to distinguish alleles at high-resolution (levels 2-4). With this in 
mind, a worldwide analysis comprising the confirmation of alleles across 
international groups and laboratories was expected to be useful in demonstrating 
how relevant these alleles are, whether they only occurred in one individual, one 
particular family, a specific geographic region or ethnic group. The analysis of rare 
alleles is described in detail in Chapter 5. 
 
1.9 Summary 
 
This chapter presented an insight into the extensive variability that is found in several 
genes involved in the immune response. The polymorphic regions covered in this 
chapter include HLA, KIR, MIC and several cytokine genes. As reviewed in this 
chapter, allele frequencies of these genes vary significantly among individuals of 
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different populations. In the case of HLA, the variability is colossal, with more than two 
thousand alleles reported in a single locus (HLA-B) and more than 6,000 alleles in total. 
Knowing the distribution of alleles would lead to improved understanding of the 
functions of the human immune system and human evolution. Therefore, the need to 
develop a database to store such amount of data is a primarily need for scientists 
interested in the analysis of these immune genes.  
 
Despite a very large amount of data has been in the public domain (mainly in the 
literature) over the last two decades, little effort has been carried out to create a generic 
database framework to store immune frequency data. Different methodologies, 
techniques and programming tools for the construction of online repositories have been 
described in this chapter. Due to the heterogeneity of data reported, a significant effort 
is required to extract information from different sources (data from journals, reports 
from IHWSs, etc.) for the design of a generic prototype. The following chapter presents 
the compilation of populations and the design of a database to contain immune gene 
frequencies in different worldwide human populations.  
 
 
  
 
 
Chapter 2  
Design of  the Allele Frequency Net 
Database: datasets, schemas and 
methods 
 
2.1 Introduction  
 
The previous chapter presented a general introduction on the impact of several immune 
genes in different clinical and research areas and explained the importance of databases 
as tools to disseminate the distribution of these genes and their corresponding alleles in 
worldwide populations.  
 
As reviewed in Chapter 1, the amount of data available in the public domain on 
frequencies of immune genes in recent years has been immense. The design of databases 
to contain immune frequencies requires the analysis of the data to identify special 
characteristics of the datasets.  
 
Chapter 2 describes the compilation of datasets containing data on frequencies of HLA, 
KIR, MIC and cytokine genes from an extensive review in the literature. Data collection 
includes the definition of demographic and frequency attributes of the populations. 
Additionally, this chapter describes the criteria used in the validation of data along with 
the controlled vocabulary used in the assignment of population attributes values.  
 
The second part of this chapter focuses on the construction of a generic database 
schema for the storage of the different immune gene frequencies. The design of the 
database includes the information workflow, metadata definition and data dictionaries 
used in the specification of population attributes and related entities.  
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2.2 Compilation of population datasets  
 
For clarity and uniformity, the term „population‟ used in this thesis refers to individuals 
who belong to the same geographical region, country, state, prefecture, city, town 
and/or ethnic background (See Section 2.2.3.1). 
 
2.2.1 Source of data 
 
The compilation of population samples was derived from two main sources: (i) from the 
literature (peer-reviewed publications and Proceedings from IHWSs) or (ii) from direct 
submissions to the AFND by users (i.e. submissions of unpublished results by 
individual laboratories). The aim of the literature review was to cover all previously 
published studies between January 1990 and December 2010 including publications 
from more than sixty five peer reviewed journals which can be consulted online via the 
http://www.allelefrequencies.net/datasets.asp link.  
  
The initial criteria used for selecting the populations were as follows: 
 
 Any peer-reviewed publication or direct submission to the AFND containing 
HLA, KIR, MIC or cytokine frequency data at allele, haplotype or genotype 
level at any level of resolution. 
 
 Any population with a sample size over 10 individuals considering that studies in 
some ethnic groups contained a low number of members. 
 
 
2.2.2 Submission protocol 
 
Submissions of population datasets were performed by curators of the AFND (Derek 
Middleton and Faviel Gonzalez) or by users wishing to submit their data. For each 
submission, individuals were (and currently are) asked to complete a set of attributes to 
describe the characteristics of the population sample. The process is divided into three 
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different steps: (i) the capture of demographic data, (ii) the submission of frequency data 
and (iii) the validation of data which is usually performed by curators of the AFND 
(Figure 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Dataflow diagram for submissions of populations in the AFND. 
 
i) Demographic data. For demographic data, authors were requested to input 
a set of minimal attributes such as the name of the population, polymorphic 
region, geographical region, country, ethnic origin, sample size, family 
background, year of sample, method(s) used for determination of 
frequencies, source of population, and the bibliographic reference if 
available. In this process, users were assisted with drop-down boxes to 
complete their data (Figure 2.2). When data for a given attribute was not 
available, values were set as „not known‟.  
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Figure 2.2: Example of demographic data capture in the AFND. 
 
After the submission of demographic data, a numeric identifier was assigned 
to each population to uniquely identify the record. Then, an e-mail 
confirmation was sent to the submitter to complete frequency data. 
 
ii) Frequency data. To complete frequency data, authors were requested to 
enter their frequencies via an online web form or by providing the pre-
formatted spreadsheet containing the full list of alleles according to releases 
from the IMGT/HLA (for HLA and MIC) and IPD-KIR databases (for 
KIR) (Figure 2.3). In the case of cytokine gene polymorphisms, entries were 
based on a suggested nomenclature which will be described in detail in 
Chapter 7. 
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Figure 2.3: Example of frequency data capture in the AFND 
 
iii) Data curation. Each submission followed a data validation procedure for 
consistency of data, which is described in Section 2.2.3. This process is 
performed by curators of the AFND.  If a particular problem in the content 
of datasets was detected, authors were contacted to verify the anomaly. 
Once the validation process was completed, datasets were set as publicly 
available in the AFND. 
 
2.2.3 Validation of population attributes and frequency data 
2.2.3.1 Validation of demographic data 
 
For each attribute in a population, a set of drop-down boxes were provided to complete 
the data (Figure 2.2). When populations were submitted with different values in a 
particular field (e.g. ethnic group, source of population, etc.) which were not included in 
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the corresponding drop-down box, the value given by the submitter was added to the 
current list to extend the list of values. This list is under continuous maintenance by 
curators of the AFND to standardise reporting and has been subject of revision by 
International groups working in the standardisation of population attributes (See 
discussion).  
 
a) Population attributes 
 
 Population identifier (ID). A number in consecutive order was given to each 
population to uniquely identify the dataset within the database. The ID number 
was used as a primary code to retrieve the corresponding information from a 
given population.  
 
E.g. 1202 Scotland Orkney 
 
Additionally, the AFND was designed to validate duplications in naming a 
population. For each new submission, demographic information of the 
population was also verified against the existing data which might have been 
entered under a similar name. 
 
 Population name. Each population was named according to the combination 
of the country name, geographical location and ethnic group when available, to 
describe the population appropriately.  
 
E.g. South Africa Natal Zulu  
 
In order to identify the polymorphic region studied in a given population an 
additional term was incorporated at the end of the name, except for HLA 
populations which were the first populations entered in the database. 
 
E.g.  South Africa Xhosa KIR   
 Italy Milan Cytokine 
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If another set of individuals from a given population, which was geographically 
and ethnically similar to an existing population in the database, was typed by a 
second laboratory, a consecutive number was assigned to that population to 
differentiate the two samples.  
 
E.g.  China Guangzhou Han,  
China Guangzhou Han pop 2 
 
In some populations, individuals were typed in a different country from their 
original ethnic background (i.e., immigrants from a different country). In these 
cases, the name of the original ethnic background was included in the name of 
the population, and the country was defined as the current location in which 
individuals were typed.  
 
E.g.  Canada Iranian KIR 
(Iranian descendant people living in Canada) 
Singapore Thai  
(Thai descendant people living in Singapore) 
 
If individuals were typed within a region or country and were part of a Bone 
Marrow Donor Registry, Cord Blood Bank or any other centre, the name of the 
source of data was included in the population name. 
 
E.g.  Taiwan Tzu Chi Cord Blood Bank 
 
Therefore, to determine the order and composition of a population name the 
following semantic notation was used: 
 
Population Name = Country + (Region | Sub-region) + (Locality) 
+ (Ethnic group) + (Centre) + (Polymorphic Region) + (pop N) 
 
Where  
 
Region = (East | West | North | South | any other region) 
Sub-region = (State | Province | County | District) 
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Locality = (City | Town | Village) 
Centre = (Bone Marrow Registry | any other centre) 
Polymorphic Region = (KIR | Cytokine | MIC) 
N = (2, 3, 4 …) 
 
 Geographical region. In order to classify all population datasets according to their 
geographical location, a total of ten geographical regions were used (Figure 2.4).  
 
 Country. The name of the country was assigned to each population according to 
the location in which the individuals were sampled.  
 
 Sub-region (optional). Different sub-regions or specific geographical locations 
were used to define a particular area within a country. E.g. State, province, county or 
district. 
 
 Ethnic group. All populations were assigned to one of 19 major ethnic groups or 
additional categories (Mixed and Other) to identify the ethnic background (Table 
2.1). The classification was based on the most frequent ethnicities reported in the 
literature. This classification was mainly used to differentiate different ethnic groups 
within a given country. For populations with a specific ethnic group such as South 
African Zulu (Williams et al. 2001), the major ethnic group was set as „Black‟  and 
the specific ethnic group (Zulu) was included in the name of the population. It is 
important to highlight that Caucasian, Hispanic, and other ambiguous terms are 
being reviewed by the HLA-NET and IDAWG international groups (See discussion 
in this chapter).  
 
 Urban or Rural. A field was included to define whether individuals were typed in 
an urban area or rural community or if they belonged to both sets. 
 
 Familial status. An additional field was used to indicate whether individuals typed 
belonged to a) descendants from parents living at the same location, b) grandparents 
living at the same location, or c) if it was unknown. 
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 Source. All populations in the AFND were also classified according to the source 
of the population, e.g. anthropology study, blood donors, Bone Marrow Registry, 
controls for a disease association study, solid organ unrelated donors or another 
type of study. 
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Figure 2.4: Classification of geographical regions in the AFND. 
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Table 2.1: Ethnic groups available in the AFND 
Ethnic group Description 
Amerindian Indigenous people from North, Central, South America and the 
Caribbean Islands. 
 
Arab Individuals from the Middle East or descendants of an Arabic 
speaking country. 
 
Asian Individuals from Central and Southern Asia (e.g. India, Pakistan, 
Sri Lanka, Uzbekistan and Kazakhstan). 
 
Australian Aborigines Individuals from indigenous communities in Australia. 
 
Black Individuals descending from Sub-Saharan Africa. 
 
Caucasoid Individuals descending from Western or Eastern Europe. 
 
Hispanic Individuals from Spanish or Latino American descents living in 
the United States. 
 
Mestizo Mixture of European and American indigenous people. 
 
Oriental Individuals from East and Southeast Asia. 
 
Siberian Individuals from the Siberian Region in Russia. 
 
Melanesian Individuals from Fiji, New Caledonia, Papua New Guinea and 
Solomon Islands. 
 
Polynesian Individuals from American Samoa, Cook Islands, New Zealand, 
Niue, Samoa, Tonga and Hawaii. 
 
Austronesian Individuals from Borneo, Canada, Indonesia, Malaysia, 
Philippines, Singapore and Timor-Lester. 
 
Micronesian Individuals from Kiribati and Nauru. 
 
Berber Indigenous individuals in North Africa from Tunisia. 
 
Jew Individuals of Jewish descent mainly from Israel. 
 
Kurd Individuals of Kurdish descending. 
 
Mulatto Individuals of black and white ancestry. 
 
Persian Individuals of Persian descending mainly from Iran. 
 
Mixed Populations which mixture was not able to be classified in another 
category. 
 
Other Individuals of other minor ethnicities or social group which could 
not be classified in other major group, e.g. Gypsies. 
 
 
 Geographical coordinates. In addition, for a graphical representation of 
populations, latitude and longitude coordinates were assigned to all populations 
when information was provided. 
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b) Sample attributes 
 
 Sample size. Sample size was used to identify the number of individuals which 
were considered in the study of the population. When the number of individuals 
typed for each locus was different, a note was included to specify sample sizes 
for each locus. 
 
 Sample year. Year in which the individuals of a population were typed. 
 
 Typing method. Method used for the typing. (E.g. SSP, SSOP, SSCP, SBT, 
RSCA, RFLP, Other – See Section 1.4.2 for description of typing methods).  
 
c) Bibliographic reference 
 
 Reference. The following data were used to cite the source from which the 
information was extracted.  
 
 Name of all authors, corresponding author, contact e-mail, journal name, 
year of publication, volume, issue and number of pages. 
 
2.2.3.2 Validations of frequency data 
 
All populations were validated for allele, haplotype and genotype frequency data 
depending on the availability of the information. To capture the information for each 
type of frequency, an online submission form or a preformatted spreadsheet were used 
(See Figure 2.3).  
 
a) Estimation of allele, haplotype and genotype frequencies and terminology 
 
The AFND contains a compilation of frequency data that was previously estimated by 
different methods by the corresponding authors. The bibliographic reference for each 
population was provided in order that a user may verify what type of analysis the author 
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used for calculating frequencies. A list of the different methods that were used to 
calculate the frequencies is shown in Table 2.2. 
 
Table 2.2: List of methods used in the estimation of frequencies 
 
Type of submission  
Type of 
frequency 
Extracted from 
literature 
Direct submission 
Description 
By the author By AFND 
AF Direct counting, 
Resampling 
§
  
Direct counting, 
Resampling 
Direct 
counting 
Proportion of allele copies in 
the gene in four-decimal 
format,  
e.g. 0.0010 
 
HF ML-EM ML-EM N/A Percentage of individuals 
carrying the haplotype, e.g. 
3.4% 
 
GF Direct counting Direct counting Direct 
counting 
Percentage of individuals 
carrying the genotype e.g. 
2.6% 
AF=Allele Frequency; HF=Haplotype Frequency; GF=Genotype Frequency; 
§
 See (Dempster, Laird & Rubin 1977; 
Good 2005; Nunes 2007) for a review of resampling methods; ML-EM=Maximum Likelihood by Expectation-
Maximization (Dempster, Laird & Rubin 1977; Excoffier & Slatkin 1995); N/A=Not available. 
 
b) Validation of frequency data 
 
 Allele frequencies. For each locus in a population sample, values were added 
and for any summation greater or less than 1.0000 authors were contacted to 
verify the difference. For frequencies that totalled greater than 1.0000 which 
could not be explained, the submission was rejected. Frequencies which added 
to less than 1.0000 were kept in the database. This occurred when a population 
which was published contained only the frequencies of the main alleles, the 
frequencies of the remaining alleles being added together to one frequency. 
Additionally, in each population the lowest expected frequency (observation of a 
single allele) was calculated and compared to possible multiples. For instance, in 
a population of 200 individuals, the minimum expected frequency was 0.0025 
(1/2n). Therefore, all frequencies had to be multiples of 0.0025 considering 
truncation and rounding. 
 
 Haplotypes frequencies. For haplotype data, only frequencies greater or equal 
to 1.0% were stored in the database, except for populations with a large number 
of individuals (n>=1000) in which no threshold was applied. 
Chapter 2      Design of the AFND: datasets, schemas and methods 
 
53 
 
 
 Genotype frequencies. For genotype data, frequencies were added and for any 
summation greater or less than 100% the author was contacted. Frequencies in 
which the sum was less than 100% the information were also kept in the 
database. 
 
 Validation of allele names. All populations on the AFND were validated to 
ensure that their corresponding frequencies were submitted under the official 
allele name for the HLA, KIR and MIC polymorphisms described on the 
IMGT/HLA and IPD-KIR databases (Robinson et al. 2003; Robinson et al. 
2005). If necessary, the author of the data was contacted with any query or any 
change made. In the case of HLA and MIC, all frequency data submitted before 
April 2010 were updated according to the new nomenclature (Marsh et al. 2010). 
To do this, a script in the AFND was implemented to convert pre-2010 allele 
designations. 
 
 Levels of resolution of alleles. In order to generate all possible alleles at 
different level of resolution (1-4 levels for HLA, MIC and KIR polymorphisms) 
a set of libraries were generated by splitting all possible subdivisions from a 
given allele.  
E.g. A*01:01:01:01 = (A*01, A*01:01, A*01:01:01) 
 
 Ambiguities in typing. When data, published or sent directly to the AFND, in 
which the author was not able to differentiate some alleles (i.e. ambiguous 
alleles), a note in the publication details was used to describe how the frequency 
data was entered for one of the ambiguous alleles. For example, „unable to 
differentiate alleles that are identical over exons 2 and 3 (Class I)‟, in which 
frequencies were given under first allele.   
 
2.2.4 Summary of population datasets 
 
The collection of datasets available on the AFND as of May 2011 consisted of 1209 
population samples covering 4,262,379 healthy unrelated individuals. Population 
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datasets comprised 844 populations for HLA, 194 for KIR, 113 for cytokine genes and 
58 for MIC (Table 2.3). The compilation of frequency datasets included more than 
100,000 records at allele, haplotype and genotype level in total. Some of the populations 
were only typed for one of the three levels. For instance, 829 out of the 844 population 
samples for HLA contained allele frequency data and 342 populations had haplotypes. 
As shown in Table 2.3, genotype frequencies were only available for 108 populations 
tested for KIR.  
 
Table 2.3: Population frequency datasets by polymorphic region on the AFND 
Region Pops Indiv 
Allele Haplotype Genotype 
Pops Indiv Freq Pops Indiv Freq Pops Indiv Freq 
HLA 844 4,213,280 829 613,553 86,843 342 3,778,303 8,916 - - - 
KIR 194 23,204 194 23,204 4,922 - - - 108 12,291 2,600 
Cyt 113 18,246 113 18,246 3,603 - - - - - - 
MIC 58 7,649 58 7649 723 20 2,426 257 - - - 
Total 1,209 4,262,379 1,194 662,652 96,091 362 3,780,729 9,173 108 12,291 2,600 
 
The vast majority of population samples (~97.7%) varied between 10 and 5,000 
individuals with only 27 populations that exceeded 5,000 subjects (Table 2.4). Nearly 
half of the datasets contained populations with 100 or more subjects.  
 
Table 2.4: Populations by sample size and polymorphic region 
 
Cytokine HLA KIR MIC 
Sample Size Pops Indiv Pops Indiv Pops Indiv Pops Indiv 
10-50 19 725 185 6,693 47 1,988 13 452 
51-100  31 2,540 263 20,506 78 5,985 14 1,168 
101-500  58 9569 298 55,504 64 10,923 30 5,526 
501-1000  3 1,835 30 20,454 4 2,843 1 503 
1001-5000  2 3577 41 79,700 1 1,465 - - 
> 5000  - - 27 4,030,423 - - - - 
Totals  113 18,246 844 4,213,280 194 23,204 58 7,649 
 
All populations were summarised by geographical region and ethnic group to illustrate 
the coverage of submissions. As shown in Table 2.5, there was a varied number of 
submissions in each polymorphic region. For instance, in HLA, KIR and MIC, most of 
the populations corresponded to individuals from Asia, Western Europe and South & 
Central America whereas for cytokines Western Europe and North America contained 
the highest number of submissions. Table 2.6 shows the number total of populations 
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classified by major ethnic groups in which the majority of submissions (51.7%) 
corresponded to individuals with Caucasian or Oriental background. 
 
Table 2.5: Population samples by geographical region 
Geographical 
Region 
Cytokine HLA KIR MIC 
Pops Indiv Pops Indiv Pops Indiv Pops Indiv 
Asia 18 2,580 272 136,209 43 4,081 20 2,489 
Australia - - 8 2,822 2 117 - - 
Eastern Europe 18 1,969 56 14,429 11 2,155 3 200 
Middle East 9 781 35 33,486 14 1,580 2 36 
North Africa 1 157 21 1,902 1 67 1 82 
North America 26 4,630 82 3,684,249 26 4,619 5 645 
Pacific - - 59 3,896 13 617 - - 
South and Central 
America 8 878 108 13,470 27 2,801 8 1,004 
Sub-Saharan Africa 3 319 55 5,878 21 2,500 3 152 
Western Europe 30 6,932 148 316,939 36 4,667 16 3,041 
Total 113 18,246 844 4,213,280 194 23,204 58 7,649 
 
Table 2.6: Population samples by ethnic group 
Ethnic 
Group 
Cytokine HLA KIR MIC 
Pops Indiv Pops Indiv Pops Indiv Pops Indiv 
Amerindian 3 231 84 6,138 15 931 7 804 
Arab 3 355 29 3,691 7 745 3 118 
Asian 3 733 54 7,096 15 1,312 1 38 
Australian Aboriginal - - 5 587 1 67 - - 
Austronesian 1 26 20 2,811 3 143 - - 
Berber - - 2 136 - - - - 
Black 10 1,486 79 426,496 26 3,333 6 452 
Caucasoid 59 11,545 237 2,782,067 67 10,845 21 3,586 
Hispanic 5 726 7 455,386 4 475 - - 
Jew 1 48 12 24,572 2 74 - - 
Kurd - - 3 205 - - - - 
Melanesian - - 29 1,892 6 280 - - 
Mestizo 3 255 21 2,324 5 696 - - 
Micronesian - - 2 129 - - - - 
Mixed 3 359 24 365,822 7 801 1 200 
Mulatto 1 100 3 270 1 42 - - 
Oriental 15 1,847 179 124,000 28 2,899 19 2,451 
Other - - 7 412 - - - - 
Persian 6 535 8 6,918 2 316 - - 
Polynesian - - 17 1,054 4 194 - - 
Siberian  -  - 22 1,274 1 51  -  - 
Total 113 18,246 844 4,213,280 194 23,204 58 7,649 
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2.3 Design of the AFND schema 
 
To date various methods for the design of databases have been described in the 
literature. Some of the most commonly used techniques in database modelling were 
reviewed in Section 1.7.3. Each methodology has its advantages and drawbacks; for 
example, OODBs are suitable for the reusability of modules but have been found to be 
difficult to implement by the different public and commercial DBMS. To my knowledge 
only a limited number of DBMSs have been implemented following this methodology 
(e.g. MyOODB, Objectivity/DB, among few others.). In this research, the Relational 
Model was used in the design of the AFND schema since it is the most widely used 
approach for the implementation of scientific and commercial databases.  
 
2.3.1 Database schemas 
 
In order to specify relationships among tables, validate data integrity and constraints on 
database components, the conceptual, logical and physical model schemas were 
designed. The current schema of the AFND consists of 72 tables (listed in Table B.1 in 
Appendix B) of which 32 correspond to the core of the database (Figure 2.5). Several 
dynamic/virtual tables (views) were included in the schema to optimise time processing 
in the retrieval of information (Table B.1).   
 
As shown in Figure 2.5, the database schema was divided into five main sections: (i) 
information on population demographic data (countries, ethnic groups, geographical 
regions, etc.), (ii) information on frequency data (allele, haplotype and genotype 
frequencies), (iii) information on DNA sequences of alleles compiled from external 
databases (IMGT/HLA and IPD-KIR), (iv) a section to analyse the rarity of alleles, and 
(v) a module to administrate the access to the information to users and/or curators of 
the AFND.  
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Figure 2.5: Conceptual schema of the AFND. 
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The conceptual, logical and physical model schemas were generated using the 
PowerDesigner Software Version 15.2.0 based on the Barker‟s notation13 to simplify 
readability. The schema was normalised to the fourth normal form (4NF) to minimise 
data redundancy. The logical and physical model schemas and the SQL schema for the 
generation of the database can be consulted in Appendix A (Figures A.1-A.10). 
 
2.3.2 Metadata: data dictionaries and controlled vocabulary 
 
In order to define the meaning and type of formats used in the different attributes 
included in the Logical and Physical Model schemas, a data dictionary was created 
containing the description of attributes and examples of accepted values (See Table B.2 
in Appendix B).  
 
The complete controlled vocabulary used in the definition of the values for ethnic 
groups, geographical regions, and other population attributes can be consulted on the 
website through the http://www.allelefrequencies.net/datasets.asp link. 
 
2.4 Discussion 
 
The compilation of datasets included in the AFND encompasses the largest collection 
of immune gene frequency data in the world. As mentioned in Section 1.1, the design of 
databases involves a number of challenges such as the standardisation of formats, the 
use of an appropriate controlled vocabulary and the interaction with other external 
databases for data validation and data exchange.  
 
Due to the wide scope of data published on immune gene frequencies spanning the last 
two decades, the first objective in the design of the AFND was to provide a description 
of the population attributes to generate a controlled vocabulary based on the 
terminology found in the literature. In this process, several problems were found such 
as the standardisation of geographical regions and ethnic groups. During the 
                                                 
13 Barker‟s notation available in the PowerDesigner Software was developed by Richard Barker and 
collaborators as a method to represent Entity-Relationships Diagrams. 
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compilation of datasets it was decided to select the term which described the 
populations more appropriately. With the aim of formulating a standard terminology in 
reporting immune gene frequencies and population attributes, several groups from 
international organisations such as the Immunogenomics Data Analysis Working Group 
(IDAWG) (Mack et al. 2009) and the European network of the HLA diversity for 
histocompatibility, clinical transplantation, epidemiology and population genetics (HLA-
NET) (Sanchez-Mazas et al. 2010) are actively participating in the definition of the 
controlled vocabulary. It is expected that in the near future the definition of terms used 
in these immune gene databases can be finalised. One of the advantages of the model 
described in this chapter is the flexibility in the modification of the physical schema 
which would allow the incorporation of new changes. 
 
The second objective was focussed on the validation of the data submitted and the 
interaction with external databases such as the IMGT/HLA, IPD-KIR. As shown in 
Section 2.2.3.2, the list of valid alleles is automatically updated after a new release is 
available, assisting in the uniformity of data submitted by users.  
 
Methodology used in the design of the AFND schema 
 
The selection of a particular model in the design of databases has been a topic of 
controversy. Databases are generally constructed considering several factors such as the 
availability of data, the origins of the information, hardware requirements, etc. 
(Bornberg-Bauer & Paton 2002). Although it was believed that OODBs would replace 
RDBs, at present 90% of the biological datasets are still based on relational models 
(Hellerstein, Stonebraker & Hamilton 2007; Rob & Coronel 2008). Two of the main 
reasons in the delay of these implementations are the complexity of migrating existing 
relational models and the difficulty of performing new implementations in existing 
OODBs. Thus, the RDB schema was used as the model for the implementation of the 
AFND. 
 
The first target in the design of the AFND schema was to generate a model which could 
encompass all four polymorphic regions presented in this research (HLA, KIR, MIC 
and several cytokine gene polymorphisms). After a preliminary analysis of the content of 
the different polymorphisms, it was concluded that the construction of general tables 
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for the storage of allele and haplotype frequency data was feasible (Figures A.2 and A.6). 
However, for genotype data, there was a need to generate a customised format to define 
the specific characteristics of the polymorphism of interest. This was the case of KIR 
genotypes. For cytokine frequencies it was opted for designing a separate table as the 
format in which cytokine polymorphisms were represented in the literature differed 
significantly from HLA, KIR and MIC. 
 
The AFND as a generic framework for the collection of immune gene 
frequencies 
 
The design of a generic model in the database schema permits the addition of other 
polymorphisms of interest with a minimum effort in the implementation. The use of 
preconfigured scripts and modules can speed up the incorporation of new 
polymorphisms such as minor Histocompatibility antigens (mHags), platelets, blood 
groups, etc. As such, an ongoing development includes a new section in the AFND to 
compile frequency data of minor Histocompatibility antigens (mHags) which are of 
relevance in haematopoietic stem cell transplantation (Simpson et al. 2002). 
Furthermore, other non-human species can be added into this schema as some of the 
genes share a similar structure, e.g. Bovine Human Leukocytes (BoLA), Dog Leukocyte 
Antigens (DLA), Feline Leukocyte Antigens (FLA), among others. This schema has 
assisted the implementation of a BoLA database prototype developed at the University 
of Liverpool which was used as supporting material for an ongoing grant application via 
the Biotechnology and Biological Sciences Research Council (BBSRC).  
 
Accuracy of data 
 
Unfortunately, on many occasions, data available in the literature are not always 
accurate. In many cases, Editors of journals were contacted to discuss these issues. 
Although the AFND cannot guarantee the accuracy of the tissue typing of the 
individuals, more than 90% of the data on the website has been peer-reviewed and 
published. Thus, the AFND relies on the accuracy of data being verified by the 
reviewers of the journals and acts mainly as a source for compiling data. Future 
developments in the AFND will include the collection the raw data in order that the 
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website can assist researchers in assessment of data quality. The module for the 
incorporation of raw data will be discussed in detail in Sections 8.2.4 and 8.3.1. 
 
2.5 Conclusions 
 
This chapter described the datasets, schemas and methods used for the construction of 
the AFND which encompasses the largest collection of immune gene frequency data in 
different worldwide populations. The information presented in this chapter included a 
full description of demographic and frequency attributes available for each population 
sample. Additionally, a set of minimal criteria to assess frequency and demographic data 
were also described in this section. The second part of the chapter comprised the 
definition of the schemas used in the implementation of the database and the metadata, 
data dictionary and controlled vocabulary employed in the standardisation of population 
attribute values.  
 
The large number of datasets available in the AFND provides an extraordinary resource 
for the research community to compare allele, haplotype and genotype frequencies from 
populations of different geographical regions, countries or ethnic groups. To provide a 
rapid and user-friendly method for the consultation of data, the following chapter 
describes a set of computational approaches used for the examination of these immune 
genes. 
 
 
 
  
 
 
Chapter 3  
Development of  the AFND website and 
online tools 
 
3.1 Introduction 
 
The previous chapter described the different methods employed in the development of 
the AFND including a complete description of the population datasets and the 
definition of the schemas utilised in the design of the back-end. 
 
Based on the needs of researchers to examine the information available in AFND in an 
interactive manner, this chapter describes a bioinformatics web-based repository which 
was developed to assist researchers in the investigation of HLA, KIR, MIC and 
cytokines gene polymorphisms in worldwide populations. Furthermore, a section to 
evaluate the performance of the software implemented and examples of website users is 
included at the end of the chapter. 
 
3.1.1 Previous work in immune gene frequency websites 
 
The collection of frequency datasets of immune genes, principally HLA, was 
implemented several years ago when a component for anthropology analysis was 
presented at the 11th IHWS [See review (Thorsby 2009)]. This component led to the 
implementation of the dbMHC database (Helmberg et al. 2004)  which was used to 
store tissue typing data of several populations from different ethnic groups across the 
world.  
 
In related work, researchers at Yale University created a database called ALFRED 
(Cheung et al. 2000) to store allele frequencies of different polymorphisms for 
anthropological analysis including the HLA region and many others. 
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To our knowledge, only these two publicly accessible databases for the storage of 
frequencies of immune genes have existed in the field of immunogenetics. The two 
databases have been described and referenced in Chapter 1 (See Section 1.7.9). 
Although both databases seem to target the same audience as the AFND, the aims of 
these two websites differ significantly from those described in this thesis. The AFND is 
a specialised database for the collection and analysis primarily of immune gene datasets 
whereas ALFRED focuses on the collection of frequencies across all polymorphisms in 
the human genome without considering any specific location in particular. To give an 
example, as of May 2011, ALFRED contained more than 600,000 polymorphisms in 
710 populations in which only 70 populations comprised information on HLA allele 
frequencies. In contrast, AFND includes more than eight hundred populations for the 
HLA region. In the case of the dbMHC database, the polymorphisms covered are 
principally focussed on genes of the HLA region and correspond to only 90 populations 
compiled for anthropological analysis. Conversely, datasets in the AFND comprise data 
for HLA, KIR, MIC and cytokine genes from diverse sources including data from 
registries, blood donors and individuals selected as controls in disease studies. 
 
AFND 
 
The AFND website was initially introduced in 2002 when a first prototype was designed 
to collect information of several immune genes (Middleton et al. 2003). In its origins, 
the website was particularly designed to store frequencies for HLA Class I and Class II 
classical genes (HLA-A, -B, -C, -DRB1, -DPA1, -DPB1, -DQA1 and -DQB1). In its 
inception, the database consisted of only 59 HLA populations having a significant 
increase over the last 8 years (Figure 3.1).  
 
In the early stages, the website was limited to the retrieval of information from a narrow 
number of dynamic web pages. One of the major concerns in the first release was the 
data validation process due to the null interaction with external databases. Moreover, the 
back-end of the database consisted of a Microsoft Access Database (.mdb) file with a 
small number of unrelated tables which did not fulfil the compliances of database 
integrity. In September 2007, the structure of the AFND was completely redesigned and 
new searching mechanisms and the new structure were set up online in October 2008, 
which are the subject of this thesis. The development of the new database version 
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included the addition of frequency data from non-classical HLA genes (HLA-DMA, -
DMB, -E and -G), KIR genes, MHC Class I related genes A and B (MICA, MICB) and 
a number of cytokine gene polymorphisms. 
 
Figure 3.1: Number of populations reported on the AFND by year. 
 
3.2 Systems and methods 
3.2.1 Website organisation and dataflow 
 
The main objective in the design of the AFND was to provide individuals with a 
software infrastructure to store immune gene frequency datasets, incorporate new 
submissions, validate existing data by the use of a controlled vocabulary and external 
libraries, and provide online tools for the consultation and analysis of data. Figure 3.2 
shows the typical workflow performed in the submission of a new population. Each 
submission (normally provided in spreadsheets, tab-separated text files or XML 
formats) is sent to the AFND or entered online. Then, the website performs a 
validation process including the confirmation of the official nomenclatures from the 
IMGT/HLA and IPD-KIR databases. After that, data is classified according to the type 
of frequency (alleles, haplotype and genotypes). Finally, end users are provided with 
several views based on the different cases of study described in Section 1.8. 
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Figure 3.2: Workflow and system architecture of the AFND. 
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Based on the available polymorphisms, the AFND website was divided into four main 
sections containing information on HLA, KIR, MIC and cytokine gene polymorphisms. 
Each section consisted of one or more searches depending on the availability of data in 
each polymorphic region, e.g. allele, haplotype or genotype frequency, and a breakdown 
section to summarise the existing data (Figure 3.3). In the first release of the website, a 
registration process was mandatory for all users. The registration consisted of 
submission of basic information about the user. The aim of the registration was to 
identify the interest of the person using the website to consider possible improvements. 
To meet the requirements of public databases, user registration was excluded in August 
2010 and was only required for submissions of new populations.  
 
 
Figure 3.3: Screenshot of the AFND website. 
 
Internally, the AFND website consists of two main layouts: user searches and a 
component for data maintenance (Figure 3.4). The first layer encompasses the different 
searching tools that can be accessed by any individual and the second a password 
restricted section for administrators/curators of the database.  
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Figure 3.4: Organisation of the Allele Frequency Net Database website.
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Nomenclature of programs 
 
All searching interfaces available in the AFND website were classified using a code of 8 
alphanumeric characters to uniquely identify the application and corresponding features 
(Figure 3.5).  The use of these program codes provided an efficient approach to invoke 
different interrelated programs, i.e., allele and haplotype frequency searches for the HLA 
system. 
 
      
 
  
     
                
    h l a 6 0 0 1 a 
 
_ x l s 
 
  
    1 2 3 4 5 6 7 8   9 10 11 12     
 
 
 
Figure 3.5: Program nomenclature in the AFND website. 
 
The first three characters describe the type of module, which normally defines the 
polymorphic region (hla, kir, cyt and mic) or an alternative module, i.e. population 
samples (pop) and management of the catalogues (man). The next four digits (4-7) were 
used to identify the type of application. For instance, programs from 0001-1999 were 
assigned to catalogues, 2000-4999 for data processing, 5000-5999 for electronic data 
exchange, 6000-8999 for searches/reports and 9000-9999 for additional tools. The 
eighth character was used to identify the release version. Additionally, a suffix was used 
to define the type of format available for data reporting (xls, csv, txt, xml).  
 
3.2.2 Software implementation 
 
Web pages were implemented using the ASP scripting environment with the assistance 
of the JavaScript for data entry validation. Additionally, the AJAX technology was used 
in some of the searching mechanisms to allow simpler user interaction and improved 
visualisations. To facilitate the maintenance and retrieval of information, the back-end 
of the AFND is based on a relational database model utilizing MySQL 5.1 
(http://www.mysql.com/) as the DBMS. For the curation of the datasets a set of stored 
procedures were executed in a mirror database using in the Microsoft SQL Server 2008 
Module Format available 
(optional) 
Program type Version 
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R2 Express Edition (http://www.microsoft.com/sqlserver) for rapid analysis of 
datasets. The analysis of information and summaries described in this thesis were 
performed by direct queries to the AFND using preconfigured stored procedures which 
were archived in the hosting server for future use. These stored procedures can be 
requested by demand via the website. 
 
3.2.3 Data visualisation 
 
To ensure the correct display of maps in web browsers, the graphical user interface was 
created using pure HTML and Cascading Style Sheets (CSS) to guarantee a standard 
visualisation in all browsers. All web pages in the AFND website were tested on 
Internet Explorer 7®, Firefox 3.5®, Safari 4®, Opera 9® and Google Chrome 3® web 
browsers. Additionally, the HTML code was validated using the Markup Validation 
Service (http://validator.w3.org/) to optimise the quality of the web pages based on the 
guidelines provided by the World Wide Web Consortium (W3C). 
 
3.2.4 Systems and hardware requirements 
 
i) Server requirements. The AFND website was hosted on a remote server. 
The following minimal configuration is required for optimal processing. 
 
 Hardware 
o Processing power. Intel Core Quad CPU @ 2.83GHz. 
o Memory. 8GB RAM.  
o Secondary storage. 1GB for database files. 
o Network access. T1 or optical fibre. 
 
 Software 
o Web server. Internet Information Service 7 to support Classic ASP. 
o Operating system. Windows 2003/2008 Server (32-bits|64-bits). 
o Other utilities. MailSender API for e-mail automatic notifications 
and ASPUpload for uploading files. 
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ii) Client machine requirements.  
To guarantee the rapid access to the website from any modern computer, 
the website was tested on different platforms. However, the following 
configuration is recommended for optimal navigation performance.  
 
 Hardware 
o Processing power. 1 GHz (32-bit|64-bit) processor. 
o Memory. 500MB RAM (1GB recommended). 
o Secondary storage. 100MB for data buffering. 
o Network access. The website was tested in different networks 
including Digital signal 1 (DS1) @ 1.4Mbs, Digital Subscriber Line 
(DSL) @ 256Kbs, Cable @ 512Kbs , Dialup @ 56Kbs, one Optical 
Carrier level 3 (OC3) @ 100Mbs, and Integrated Services Digital 
Network (ISDN) @ 128Kbs. A minimum connection of 512Kbs is 
recommended. 
 Software 
o Operating system. The website was tested in the following 
operating systems: Mac OS X v10.5, Windows XP Service Pack 2, 
Windows Vista, Windows 7 and Linux Fedora core 14. 
o Web browser. Internet Explorer 7+, Safari 4+, Firefox 3+, Opera 
9+ and Chrome 3+. 
o Other features. Javascript should be enabled in web browsers for 
web pages with AJAX based implementations. 
 
3.3 Navigation in population samples 
 
As of May 2011, the AFND consisted of more than one thousand populations which 
were described in Section 2.2.4. To allow individuals to consult the populations available 
in an interactive manner, a graphical interface was included in the website based on the 
use of the Google maps API to display the population‟s geographical location (Figure 
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3.6). This tool was intended to serve as an index module to provide rapid access to the 
demographic details of the population sample. Figure 3.6 illustrates the wide coverage of 
HLA (blue), KIR (red), MIC (yellow) and cytokine genes (green) across the world. 
 
 
Figure 3.6: Geographical location of population samples in the AFND. 
 
3.4 Frequency Search Interfaces 
 
The core of the implementations in the AFND website involved principally the 
examination of frequency datasets by providing a set of tools to search and explore the 
different types of frequencies at allele, haplotype, genotype and amino acid level.  
 
3.4.1 The Allele Frequency Search (AFS) 
 
Since its inception, the most commonly used tool within AFND website has been the 
Allele Frequency Search (AFS). This search was designed to allow users to examine the 
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frequency of a particular allele in the existing population sample datasets, by filtering 
results using a set of criteria. The AFS was implemented for all polymorphisms available 
on the website (HLA, KIR, MIC and cytokine genes).  
In this search, users normally start with the selection of a locus and a specific allele to 
identify which populations are more likely to present this allele. Figure 3.7 shows an 
example of the search by determining the A*68:01 allele in all populations available in 
the AFND. The example illustrated in Figure 3.7 includes two additional parameters 
(shown in green) to specify the source of datasets (i.e., populations extracted from the 
literature) and a minimum typing resolution level (≥ 2). By setting these two parameters 
users would guarantee that resulting frequencies followed a peer-review process 
performed by journals and would exclude alleles with lower resolution (e.g. A*68).  
 
 
Figure 3.7: Example of the Allele Frequency Search (AFS). 
 
To extend the searching parameters, users can select one, several or all populations, a set 
or range of alleles, or a particular country, geographical region and/or ethnicity. In 
HLA, MIC and KIR polymorphisms, alleles can be typed at different levels of 
resolution (i.e. allele group, specific HLA protein, synonymous allele with a nucleotide 
substitution within the coding region and alleles with differences in a non-coding 
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location in that order e.g. HLA-A*68:01:01:01). The official nomenclature available on 
the IMGT/HLA and IPD-KIR databases describes alleles only at the highest resolution. 
Therefore, to ensure that high-resolution data could be retrieved when a low level 
resolution allele was selected, the searching tool implements parsing methods to display 
information that may be relevant to the user. For instance, in the search of the HLA-
A*68:01 allele, the results will include alleles at high-resolution that start with HLA-
A*68:01 (e.g. A*68:01:01:01, A*68:01:01:02 and A*68:01:02 to A*68:01:10).  
 
Additionally, users are able to optimise their queries to further refine datasets by 
selecting populations with a sample size from a range of values or the year in which the 
population was sampled. Populations from recent years are more likely to contain alleles 
with a high-resolution level and possibly, more accurate data. Furthermore, recent 
additions included filters to search information on a specific source of dataset (e.g. 
literature, unpublished data) and type of study (e.g. populations available in the literature 
oriented to anthropology studies, or individuals which were part of a Bone Marrow 
Registry, blood donors, solid organ unrelated donors or which were controls for a 
certain disease study).  
 
Display of results 
 
Results displayed in the AFS include the allele name, name of the population, allele 
frequency and/or the percentage of individuals which carry the allele, sample size of the 
population and additional notes included in the original submission. By clicking on the 
„Population Name‟ hyperlink, users can access demographic details of the population in 
which the allele is present. The list of output records can be sorted by allele or 
population and the corresponding frequency from highest to lowest value. An additional 
column is included in the results to consult the original sequence of the allele in the 
IMGT/HLA or IPD-KIR databases depending on the selected search.  
 
Frequency distribution maps 
 
One of the most used tools in the examination of the distribution of allele frequencies is 
the map overlay display. This interface, which does not require a complex mechanism to 
depict allele frequencies, can clearly illustrate the frequency distribution of a particular 
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allele across the world (Figure 3.8A and B). The example shown in this figure illustrates 
the overall frequency distribution of the HLA-A*68:01 allele. If one examined the 
distribution at protein level (Figure 3.8A), the frequency distribution may look uniform, 
however, when the search includes a higher resolution, certain alleles may be more 
specific of certain regions. For example, HLA-A*68:01:02 has been found to be higher 
in several Amerindian populations (Figure 3.8B). The differences in frequencies in these 
two figures correspond to the availability of data for each different level of resolution. 
A)   A*68:01 
 
B)   A*68:01:02 
 
Figure 3.8: Overall frequency distribution of the A*68:01 allele. 
In this figure, A) Frequency distribution of the A*68:01 allele and B) Frequency distribution of the A*68:01:02 allele. 
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Grid display 
 
Another facility included in the AFS is the display of frequencies in a grid format. This 
option allows a set of alleles to be specified; e.g. alleles from an individual‟s tissue type. 
This option is mainly used by clinical scientists to compare the frequencies of a given 
tissue typing and rapidly identify those populations with the highest occurrences of the 
alleles. Figure 3.9 shows an example of the frequencies of two alleles HLA-A*68:01 and 
HLA-B*40:02 which belong to the same individual. To optimise the visualisation of the 
results, a maximum of 100 populations and twenty specific alleles are allowed in the grid 
display. The grid is only an approximation to use the frequencies of the allele in the 
populations when raw data is not available.  
 
 
Figure 3.9: Example of the grid view on the AFS. 
3.4.2 The Haplotype Frequency Search (HFS) 
 
The AFND website also includes a tool for querying haplotype frequencies called the 
Haplotype Frequency Search (HFS) (Figure 3.10). As of May 2011, the data available for this 
search consisted of 8,916 HLA haplotypes and 257 MICA-HLA-B association records 
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from more than 3 million individuals, which are discussed in detail in Chapters 4 and 7. 
The origin of the haplotypes corresponded to 342 globally distributed populations from 
81 countries.  
 
The HFS allows users to customise a frequency search by inputting a given allele for one 
or several loci and search for associated haplotypes. Results can be filtered by a 
particular population, country, source of data, geographical region, ethnicity of the 
individual, and number of loci tested for the haplotype.  
 
 
Figure 3.10: Example of the Haplotype Frequency Search (HFS). 
 
Figure 3.10 shows an example of the alleles associated to the HLA-A*68:01 allele 
containing at least one HLA-B allele. As shown in this search, the highest frequency was 
found in the ‘Mexico Oaxaca Mixtec’ population with a frequency of 6% in the 
A*68:01-B*35:01-DRB1*04:07 haplotype (Hollenbach et al. 2001). The haplotypic 
information can be more useful than information only on the allele, especially in clinical 
applications, i.e. in transplantation in which the higher number of matches will result in 
best chances of survival. Therefore, this search can be used as a complement of 
haplotype searches performed in Bone Marrow and Solid Organ Transplant Registries in 
which, on some occasions, the information about the ethnicity of the individual is not 
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known. The HFS is available for the eight routinely typed HLA loci (HLA-A, -B, -C, -
DRB1, -DPA1, -DPB1, -DQA1 and -DQB1) and for MICA and HLA-B associations. 
 
3.4.3 The Genotype Frequency Search (GFS) 
 
One of the latest developments included in the AFND website was the compilation of 
an inventory of KIR genotype profiles (presence or absence of genes in and individual) 
published in the literature. This novel KIR genotype database comprises the most 
extensive archive of KIR genotypes and their corresponding frequencies in worldwide 
populations. As of May 2011, genotype data encompassed 2600 records of which 396 
distinct KIR genotype profiles were identified. The content of the KIR genotype 
database will be reviewed in detail in Chapter 6.  
 
In the Genotype Frequency Search (GFS), users can search for a particular genotype and 
examine its corresponding frequency from a list of 108 populations available with KIR 
genotype data. As mentioned in Chapter 1, the KIR gene cluster consists of fifteen 
genes and two pseudogenes; however, the availability of KIR genotype data from 
publications was limited to 16 genes due to KIR2DL5A and KIR2DL5B genes were 
reported as KIR2DL5. Therefore, the KIR genotype composition in the GFS consisted 
of sixteen genes which defined the presence or absence of the gene.   
 
Genotype reference list 
 
The GFS provides different approaches to find the occurrence of a specific KIR profile. 
A list of all genotypes and the number of populations and individuals in which the 
profile has been found is shown in the main screen (Figure 3.11).  
 
The information displayed includes the haplotype group of the genotype (AA, Bx where 
x can be A or B), the genotype ID which is automatically assigned by the AFND as a 
consecutive number, the genes that constitutes the genotype, the number of populations 
and individuals in which the genotype was found, and the name of the population if the 
genotype was reported only once. 
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Figure 3.11: Example of the Genotype Frequency Search (GFS). 
In this figure, KIR genotypes are illustrated as the presence (grey) and absence (white) of the gene.  
 
Searching a genotype 
 
Users are provided with a range of options including the selection of one or many 
populations and one or many genes that constitute the genotype. Similarly to the AFS 
and HFS, users can select additional criteria to filter results by geographical region, 
ethnic origin, type of study and the source of datasets. 
 
Figure 3.12A shows an example of the most common „A‟ genotype (Genotype 1). This 
genotype has been reported to be present in all of the 108 population samples and in a 
total of 3,686 individuals at different frequencies. For instance, the ‘Borneo 
Kalimantan KIR’ population (Velickovic et al. 2009) presented a high frequency 
(41.7%), contrasting with ‘Australia South Aborigine KIR’ and ‘Brazil 
Amazon KIR’ populations with 1.5% and 2.5% respectively (Ewerton et al. 2007; 
Toneva et al. 2001). If users click on the genotype ID, a graphical summary of the 
frequency distribution across the world is presented as shown in Figure 3.12B. 
Additionally, the total number of genotypes of a given population can be accessed by 
clicking on the name of the population. The search presents a similar organisation of 
results by including the haplotype group, genotype ID, KIR genes in the genotype and 
the corresponding frequency (Figure 3.12C). Finally, if the genotype is not found from 
the initial search, users are provided with a list of the closest genotypes differing by one 
Chapter 3      Development of the AFND website and online tools 
 
79 
 
gene (Figure 3.12D). This option allows individuals to identify possible mistakes in the 
determination of KIR genes or typographical errors in reporting genotypes.  
 
 
 
 
 
 
Figure 3.12: KIR genotype searching options in the AFND. 
A) A search is performed to query a specific KIR genotype. B) Frequency distribution of the KIR genotype „1‟ in 
worldwide populations.  
 
 
A) 
B) 
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Figure 3.12: KIR genotype searching options in the AFND (Continued). 
C) Total genotypes in the „Borneo Kalimantan KIR‟ population (Velickovic et al. 2009). D) Search performing a 
query of a genotype which has not been reported to the AFND. Two closest genotypes differing by one gene are 
shown in the example. 
 
 
 
C) 
D) 
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3.5 Amino acid frequency comparisons in populations 
 
One of the approaches commonly used by researchers in disease association studies is 
to compare frequencies of HLA alleles between patient and control groups. The 
development of the AFND website included a bioinformatics tool called the Amino Acid 
Frequency Analysis Tool (AAFAT). This tool allows users to investigate potential 
molecular mechanisms in disease associations by analysing the main differences in 
frequencies for a specific position of the allele at amino acid level. Figure 3.13 shows an 
example of the differences in amino acids at a given position, based on the original 
sequence submitted to the IMGT/HLA database.  
 
A summary of frequencies for each differing amino acid is presented, allowing users to 
compare occurrences that may be implicated in the association. One additional feature is 
that users can also enter their own data in a tab-separated text file or use one of the 
existing populations available in the AFND. All populations available for this analysis 
need types at protein level or above (e.g. A*68:01) for the analysis to be performed. 
 
 
Figure 3.13: Example of the Amino Acid Frequency Analysis Tool (AAFAT). 
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3.6 Accessibility of data 
 
An important feature included in the AFND website was the ability to interact with 
external websites by the use of bidirectional links. For instance, in the AFS, a complete 
list of all population samples carrying the A*68:01 allele can be accessed using the code 
hla_selection=A*68:01 at the end of the application‟s URL.  
 
E.g. http://www.allelefrequencies.net/hla6006a.asp?hla_selection=A*68:01 
 
The complete list of reference links is available on the „External access‟ section of the 
website (http://www.allelefrequencies.net/extaccess.asp).  
 
In addition, the site provides the option to export data to different format files including 
XML, tab-separated and comma-separated text files for the „HLA Rare Allele‟ section 
(described in Chapter 5), allowing users to integrate the information available in AFND 
with alternative bioinformatic packages. At present, users can print results from all 
searches using the printer-friendly version available for each search which can be used 
to export datasets in tabular format. To complement frequency data in searches for 
further analyses, the printer-friendly option includes information of latitude and 
longitude if users wish to plot frequencies on maps.  
 
3.7 Database users and software metrics 
 
The use of software metrics, especially in research, is an essential requirement. Thus, 
quality assurance tests were performed by optimising the number of line codes and 
program size for each module available in the website. To complement the software 
metrics, the AFND website included the Google Analytics API (available at 
http://www.google.com/analytics/) to examine the different users who have accessed 
the website along with the system configuration used for querying data. From 4 August 
2010 to 4 August 2011, a total of 37,077 visits were recorded comprising 15,784 unique 
visitors from 2,758 cities in 136 countries (Figure 3.14).  
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Figure 3.14: Number of visits to the AFND by country. 
 
To identify user preferences, a page count was implemented in all searches. Table 3.1 
summarises the top 10 searching tools accessed in the AFND website. The majority of 
visits corresponded to users interested in consulting the AFS and HFS in the HLA 
region. Interestingly, the Rare Allele Search, which will be discussed in detail in Chapter 
5, was the third most popular search in the AFND despite its recent implementation.  
 
Table 3.1: Top 10 searches accessed by users 
Searching tool Page views % 
HLA Allele Frequency Search 95,177 40.0 
HLA Haplotype Frequency Search 35,876 15.1 
Publication Details Report 16,222 6.8 
Rare Allele Search 12,698 5.3 
KIR Genotype Search 7,633 3.2 
KIR Allele Frequency Search 4,892 2.1 
Population by Geographical Region Search 3,070 1.3 
HLA Frequency Distribution Map 2,911 1.2 
HLA Allele Frequency Grid Search 2,111 0.9 
Geographical Regions Search 1,984 0.8 
Other searches 55,185 23.2 
 
The analysis of software metrics was extended to examine the different network 
connections (Table 3.2), platforms (Table 3.3) and browser capabilities (Table 3.4) to 
provide users with an optimal performance for the retrieval and visualisation of data. As 
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expected, the operating systems and web browsers in which the website was tested 
comprised 99.3% and 99.6% of the visits respectively, ensuring the correct retrieval and 
visualisation of data. 
 
Table 3.2: Number of visits by connection speed 
Connection Speed Visits % 
Pages/ Average time 
Visit 
on site in 
seconds 
Unknown 24,154 65.1 6.4 7.4 
T1@ 1.4Mbs 7,528 20.3 6.8 7.5 
DSL @ 256Kbs 2,892 7.8 6.6 8.0 
Cable @ 512Kbs 1,915 5.2 5.9 5.6 
Dialup @ 56Kbs 510 1.4 6.6 7.1 
OC3 @ 100Mbs 75 0.2 5.0 6.3 
ISDN @ 128Mbs 3 0.0 1.7 1.1 
 
Table 3.3: Number of visits by operating system 
Operating System Visits % 
Windows 31,845 85.9 
Macintosh 4,465 12.0 
Linux 521 1.4 
iPhone 78 0.2 
iPad 57 0.2 
Android 23 0.1 
iPod 13 0.0 
Others 18 0.0 
Not identified 57 0.2 
 
Table 3.4: Number of visits by web browser 
Browser Visits % 
Internet Explorer 20,686 55.8 
Firefox 9,551 25.8 
Safari 3,379 9.1 
Chrome 2,986 8.1 
Opera 306 0.8 
SeaMonkey 48 0.1 
Others 121 0.3 
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3.8 Discussion 
 
The implementation of searching mechanisms in the AFND website has provided the 
medical and scientific community with a practical approach to investigate the 
occurrence of genes and their corresponding alleles among populations. The multiple 
filter schemes performed in each of the frequency searches allows users to optimise 
their searches and obtain the closest matching results. For instance, by setting 
customised criteria, individuals can look into only specific datasets which followed a 
previous peer reviewed process and/or only alleles typed at high-resolution. 
 
Comparison of AFND and other immune gene frequency databases 
 
To my knowledge, two databases also contain frequency data of alleles of the HLA 
system: the dbMHC database (Single et al. 2007b)  and ALFRED (Cheung et al. 2000). 
However, the aims of these two databases differ considerably from the objectives of 
AFND. The dbMHC database, which contains more than 90 populations, was mainly 
designed for the storage of data from anthropological analysis components presented at 
the 13th and 14th IHWS (Single et al. 2007b). Thus, the aim of the database was to serve 
as an electronic warehouse to display results analysed in these components without the 
option to add more data. In contrast, ALFRED contains a large amount of datasets 
(~700 populations from >3,500 samples). However, the aim of ALFRED was to cover 
any type of polymorphism (>650,000 as of August 2011). Consequently, only few 
populations containing data on immune gene frequencies are stored in ALFRED. For 
instance, HLA-A frequency data is limited to only 51 populations compared to >800 
population samples listed in the AFND. Additionally, AFND includes data from a wide 
number of sources such as anthropological studies, healthy individuals selected as 
controls in disease association studies, and large datasets from registries (e.g. bone 
marrow registries, cord blood banks, etc.). Lastly, none of the two databases are active 
in trying to obtain new data or possess specific tools for the analysis of the frequencies 
in different regions as those presented in this research, making the AFND as a unique 
resource for the analysis not only of HLA but also KIR, MIC and cytokine gene 
polymorphisms.  
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The AFND website aiding the research 
 
The display of frequencies using distribution maps was shown to be a useful mechanism 
for illustrating differences in the frequencies of HLA, KIR or MIC alleles. With the use 
of this tool, researchers have included in their publications specific regions in which the 
allele has been found to be more frequent. For example, Chen and colleagues included 
two figures which were generated with this interface to exemplify the distribution of 
HLA-DPB1*05:01 and HLA-DRB1*03:01 which were associated to Graves‟ disease 
(Chen et al. 2011). The current overlaid maps could be optimised by setting gradients 
layers to display possible pathways of human migration, however, data with a strictly 
defined sample area would be needed.  
 
In the haplotype frequency display, perhaps one of the limits is the narrow number of 
haplotypes submitted to the AFND. Haplotype data is not often disclosed in 
publications. On some occasions, only two loci haplotypes were reported, whilst in 
others, only the most frequent haplotypes were included in the report. It is known that 
long haplotypes (six to eight routinely typed alleles) would be more useful in defining 
the possible origin of the haplotype in populations. Conversely, two loci haplotypes 
could be useful in the examination of strongest relationships between two loci. Due to 
the limited amount of data for haplotypes, at present, the graphical display of the 
haplotypes is not as globally representative as for the AFS, especially in the selection of 
haplotypes with more than three loci.  
 
Future implementations in the AFND website 
 
Future developments in the website include the incorporation of HLA haplotypes using 
raw data (genotypes of individuals). This is expected to be a useful tool for a wide range 
of areas including population genetics and pharmacogenetics analyses. For instance, 
having genotype data would assist scientists in the examination of the strongest 
relationships between two loci and generate all possible haplotype combinations based 
on the number of loci typed. In addition, the amino acid frequency tool will be 
expanded to include eplets (polymorphic residues for epitopes) and triplets as examined 
by Duquesnoy and colleagues in which the analysis of specific group of amino acids at 
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certain positions may be more significant than presenting frequencies for each single 
position (Duquesnoy & Askar 2007).  
 
3.9 Conclusions 
 
This chapter described several searching mechanisms and bioinformatics tools used for 
the examination of immune genes in worldwide populations. Being accessed more than 
100 times per day on average, the AFND website has been shown to be an important 
resource for a diverse number of fields and disciplines including histocompatibility, 
immunogenetics, pharmacogenetics, population genetics, among many others. The 
development of novel mechanisms for querying and the incorporation of new 
polymorphisms have enriched the functionality of the AFND. At present, there are no 
similar online mechanisms publicly available for consultation of allele, haplotype and 
genotype frequency of immune genes converting the AFND website as the central 
source for the investigation of frequencies of these genes at different level. 
 
The implementation of the AFS, HFS, GFS, AFAAT and the visualisation of frequency 
distribution in overlaid maps has assisted researchers in the analysis of immune genes. 
The capabilities of these tools will be exemplified in the analyses carried out in each of 
the polymorphic regions which will be discussed in the following four chapters. 
 
 
 
  
 
 
Chapter 4  
HLA allele and haplotype frequency 
data 
 
4.1 Introduction  
 
The previous two chapters described the design and implementation of the AFND as an 
electronic resource for the collection of frequency data of several immune genes. To 
examine the genes and the corresponding alleles in human populations, a set of online 
software tools were presented in Chapter 3, including several examples of queries 
performed in different polymorphic regions.  
 
This chapter focuses on the analysis of the frequencies of HLA alleles. As mentioned in 
Section 1.4, the HLA region contains more than twenty genes located on chromosome 
6 at position 6p21.3 and encompasses the most polymorphic region in the human 
genome. The diversity is mainly presented in several loci commonly known as classical 
loci (HLA-A, -B, -C, -DRB1, -DQA1, -DQB1, -DPBA1 and -DPB1) and less observed 
in non-classical loci. As of January 2011, 6,072 alleles had been described in release 3.3.0 
available in the IMGT/HLA database (Robinson et al. 2003) of which 5,827 
corresponded to alleles from classical loci and 245 alleles from non-classical loci.  
 
For many years, researchers have investigated the genetic factors in this genomic region. 
Due to the observation that HLA alleles were shown to present different frequencies in 
various populations, several studies have been carried out in anthropological 
components of the IHWSs to investigate the polymorphism in HLA genes [See reviews 
in (Terasaki 2007; Thorsby 2009)]. To examine the global distribution of HLA alleles, 
different human populations across the world were analysed and data was deposited in 
the dbMHC database (Single et al. 2007b). However, more information on HLA 
frequencies has become available in the public domain (mainly in the literature), 
comprising not only data from anthropological studies but also from healthy individuals 
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used as controls in disease association studies or from individuals from large registries 
(e.g. Bone Marrow Donor Registries, Cord blood banks, etc.). Therefore, the design of a 
database and software tools to analyse such extensive amount of data was a primary 
need for the scientific community.  
 
This chapter provides an insight into the frequencies of HLA alleles in worldwide 
populations. The information presented in this chapter includes the compilation of 
more than 800 populations in more than four million individuals comprising the most 
extensive electronic resource of HLA frequency data.  To allow individuals to analyse 
frequency data, a set of software tools were implemented in the AFND and are 
described in this chapter. The implementation of searching mechanisms was aimed to 
assist individuals in the investigation of the distribution of HLA alleles. 
 
4.2 Materials and methods 
4.2.1 Population datasets 
 
A total of 844 population samples containing data on HLA frequencies from 4,213,280 
healthy and unrelated individuals were submitted to the AFND and included in the 
analysis. The compilation of data comprised three main sources: 639 population samples 
reported in the literature (forty-nine peer-reviewed Journals from January 1990 to 
December 2010), 76 population samples from Proceedings of IHWSs and 129 
unpublished datasets which were submitted directly to the AFND. The criteria applied 
for the selection of populations are described in Section 2.2.3.  
 
From the 844 population datasets, only 327 covering 178,576 individuals contained both 
allele and haplotype frequencies, 502 populations including 434,977 individuals 
contained allele frequencies only and 15 populations comprising 3,599,727 individuals 
contained haplotype frequencies only. The contrasting difference between the number 
of individuals containing allele and haplotype frequencies corresponded to 3,583,336 
volunteers listed in the National Marrow Donor Program Registry in the US in which 
only haplotype frequencies were disclosed (Kollman et al. 2007). 
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In order to compare the distribution and availability of frequency data, samples were 
classified in ten geographical regions: Asia (ASIA), Australia (AUST), Eastern Europe 
(EEUR), Middle East (MIDE), North Africa (NAFR), North America (NAME), Pacific 
(PACI), Sub-Saharan Africa (SAFR), South and Central America (SCAM) and Western 
Europe (WEUR).  
 
4.2.2 Frequency data and terminology  
 
Frequency datasets used for the analysis of HLA genes were available in two formats:  
allele and haplotype frequencies.  
 
Allele frequencies  
 
Frequency information for each HLA allele was given in two types: (i) allele frequency 
usually at four-decimal format and (ii) as the percentage of individuals carrying the allele 
with two decimals of precision. Although the schema in the AFND was designed to 
store up to eight decimals of precision, only few large datasets (>10000 individuals) 
needed more than four decimals. The compilation of allele frequencies consisted of 
16,718 records containing alleles at low resolution (level 1) and 69,725 records for high 
resolution (levels 2-4) (For levels of resolution see Section 1.4.2).  
 
Table 4.1: Population samples with allele frequency data by geographical region 
Geographical region Populations Individuals Populations by country 
Asia 272 136,209 China (69), India (43), Taiwan (37), 
Russia (35), Japan (26), Others (62) 
Australia 7 2,645 Australia (7) 
Eastern Europe 56 14,429 Croatia (7), Greece (7), Turkey (7), 
Others (35) 
Middle East 34 33,188 Israel (13), Iran (9), Others (12) 
North Africa 21 1,902 Tunisia (7), Morocco (6), Others (8) 
North America 77 99,014 US (52), Mexico (23), Canada (2) 
Pacific 59 3,896 Papua New Guinea (27), Indonesia (8), 
Others (24) 
South and Central America 108 13,470 Colombia (29), Brazil (25), Argentina 
(16), Venezuela (13), Others (25) 
Sub-Saharan Africa 55 5,878 Cameroon (8), Guinea-Bissau (5), 
Others (42) 
Western Europe 140 302,922 Portugal (30), Spain (27), Italy (18), 
England (15), France (12), Others (38) 
Total 829 613,553  
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Nearly half of the allele frequency datasets submitted to the AFND corresponded to 
population samples from Asia and Western Europe as shown in Table 4.1. Based on the 
number of individuals typed, the highest percentage (49.3%) belonged to individuals 
from Western Europe. 
 
 
Validation of HLA alleles and ambiguities 
 
All alleles were validated against release 3.3.0 available in the IMGT/HLA database 
using the online submission form shown in Section 2.2.2. For entries in which authors 
were unable to distinguish alleles, i.e. alleles with identical sequences over exons 2 and 3 
for Class I and exon 2 for Class II, frequencies were inputted under the first allele and 
the corresponding notes were included in the demographic details of the population.  
 
 
Haplotype frequencies 
 
To analyse the combinations of HLA alleles, a total of 8,916 haplotype frequencies 
(proportion of haplotype copies in the population) were compiled in the AFND. HLA 
haplotypes consisted of 2 to 8 classical loci (HLA-A, -B, -C, -DRB1, -DPA1, -DPB1, -
DQA1 and -DQB1). To cover populations with large numbers of individuals typed, 
frequencies were collected in percentages with two decimals of precision for optimal 
representation of low frequencies.  
 
Table 4.2 summarises all 342 HLA populations with haplotype data divided by 
geographical region. The majority of the submissions (38.8%) belonged to population 
samples reported in the Asian continent. In terms of individuals typed, the vast majority 
comprised data from individuals in North America in which more three million 
individuals belonged to NMDP registered donors as mentioned previously in this 
section.  
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Table 4.2: Populations with haplotype frequency data by geographical region 
Geographical Region Populations Individuals Populations by country 
Asia 133 72,050 Taiwan (28), China (27), Russia (26), 
India (15), Others (37) 
Australia 1 177 Australia (1) 
Eastern Europe 19 3,172 Belarus (3), Greece (3), Others (13) 
Middle East 19 2,155 Israel (10), Iran (6), Others (3) 
North Africa 11 1,027 Tunisia (1), Morocco (3) 
North America 32 3,596,559 US (16), Mexico (15), Canada (1) 
Pacific 14 682 Papua New Guinea (5), Others (9) 
South and Central America 25 6,138 Brazil (9), Others (16) 
Sub-Saharan Africa 23 2,778 Uganda (3), Kenya (2), Others (18) 
Western Europe 65 93,565 Portugal (28), Spain (14), Italy (10), 
Others (13) 
Total 342 3,778,303  
 
4.2.3 Data analysis and visualisation 
 
Data analysis described in this chapter was performed by direct queries to the AFND 
using preconfigured SQL stored procedures which were archived in the hosting server 
for future use.  
 
To illustrate the geographical location of HLA allele and haplotypes across the world, 
overlaid maps were automatically generated using the frequency distribution map tool 
described in Section 3.4.1. The automated maps were based on geographical coordinates 
for each of the populations with HLA data. For those populations in which 
geographical coordinates were not described by authors, the coordinates were assigned 
to the closest location (city, town, region) using the Google maps API 
(http://code.google.com/apis/maps/index.html). 
 
4.3 Results 
4.3.1 Summary of HLA frequency data in the AFND  
4.3.1.1 HLA allele frequencies 
 
The majority of population samples submitted to the AFND with allele frequency data 
were typed at a different number of loci (1-8 loci). To show the availability of data, 
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samples were organised by classical (Table 4.3) and non-classical loci (Table 4.4). Table 
4.3 shows the total of submissions containing classical loci classified by geographical 
region and level of resolution. As shown in this table, all classical loci bar HLA-DPA1 
contained allele frequencies in at least one population in each geographical region, 
indicating the wide coverage of populations across all regions. HLA-A, -B and -DRB1 
were the loci with more submissions containing more than half million individuals typed 
in each locus. In terms of frequencies, the vast majority of the inputs (~80%) were 
samples of individuals typed at high-resolution. A similar analysis was performed in 
non-classical HLA loci as shown in Table 4.4. Contrary to classical HLA loci, very few 
populations were available for each geographical region. The HLA-G locus, which is 
believed to play an important role in pregnancy (Hviid 2006), was the locus with the 
most submissions in the AFND.  
 
Table 4.3: Availability of frequency data of classical HLA loci by geographical region 
     
Frequency data records 
by level of resolution 
Locus 
Geographical 
Region 
Countries Pops Individuals 1 2 3 4 
A ASIA 15 138 117,866 1,384 4,375 278 34 
  AUST 1 6 1,435 51 78 6 0 
  EEUR 12 23 10,567 291 688 46 7 
  MIDE 6 14 31,308 168 220 19 4 
  NAFR 4 12 1,068 138 1,031 197 6 
  NAME 2 41 88,627 237 2,330 109 18 
  PACI 6 14 1,259 22 265 24 10 
  SAFR 14 32 3,049 89 894 55 4 
  SCAM 13 47 9,901 654 438 27 8 
  WEUR 16 81 278,294 1,234 737 40 3 
B ASIA 15 147 119,007 2,509 6,584 418 18 
  AUST 1 6 1,435 75 164 0 0 
 
EEUR 12 24 10,669 476 1,285 98 8 
  MIDE 6 14 31,308 264 450 25 1 
  NAFR 4 12 1,068 196 1,771 275 5 
  NAME 2 43 90,378 450 4,564 99 15 
  PACI 6 14 1,259 36 495 45 6 
  SAFR 16 31 3,290 161 1,291 52 1 
  SCAM 12 46 9,718 1,052 961 17 3 
  WEUR 16 81 277,103 2,039 1,240 26 1 
C ASIA 13 97 12,851 663 2,038 309 12 
  AUST 1 5 544 28 71 2 0 
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Table 4.3: Availability of frequency data of classical HLA loci by geographical region 
(Continued) 
     
Frequency data records 
by level of resolution 
Locus 
Geographical 
Region 
Countries Pops Individuals 1 2 3 4 
 C EEUR 10 13 8,748 109 133 9 0 
  MIDE 5 7 923 4 201 28 0 
  NAFR 4 8 686 63 598 133 4 
  NAME 2 25 14,120 32 1,253 56 4 
  PACI 5 11 786 14 181 13 0 
  SAFR 12 21 2,502 46 413 13 0 
  SCAM 9 21 2,100 196 75 10 0 
 
WEUR 14 43 39,497 365 610 15 0 
DRB1 ASIA 14 199 126,444 874 3,964 884 0 
  AUST 1 5 2,436 38 45 2 0 
  EEUR 16 41 12,674 269 1,278 112 0 
  MIDE 6 28 32,504 69 668 35 0 
  NAFR 4 18 1,632 63 719 81 0 
  NAME 3 55 94,427 177 3,949 136 0 
  PACI 14 49 3,199 30 913 130 0 
  SAFR 15 22 2,500 84 668 86 0 
  SCAM 15 77 11,725 497 3,785 127 0 
  WEUR 18 103 293,102 890 2,596 93 0 
DPA1 ASIA 6 15 1,835 10 39 41 0 
  EEUR 1 1 100 0 3 4 0 
  NAME 2 3 152 0 5 4 0 
  PACI 6 9 436 0 37 27 0 
  SAFR 7 8 969 0 30 35 0 
  SCAM 4 9 741 8 14 7 0 
  WEUR 5 6 908 2 24 9 0 
DPB1 ASIA 10 69 8,084 1 1,299 125 0 
  AUST 1 2 144 7 15 0 0 
  EEUR 5 9 957 0 213 13 0 
  MIDE 2 5 305 0 75 7 0 
  NAFR 2 3 397 0 64 0 0 
  NAME 2 15 1,638 0 182 2 0 
  PACI 9 22 1,174 0 431 28 0 
  SAFR 10 12 1,549 1 465 25 0 
  SCAM 6 39 2,192 4 341 4 0 
  WEUR 14 35 9,792 10 1,017 15 0 
DQA1 ASIA 8 68 9,284 28 622 29 0 
  AUST 1 2 144 8 12 2 0 
  EEUR 8 23 2,715 13 168 9 0 
  MIDE 3 16 1,574 16 98 4 0 
  NAFR 3 5 498 5 54 0 0 
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Table 4.3: Availability of frequency data of classical HLA loci by geographical region 
(Continued) 
     
Frequency data records 
by level of resolution 
Locus 
Geographical 
Region 
Countries Pops Individuals 1 2 3 4 
  NAME 3 19 2,165 15 136 7 0 
  PACI 10 13 761 2 96 0 0 
  SAFR 9 11 1,403 7 88 5 0 
  SCAM 12 42 3,544 78 215 11 0 
  WEUR 13 36 6,587 42 320 29 0 
DQB1 ASIA 13 116 13,752 99 1,337 181 0 
 
AUST 1 2 144 9 18 0 0 
 
EEUR 11 31 10,737 37 324 8 0 
 
MIDE 5 25 2,831 15 268 31 0 
  NAFR 4 13 1,327 2 244 6 0 
  NAME 3 40 23,771 38 503 3 0 
  PACI 12 24 1,483 7 280 39 0 
  SAFR 14 19 2,535 31 234 34 0 
  SCAM 15 59 5,001 94 580 47 0 
  WEUR 16 55 16,122 92 743 19 0 
Totals 16,718 64,613 4,940 172 
ASIA=Asia; AUST=Australia; EEUR=Eastern Europe; MIDE=Middle East; NAFR=North Africa; NAME=North 
America; PACI=Pacific; SAFR=Sub-Saharan Africa; SCAM=South and Central America; WEUR=Western Europe. 
 
 
Table 4.4: Availability of frequency data of non-classical HLA loci by region 
     
Frequency data records 
by level of resolution 
Locus 
Geographical 
Region 
Countries Pops Individuals 1 2 3 4 
DMA EEUR 1 1 202 0 4 0 0 
  NAME 1 1 263 0 4 0 0 
  WEUR 1 1 90 0 4 0 0 
DMB EEUR 1 1 202 0 4 0 0 
  NAME 1 1 263 0 4 0 0 
 DMB WEUR 1 1 90 0 5 0 0 
DRB3,4,5 SCAM 1 1 130 8 0 0 0 
E ASIA 4 4 756 0 8 6 0 
  NAME 2 3 194 0 4 6 0 
  SCAM 2 4 215 0 4 8 0 
  WEUR 2 2 142 0 5 0 2 
G ASIA 4 5 847 0 11 27 0 
  EEUR 1 1 58 0 2 6 0 
  MIDE 1 1 102 0 1 8 0 
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Table 4.4: Availability of frequency data of non-classical HLA loci by region (Continued) 
     
Frequency data records 
by level of resolution 
Locus 
Geographical 
Region 
Countries Pops Individuals 1 2 3 4 
  NAME 1 2 122 0 5 3 0 
  SAFR 3 3 406 0 5 16 0 
  SCAM 1 2 155 0 7 19 0 
  WEUR 3 3 396 0 11 3 0 
Totals 8 88 102 2 
ASIA=Asia; AUST=Australia; EEUR=Eastern Europe; MIDE=Middle East; NAFR=North Africa; NAME=North 
America; PACI=Pacific; SAFR=Sub-Saharan Africa; SCAM=South and Central America; WEUR=Western Europe. 
 
4.3.1.2 HLA haplotype frequencies 
 
At the beginning of data collection, only haplotypes with the highest number of loci 
typed were entered. In later submissions, haplotype data with different numbers of loci 
combinations were included for the same population. Therefore, several submissions in 
the AFND contained HLA haplotype frequencies with a different number of loci from 
the same population.  
 
Table 4.5 shows a summary of populations containing 1-4 different HLA haplotype 
datasets. For instance, one population stored in the AFND contained data in four 
different formats (e.g. A-B, A-B-C, DRB1-DQB1 and A-B-C-DRB1-DQB1). Thus, 
haplotypes in the AFND corresponded to 403 datasets from 342 population samples. 
 
Table 4.5: Number of HLA haplotype datasets available in the AFND 
Populations Formats reported Total datasets 
1 4 4 
3 3 9 
52 2 104 
286 1 286 
Total      342 
 
403 
 
A further analysis was carried out to explore the availability of haplotypes according to 
the number of loci typed (2 to 8 loci). Table 4.6 shows the number of haplotype 
submissions for each haplotypic combination. As an example, one population contained 
15 haplotype frequencies in which 8 loci were typed. In terms of datasets, haplotypes 
containing two and three loci were those with most entries (128 and 209 datasets 
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respectively). The main reason was that in many publications few loci were considered 
for haplotype analysis. Submissions for A-B-DRB1 and DRB1-DQA1-DQB1 were the 
haplotypes with more haplotype frequencies reported comprising 44% of the haplotypes 
available in the AFND. 
 
Table 4.6: HLA haplotype datasets by number of loci typed 
Number of 
loci typed 
Number of 
datasets 
Loci typed 
 
Haplotype Frequency 
Records 
8 1 A-B-C-DRB1-DPA1-DPB1-DQA1-DQB1 15 
6 6 A-B-C-DRB1-DPB1-DQB1 58 
  
A-B-DRB1-DRB3-DQA1-DQB1 3 
  
A-B-DRB1-DRB4-DQA1-DQB1 3 
  
A-B-DRB1-DRB5-DQA1-DQB1 1 
5 23 A-B-C-DRB1-DQB1 131 
  
A-B-DRB1-DQA1-DQB1 52 
4 36 A-B-C-DRB1 76 
  
A-B-DRB1-DPB1 11 
  
A-B-DRB1-DQB1 237 
  
B-C-DRB1-DQB1 16 
  
DRB1-DPA1-DPB1-DQA1 14 
  
DRB1-DPB1-DQA1-DQB1 86 
3 209 A-B-C 532 
  
A-B-DRB1 2,461 
  
B-C-DRB1 36 
  
B- DRB1-DQB1 22 
  
DRB1-DPA1-DPB1 17 
  
DRB1-DPB1-DQB1 145 
  
DRB1-DQA1-DQB1 1,476 
  
DRB1-DRB3-DQB1 9 
  
DRB1-DRB4-DQB1 6 
  
DRB1-DRB5-DQB1 6 
2 128 A-B 936 
  
A-C 295 
    B-C 700 
    B-DRB1 388 
    DPA1-DPB1 168 
    DRB1-DPB1 116 
    DQA1-DQB1 217 
    DRB1-DQA1 23 
    DRB1-DQB1 652 
    DRB1-DRB3 8 
Total 403   8,916 
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4.3.2 Occurrence of high-resolution HLA alleles  
 
To investigate the occurrence of HLA alleles submitted to the AFND, a meta-analysis 
was carried out by examining the number of confirmations of HLA alleles typed at high-
resolution (variants at protein level). Figure 4.1 shows the number of alleles in all three 
classical loci for Class I (HLA-A, -B, -C) divided by geographical regions. As expected, 
the majority of confirmations for Class I loci were reported in the HLA-B locus, which 
is the most polymorphic locus within the HLA region with 2,068 alleles described in 
release 3.3.0 in the IMGT/HLA database. Asia was the geographical region with more 
confirmations of high-resolution alleles for Class I (459 alleles), mainly due to the fact 
that more individuals were typed in this region compared to the rest. Due to the 
heterogeneity of data compiled at different years it was not possible to compare ratios 
between geographic regions. For instance, different laboratories may have used a 
different allele list as reference. However, Figure 4.1 serves as an indication of the 
occurrence of alleles at a particular geographical region. 
 
 
Figure 4.1: Occurrence of high-resolution alleles of HLA Class I loci by region. 
In this figure, horizontal bars indicate the number of alleles reported at high-resolution organised by geographical 
region. Numbers in brackets represent the total number of individuals typed for each locus. ASIA=Asia, 
AUST=Australia, EEUR=Eastern Europe, MIDE=Middle East, NAFR=North Africa, NAME=North America, 
PACI=Pacific, SAFR=Sub-Saharan Africa, SCAM=South and Central America, WEUR=Western Europe.  
 
A similar analysis was performed in classical loci of Class II (HLA-DRB1: 873 alleles, -
DPA1: 28 alleles, -DPB1: 145 alleles, -DQA1: 35 alleles and -DQB1: 144 alleles 
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described in the IMGT/HLA as of release 3.3.0) shown in Figure 4.2. As expected, the 
highly polymorphic HLA-DRB1 locus contained the top number of confirmations of 
alleles at high-resolution with 775 alleles. Again, the majority of the high-resolution 
allele confirmations were observed in Asia (294 alleles in total). 
 
 
 
Figure 4.2: Occurrence of high-resolution alleles of HLA Class II loci by region. 
In this figure, horizontal bars indicate the number of alleles reported at high-resolution organised by geographical 
region. Numbers in brackets represent the total number of individuals typed for each locus. ASIA=Asia, 
AUST=Australia, EEUR=Eastern Europe, MIDE=Middle East, NAFR=North Africa, NAME=North America, 
PACI=Pacific, SAFR=Sub-Saharan Africa, SCAM=South and Central America, WEUR=Western Europe.  
 
4.3.3 Online applications for the analysis of HLA alleles 
 
Based on the need to investigate the frequency distribution of HLA frequencies among 
different groups (e.g. most frequent alleles and/or overall frequencies by geographical 
region, country, ethnic group, etc.), two main software applications were implemented 
in the AFND website: (i) the Allele Frequency Calculator and (ii) the Allele Frequency 
Search. 
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4.3.3.1 Estimation of Global Allele Frequencies 
 
As described in the literature, HLA frequencies vary significantly among geographical 
regions and ethnic groups. In order to provide the research community with a flexible 
application to estimate the overall allele frequencies of HLA data available, the Allele 
Frequency Calculator (AFC) tool was implemented in the AFND website (Figure 4.3). This 
searching mechanism allows individuals to examine the overall frequencies depending 
on criteria inputted by users. Figure 4.3 shows an example of the overall frequencies of 
fifteen HLA-A alleles sorted by the number of reports in descending order.  
 
 
Figure 4.3: Example of the Allele Frequency Calculator (AFC). 
 
The AFC is available for alleles typed at high-resolution only. In the example of Figure 
4.3, HLA-A*02:01 was the allele with most reports for HLA-A locus (reported in 128 
populations). The difference in the number of reports of HLA-A*02:01 (128 times) and 
HLA-A*32:01 (120 times) can be explained by the fact that HLA-A*32:01 contained 
considerable lower frequencies (Figure 4.4), thus, several authors may have not found 
this allele in their studies. As shown in Figure 4.3, several filters can be applied to the 
search including the source of data (literature, unpublished data), type of study  
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(Anthropology Study, Bone Marrow Registry, Solid Organ Unrelated Donors, Controls 
for Disease Study, Blood Donors, Other), sample size and year of the sample. The 
output list comprises the allele name, number of times reported in the AFND, number 
of allele copies, sample size (2n) and an approximation of the overall frequency. The 
search can be customised to examine the frequencies at different levels: Overall 
frequency  Geographical region  Country  Ethnic origin. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Frequency distribution of the HLA-A*02:01 and HLA-A*32:01 alleles. 
 
4.3.3.2 The Allele Frequency Search 
 
The AFC application, shown in Figure 4.3, was designed for the estimation of overall 
frequencies in a given ethnicity or geographical region. However, HLA alleles differ in 
populations within these groups. To analyse the frequency distribution of alleles in the 
different populations, the AFS (Reviewed in Section 3.4.1), was implemented as the core 
of the searching mechanisms in the HLA section.  
 
4.3.4 Software for analysis of HLA haplotype distribution 
 
Haplotype frequency data collected in the AFND was significantly lower (~10 times) 
than allele frequency information as shown in Section 4.2.2. The HLA-A-B-DRB1 and 
HLA-DRB1-DQA1-DQB1 datasets were the haplotypes that contained the highest 
number of frequency records with 2,461 and 1,476 respectively (Table 4.6). From these 
two datasets, HLA-DRB1-DQA1-DQB1 haplotypes, which contained more data at 
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high-resolution, were further examined using the HFS described in Section 3.4.2. Figure 
4.5 shows one of the haplotypes with more reports in the AFND, DRB1*14:02-
DQA1*05:01-DQB1*03:01, which was reported in 13 different populations. In this 
example, the highest frequencies were found in Amerindian populations [Athabaskan in 
Canada = 34.7% (Monsalve, Edin & Devine 1998), Xavantes in Brazil = 25.7% (Cerna 
et al. 1993) and Wichis in Argentina = 22.4% (Cerna et al. 1993)]. The high percentages 
shown in several haplotypes, for instance in Athabaskan, are the result of selection of 
individuals with minimal admixture with other populations. Using the map generation 
tool available in the HFS, the frequency distribution of this haplotype across the world 
is illustrated in Figure 4.6. Although little haplotype data was submitted for this 
haplotype, a pattern in the occurence of haplotypes can be observed which may be 
useful to identify possible patterns of human migration. To extend the usefulness of the 
HFS, hyperlinks were implemented in the map generation tool to examine the 
occurence of the specific alleles of the haplotype. As shown in Figure 4.7A-C similar 
patterns observed in the HFS were confirmed with data from alleles, demonstrating that 
the interaction of the two searching mechanisms may assist users when low haplotype 
frequency data is available. 
 
 
Figure 4.5: Example of the HLA haplotype frequency search. 
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Figure 4.6: Distribution of the HLA-DRB1*14:02-DQA1*05:01-DQB1*03:01 haplotype. 
 
 
 
 
 
 
Figure 4.7: Distribution of the (A) DRB1*14:02, (B) DQA1*05:01 and (C) DQB1*03:01 alleles. 
 
 
DRB1*14:02 
A) 
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Figure 4.7: Distribution of the (A) DRB1*14:02, (B) DQA1*05:01 and (C) DQB1*03:01 alleles 
(Continued). 
4.4 Discussion 
 
There is a tremendous amount of data available in the literature on the frequencies of 
HLA alleles in populations from different geographical regions. In this study, more than 
800 populations were compiled in the AFND comprising the largest collection of HLA 
data from different ethnic groups across the world. Having allele and haplotype 
frequencies of HLA genes in a readily available electronic format has been shown to be 
a valuable resource for meta-analysis. Greater knowledge of the distribution of HLA 
and other immunogenetic gene alleles in human populations may aid matching of 
DQA1*05:01 
DQB1*03:01 
B) 
C) 
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donors and recipients in stem cell transplantation and facilitate tracing of the history and 
origins of human populations. To the best of knowledge, the dbMHC and ALFRED 
databases are the only publicly available resources with HLA data. The amount of data 
available in these two databases is considerably lower than in the AFND and these 
databases have not had the addition of new populations in several years (See discussion 
in Chapter 3). The major difficulty in the compilation and analysis of HLA information 
on a large scale was the highly diverse type of data reported in the literature by different 
authors. Mechanisms of data collection implemented in the AFND website allowed the 
validation of data content, particularly in the capture of HLA allele names using the 
official nomenclature from the IMGT/HLA database. The series of nomenclature 
updates from IMGT/HLA are synchronously reflected into the AFND making the 
website an up-to-date resource for the analysis of HLA alleles.  
 
Different meta-analyses have been performed principally on data collected for 
anthropological components in IHWSs (Mack et al. 2007; Nunes et al. 2010; Sanchez-
Mazas 2007). The widest meta-analysis covering HLA data from different sources was 
carried out by Solberg and colleagues in which 497 populations with HLA frequency 
data were analysed for comparisons of balancing selection and heterogeneity including 
data from the literature, IHWSs and 70 populations from AFND (Solberg et al. 2008). 
The analysis of HLA mechanisms of selection are beyond the scope of this 
investigation. The analysis of HLA data was oriented to the development of 
computational approaches and mechanisms for the examination of frequencies in 
different populations. 
 
The analysis carried out in this chapter was focussed on the examination of the high-
resolution alleles to provide an insight into the occurrence of alleles within the entire 
collection and within a specific geographical region. The division of geographical 
regions described in this chapter may lead to controversy. The classification used in the 
AFND differs from the groups provided by Meyer and Single who performed analysis 
using data from the dbMHC database (Meyer et al. 2006). For example, in AFND, Asia 
encompasses South West, South East and North Asia used by Meyer and Single. This 
may lead to an overestimation of the confirmation of high-resolution alleles in certain 
geographical regions. However, in other cases, AFND covered a more specific area, for 
example Europe, which was divided into Eastern and Western compared to the division 
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provided by Meyer and Single. The advantage of software online tools and stored 
procedures implemented in the AFND facilitates the expansion and recalculations of 
the geographical divisions by the assignment of each country to the new geographical 
region subdivision. Interestingly, despite the high polymorphism observed in alleles of 
the HLA genes, less than 50% the alleles were confirmed at high-resolution, leading to 
the possibility that many of these alleles could be dubious. To analyse the rarity of the 
HLA alleles in depth, Chapter 5 presents an extensive analysis by compiling data from 
different sources. 
 
The three main searching mechanisms (AFC, AFS and HFS) referenced in this chapter 
are expected to increase the usefulness of the AFND in the examination of allele and 
haplotype frequencies. The AFC may help individuals in the rapid consultation of those 
alleles more frequently observed in a given geographical region, country and/or 
ethnicity. However, calculation of global frequencies should be considered only as an 
approximation due to some alleles may have not been considered in old publications 
leading to an under/over estimation of real frequencies. As frequencies may vary 
significantly among populations from the same geographical region, the AFS may serve 
as the best approach in the understanding of the occurrence of a given allele in a 
particular geographical region and/or ethnic group. Additionally, the AFS can run 
semantic algorithms to include information on low-resolution when a high-resolution 
alleles is searched. This software implementation was of great importance since ~20% 
of the data submitted to the AFS relates to low-resolution typing (Table 4.3 and Table 
4.4). The generation of automatic overlaid maps has also been widely used in the 
visualisation of the occurrence of a specific allele or haplotype across the world. 
Hyperlinks among the HFS and AFS have also been important in several cases when the 
availability of data is limited, particularly in haplotype data. Haplotypes can be more 
useful in the understanding of relationships among populations than analysing separate 
alleles. However, one of the major problems found in the compilation of haplotype 
frequency data from the literature is that many investigators do not look at haplotypes 
frequencies due to the number of subjects to obtain haplotypes is small. In other cases, 
authors tend to report only those haplotype frequencies which are highest in their 
population. Although the structure of the AFND can support the addition of raw data 
(individuals‟ genotypes), at present no information has been submitted to the database. 
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The use of raw data will increase considerably the number of analysis (e.g. Hardy-
Weinberg, tests of neutrality, etc.) in the website.  
 
The most consulted section in AFND has been the HLA frequency database. This 
section has facilitated the analysis in numerous projects in a wide range of contexts. 
First, population genetics researchers have used the AFND for studying local or global 
distributions of particular alleles. As one example, Solberg and colleagues used AFND 
for performing a population meta-analysis to search for evidence of balancing selection 
and heterogeneity in the HLA genes (Solberg et al. 2008). Also, Zhang and co-workers 
described a meta-analysis to investigate the relationships between HLA-DRB1 and 
multiple sclerosis in Caucasians using several datasets listed in the website (Zhang et al. 
2011). The database has also provided assistance in the analysis of evolution of allele 
families as referred by Martinez-Laso and collaborators who analysed the HLA-B*15 
allele (Martinez-Laso et al. 2011). Second, immunology researchers working to 
understand the basic mechanisms of self and non-self recognition, e.g. Ziegler‟s group 
who reported current theories for T cell selection and compared the amino acid 
sequence of different HLA alleles using frequency data available in AFND (Ziegler et al. 
2009). Third, researchers working in infection biology or immunology used AFND to 
determine how common particular alleles are in a specific population, e.g. Wahl et al. 
studied influenza peptides presented by the HLA-B*07:02 allele and used AFND to 
demonstrate its frequency in North American populations (Wahl et al. 2009). Finally, 
researchers working in pharmacogenetics who have used frequency data to investigate 
distributions of alleles which are known to react differently to drug treatments, i.e. co-
amoxiclav in liver injury (Donaldson et al. 2010), or examining effects such as cutaneous 
adverse drug reactions (Aihara 2011). Additionally, AFND has become a daily tool for 
many histocompatibility laboratories to consult which alleles appear in other 
populations and search for locations of possible bone marrow donors for their patients. 
 
4.5 Conclusions  
 
The results presented in this chapter provided an insight into the frequencies of HLA 
alleles and haplotypes across worldwide populations. Data compiled in the AFND 
corresponds to the largest collection of HLA frequencies in different worldwide 
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populations comprising more than 800 population samples in more than four million 
individuals. Results described in this chapter included the examination of data by 
geographical region and the use of software applications for the estimation of global 
allele frequencies. One of the major outcomes of the analysis was that despite the high 
polymorphism that has been shown in genes of the HLA region, less than a half of the 
alleles at high resolution were reported in the data compiled. Thus, the analysis of the 
occurrence of HLA alleles will be discussed in detail in the following chapter. 
 
 
 
 
  
 
 
Chapter 5  
 
A bioinformatics approach to ascertain 
the rarity of  HLA alleles 
 
5.1 Introduction  
 
As mentioned in Section 1.4.1, the increase in the number of HLA alleles, particularly 
since the implementation of molecular techniques has been colossal. Nearly 6,000 HLA 
alleles from classical genes (HLA-A, -B, -C, -DRB1, -DQA1, -DQB1, -DPA1 and -
DPB1) had been reported as of January 2011 at release 3.3.0 in the IMGT/HLA 
database.   
 
The sequences of new HLA alleles are submitted to the IMGT/HLA database which 
assigns the official name for the novel allele according to a set of guidelines that are 
maintained by the Nomenclature Committee for Factors of the HLA System (Marsh et 
al. 2010). After the initial submission, other individual laboratories may report to the 
IMGT/HLA database if the same sequence was found in a different individual.  In this 
case, the second submission is reported by the Nomenclature Committee as a 
confirmatory sequence.   
 
Despite the massive number of alleles, many of these sequences have only been 
reported in one individual, which corresponds to the original sequence submitted to the 
IMGT/HLA database. Also, some alleles may have been found in more than one 
individual but reported by the same laboratory, leading to the possibility that the original 
submission and confirmatory sequences could have been erroneous. Thus, the 
confirmation of HLA alleles by different laboratories across the world was expected to 
provide more evidence on the occurrence of the HLA alleles described in the 
IMGT/HLA database. 
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The aim of this chapter is to describe the computational approach which was used to 
ascertain the rarity of HLA alleles based on the number of confirmations reported by 
different sources (databases and individual laboratories). This chapter includes a 
complete description of the datasets that were used for the confirmation of HLA alleles 
and presents a summary of the findings related to the occurrence of the HLA alleles. 
The present chapter includes an update of this work which was published in 2009 in 
Tissue Antigens (Middleton et al. 2009). 
 
5.2 Materials and methods 
5.2.1 Datasets 
 
The information gathered for the analysis of the rarity of HLA alleles was compiled 
from three databases and submissions from individual laboratories. 
 
 IMGT/HLA. This database was used for compiling information on the initial 
sequence of the allele and whether the allele was reported in another individual 
by the same laboratory or by a different group. The information was provided in 
a tab-separated text file including the name of the allele, the number of cells in 
which the allele was seen, the number of groups that confirmed the allele, and 
whether the allele was confirmed or unconfirmed based on the number of cell 
confirmations, i.e. confirmed (cells > 1), unconfirmed (cells = 1). The file is 
deposited in a server machine after every new release from the IMGT/HLA 
database. The analyses described in this chapter are based on release 3.3.0. 
 
 National Marrow Donor Program (NMDP). A spreadsheet file containing a 
list of alleles which were described as rare alleles by the NMDP was included in 
the compilation of data. The information described in the file consisted of the 
name of the allele and the number of times that the allele was seen in the United 
States classified in six ethnic groups [African Americans (AFA), Asian and 
Pacific Islanders (API), Caucasians (CAU), Hispanics (HIS), Native Americans 
(NAM) and Others (OTH)]. This file is generated biannually and publicly 
available at the following link: 
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 (http://bioinformatics.nmdp.org/HLA/Rare_Allele_Lists/Biannual_Rare_Allele_Lists.aspx) 
 
 AFND. Information on the number of times that the alleles have been reported 
in the Allele Frequency Net Database was also included in the collection of data.  
 
 Individual laboratories.  
The information from individual laboratories consisted of four groups which 
were interested in participating in the confirmation of alleles. 
o 19 laboratories who submitted data from January 2008 to August 2008 
as part of a project presented at the 15th IHWS in Buzios, Brazil in 
September 2008. 
o 10 laboratories from the National Health Service (NHS) in the United 
Kingdom and Ireland who submitted data from January 2010 to May 
2011. 
o 14 laboratories participating in the European Network HLA-NET who 
submitted data from January 2010 to May 2011.  
o 17 laboratories who sent data from September 2009 to May 2011 and 
who were classified as participants of the 16th IHWS which will be 
hosted in Liverpool, UK in May 2012. 
 
5.2.2 Collection of confirmatory data from individual laboratories 
 
Generation of the rare alleles list 
 
An initial list was generated using data available from the IMGT/HLA, NMDP and 
AFND databases. The number of confirmations of these three sources was combined 
to identify those alleles which were found on less than four occasions in unrelated 
individuals. The alleles that matched that criterion were temporarily classified as rare 
alleles and the output list was exported into a spreadsheet file. The list consisted of 1700 
alleles for classical loci (HLA-A, -B, -C, -DRB1, -DPA1, -DPB1, -DQA1 and -DQB1). 
Afterwards, the file was sent to each laboratory who had expressed interest in 
participating in the confirmation of the rare alleles. Each laboratory was given the 
instruction to review the list and report the alleles that may have been typed in its 
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installations. The list was initially sent to laboratories participating in the 15th IHWS. 
Then, to extend the analysis of rare alleles in specific geographical locations, the list was 
sent to participants from the HLA-NET group in Europe and to NHS tissue typing 
laboratories located in the United Kingdom and Ireland. 
 
Information required for rare allele confirmations 
 
If an allele was reported by a laboratory, a questionnaire was sent asking for minimum 
information on the allele such as the ethnicity of the individual in whom the allele was 
found, name of the population from where the individual came, reason for which the 
individual was typed (e.g. disease association study, renal patient, bone marrow related 
donor, bone marrow unrelated donor, bone marrow patient, kidney donor or other), 
and the method used to detect the allele (e.g. SBT, SSP, SSO, direct sequencing or any 
other method). Additionally, details of the laboratory submitting the confirmation of the 
rare allele were required for each submission. 
 
Furthermore, the haplotype or genotype of the individual was required to complete the 
submission. If the haplotype was known by pedigree analysis, only the haplotype 
containing the rare allele was entered to the AFND.  If the haplotype was deduced by 
the maximum likelihood method or any other estimation method (e.g. resampling) then 
both haplotypes were required. However, if haplotypes were not known, the genotype 
of the individual was requested.    
 
Online submissions 
 
At the beginning of the project, each participating laboratory sent the information using 
a preformatted spreadsheet file. These confirmations were subsequently entered to the 
AFND via an online form available on the website (Figure 5.1). Official names and 
ethnicities of the individuals were validated through this form.  
 
On some occasions, laboratories decided to send a file containing raw data (genotypes 
of individuals) due to the large amount of data available in their centres. For these large 
datasets, the Rare Allele Detector (RAD) application was used to identify those alleles 
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which were considered as rare. The functionalities of the RAD module are described in 
this chapter in Section 5.3.6.  
 
 
 
Figure 5.1: Screenshot of the online submission form for rare allele confirmations. 
 
 
5.3 Results 
5.3.1 Summary of submissions 
 
A total of 1180 allele confirmations were submitted to the AFND by participating 
laboratories from 24 different countries (Table 5.1). Nearly half of the confirmations 
(45.5%) corresponded to submissions from participants of the 15th IHWS. The rest of 
the submissions were 23.8% from UK laboratories, 22.1% from HLA-NET and 8.3% 
from participants of the 16th IHWS. In some occasions, several rare alleles were 
confirmed more than once from the same laboratory. For example, 61 submissions were 
sent by a laboratory in Curitiba, Brazil for the 15th IHWS, however, only 28 different 
rare alleles were found from those submissions. From the entire datasets, 356 alleles 
were reported only once in the accumulated data as shown in Table 5.1. 
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Table 5.1: Rare alleles reported to AFND by individual laboratories 
Dataset City Country 
Total 
Sent 
Different 
alleles in 
each lab 
Alleles reported 
only once in the 
accumulated data 
15th IHWS Buenos Aires Argentina 3 3 2 
 
West Australia Australia 1 1 0 
 
Curitiba Brazil 61 28 9 
 
Rio de Janeiro Brazil 13 6 2 
 
Sao Paulo Brazil 4 2 0 
 
Ottawa Canada 13 12 8 
 
Helsinki Finland 25 11 1 
 
Paris France 12 8 5 
 
L‟Aquila Italy 25 21 15 
 
Milan Italy 5 3 1 
 
Pavia Italy 29 15 4 
 
Barcelona Spain 22 19 12 
 
Geneva Switzerland 14 14 9 
 
Hualien Taiwan 19 19 16 
 
Newcastle United Kingdom 8 8 5 
 
Aurora United States 100 17 2 
 
Houston United States 101 31 7 
 
Oklahoma United States 43 24 13 
 
Seattle United States 40 24 12 
16th IHWS Adelaide Australia 1 1 0 
 
Perth Australia 10 9 6 
 
Curitiba Brazil 22 20 11 
 
Montreal Canada 4 4 3 
 
Pilsen Czech Republic 6 3 1 
 
Paris France 3 2 0 
 
Hyderabad India 8 5 2 
 
Cagliari Italy 3 2 1 
 
Milan Italy 5 5 2 
 
Roma Italy 3 3 2 
 
Uppsala Sweden 26 26 11 
 
Taipei Taiwan 6 6 4 
 
Aurora United States 1 1 1 
 
Portland United States 1 1 0 
HLA-NET Vienna Austria 26 26 16 
 
Sofia Bulgaria 6 6 3 
 
Zagreb Croatia 3 3 1 
 
Helsinki Finland 3 3 1 
 
Besançon France 14 13 9 
 
Lyon France 50 45 30 
 
Athens Greece 7 3 0 
 
Milan Italy 38 30 5 
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Table 5.1: Rare alleles reported to AFND by individual laboratories (Continued) 
Dataset City Country 
Total 
Sent 
Different 
alleles in 
each lab 
Alleles reported 
only once in the 
accumulated data 
HLA-NET Leiden Netherlands 76 66 35 
 
Oslo Norway 5 5 2 
 
Lisbon Portugal 27 27 18 
 
Ljubljana Slovenia 4 3 1 
 
Geneva Switzerland 1 1 0 
 
Glasgow  United Kingdom 1 1 1 
UK Labs Dublin Ireland  25 22 11 
 
Birmingham United Kingdom 7 4 0 
 
Cambridge United Kingdom 2 2 0 
 
Cardiff United Kingdom 122 55 14 
 
Glasgow United Kingdom 5 5 1 
 
Leeds United Kingdom 13 10 3 
 
London a United Kingdom 19 19 3 
 
London b United Kingdom 47 44 28 
 
Manchester United Kingdom 34 34 2 
 
Sheffield United Kingdom 8 8 5 
Total 
  
1180 
 
356 
a Barts and the London NHS Trust, b Anthony Nolan Research Institute. 
 
Table 5.2 shows a summary of the number of times an allele was reported by individual 
laboratories. A total of 584 different alleles were reported among the 1700 rare alleles 
that were initially asked for. As shown in Table 5.2, the allele C*07:18 was confirmed 44 
times indicating a low representation of some of the alleles in the IMGT/HLA, AFND 
and NMDP databases. Interestingly, 90.4% of the alleles that were considered as „rare‟ 
in the initial spreadsheet were confirmed only 1-3 times considering all submissions.  
 
Table 5.2: Number of allele confirmations by times seen 
Number of alleles 
Times 
seen 
Number of alleles 
Times 
seen 
1 (C*07:18) 44 4  8 
1 (B*35:16) 24 6  7 
1 (DQB1*03:19) 22 7  6 
1 (B*07:06) 18 9  5 
1 (C*18:02) 14 18  4 
1 (C*15:09) 13 47  3 
1 (B*35:14:01) 12 125  2 
3  11 356  1 
2  10    
Total   584  
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5.3.2 Classification of HLA alleles 
 
An analysis was performed according to whether the alleles had been sequenced only in 
one cell (unconfirmed) or sequenced and reported in more than one cell (confirmed) in 
the IMGT/HLA database. Each of these two categories was compared against 
confirmations from the other three datasets (AFND, NMDP and other laboratories) to 
examine differences. Results are shown in Figure 5.2. This figure is quite revealing in 
several ways. First, only 35.7% of the submissions to the IMGT/HLA had been 
confirmed in more than one cell. Second, 47.1% of the unconfirmed alleles (only one 
cell) described in the IMGT/HLA database have also never been found in any other 
source (AFND, NMDP and other laboratories) as of May 2011. Surprisingly, 15.6% 
alleles which were „confirmed‟ in the IMGT/HLA database have never been found in 
any of the three datasets. From Figure 5.2 one can also conclude that, whereas the 
majority of alleles only sequenced once had never been reported in any other source of 
data (47.1%), those alleles which had been sequenced and reported in a second 
individual in the IMGT/HLA database were likely to be found on more than three 
occasions in the other datasets (11.9%). The high percentage (15.6%) of the confirmed 
alleles that were not found in any of the three sources may be the result of new 
sequences included in the IMGT/HLA database. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Summary of findings of HLA alleles. 
 
AFND + NMDP + Labs AFND + NMDP + Labs 
Alleles 
(Classical loci) 
Unconfirmed (one cell) Confirmed (More than one cell) 
0 
100% 
5,827 
35.7% 64.3% 
1 2 3 >3 0 1 2 3 >3 
47.1% 7.1% 3.1% 1.7% 5.3% 15.6% 3.7% 2.6% 1.9% 11.9% 
Reported to IMGT/HLA 
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During the course of discussions in the 15th IHWS between participating laboratories, it 
was decided that alleles only found once (initial sequencing reported to IMGT/HLA) 
and not on any other source would be called „very rare‟, those found on 1-3 occasions 
(excluding the initial sequence), would be called „rare‟, and those found on more than 
three occasions (excluding the initial sequence) called non-rare or „frequent‟. Following 
this classification, 47.1% of all alleles were never reported after the first sequence report, 
thus very rare (Table 5.3).  The percentage was similar for all HLA Class I classical genes 
(HLA-A, -B, -C) with a range from 48.1-50.8%. For HLA Class II classical genes (HLA-
DRB1, -DQA1, -DQB1, -DPA1 and -DPB1) there was a wide variation with a range 
from 17.1-52.8% possibly due to a lower number of alleles described in these genes. 
Notably, only 23.6% of the alleles of classical genes have been reported as frequent 
(more than three times excluding the initial sequence). 
 
Table 5.3: Summary of results of rare alleles 
HLA locus 
 
Number of 
alleles 
Very rare (%) 
 
Rare (%) 
 
Frequent (%) 
 
All 5,827 2,745 (47.1) 1,704 (29.2) 1,378 (23.6) 
A 1,518 763 (50.3) 434 (28.6) 321 (21.1) 
B 2,068 994 (48.1) 578 (27.9) 496 (24.0) 
C 1,016 516 (50.8) 319 (31.4) 181 (17.8) 
DRB1 873 335 (38.4) 276 (31.6) 262 (30.0) 
DQA1 35 6 (17.1) 13 (37.1) 16 (45.7) 
DQB1 144 76 (52.8) 36 (25.0) 32 (22.2) 
DPA1 28 12 (42.9) 6 (21.4) 10 (35.7) 
DPB1 145 43 (29.7) 42 (29.0) 60 (41.4) 
Very rare: 0 times; Rare: 1, 2, 3 times excluding the initial confirmation; Frequent: more than 3 times excluding the 
initial confirmation 
 
Table 5.4 shows the percentage of the confirmations by the different sources for those 
alleles which were reported 1-3 times after their initial sequence report to the 
IMGT/HLA database. The majority of the confirmations (61.6-69.9%) for alleles of the 
HLA-A, -B, -C, and -DRB1 loci were reported to the IMGT/HLA database as a second 
confirmatory sequence. For alleles of the HLA-DQA1, -DPA1 and -DPB1 loci the 
highest percentages of confirmations were found in the AFND and in individual 
laboratories for HLA-DQB1. 
 
 
 
Chapter 5      A bioinformatics approach to ascertain the rarity of HLA alleles 
 
118 
 
Table 5.4: Origin of rare alleles (1, 2 and 3 times) 
HLA locus Total 
IMGT/HLA 
(%) 
NMDP a 
(%) 
AFND 
(%) 
Labs 
(%) 
All 1704 65.4 32.2 15.1 15.6 
A 434 62.9 33.9 8.5 13.4 
B 578 61.6 35.8 11.8 13.8 
C 319 69.9 25.1 10.0 12.9 
DRB1 276 48.2 41.3 18.1 18.5 
DQA1 13 30.8 
 
69.2 30.8 
DQB1 36 33.3 
 
38.9 44.4 
DPA1 6 33.3 
 
66.7 16.7 
DPB1 42 19.0 
 
69.0 35.7 
a NMDP only sent data for HLA-A, -B, -C, -DRB1 
 
Considering the fact that several of the HLA alleles share identical sequences over exons 
2 and 3 for Class I and exon 2 for Class II (See Figure 1.4 in Chapter 1), very rare alleles 
were analysed according to whether HLA alleles encode the same protein (P) or had 
identical nucleotide sequences (G) for the peptide binding domains. Table 5.5 shows 
that from the 2745 alleles which were identified as very rare, 1752 alleles did not contain 
identical nucleotide or protein sequences. Therefore, although individuals may attribute 
that some alleles may have been confirmed in another identical sequence, the number of 
very rare alleles was still high considering G and P groups. 
 
Table 5.5: Very rare alleles by identical sequences 
HLA locus 
Very 
Rare 
Identical 
sequences (G) 
Identical 
sequences (P) 
G or P Not G and not P 
All 2,745 255 977 993 1,752 
A 763 80 266 274 489 
B 994 81 321 327 667 
C 516 54 184 186 330 
DRB1 335 12 139 139 196 
DQA1 6 3 4 4 2 
DQB1 76 22 43 43 33 
DPA1 12 0 7 7 5 
DPB1 43 3 13 13 30 
G=Identical nucleotide sequences over exons 2 and 3 for Class I and exon 2 for Class II; P=Identical protein 
sequences over exons 2 and 3 for Class I and exon 2 for Class II. 
 
Finally, an analysis was performed to identify the year in which these very alleles were 
described in the IMGT/HLA. Figure 5.3 indicates that 1343 out of the 2745 very rare 
alleles were reported in 2010. However, more than a half of the very rare alleles reported 
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in previous years have never been found in any of the sources (NMDP, AFND, 
individual laboratories). For instance, the HLA-A*02:31 allele was submitted to the 
IMGT/HLA database in February 1999 after being found in an individual of African 
background (Ellis et al. 2000). However, since then, the allele has not been reported in 
any of the data sources.  
 
 
 
Figure 5.3: Very rare alleles by year of submission. 
 
 
5.3.3 Investigation of the rarity of HLA alleles in UK laboratories 
 
To investigate the rarity of HLA alleles in a specific country, data submitted by UK 
laboratories was analysed. A total of 290 submissions were compiled from UK 
laboratories (Table 5.6). Nearly half of the submissions corresponded to confirmations 
of alleles performed in the Welsh Transplantation and Immunogenetics Laboratory in 
Cardiff. In contrast, Belfast, Edinburgh, Harefield, Leicester, Liverpool and Plymouth 
laboratories did not report any rare allele due to only low resolution typing was 
available. Of the 290 submissions, 117 alleles were reported on only one occasion in the 
accumulated data. 
 
 
 
Year 
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o
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A
lle
le
s
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Table 5.6: Rare allele submissions by UK laboratories 
City 
Number of 
submissions 
Alleles reported only once in 
the accumulated data 
Belfast 0 0 
Birmingham 7 0 
Cambridge 2 0 
Cardiff 122 21 
Dublin 25 11 
Edinburgh 0 0 
Glasgow 5 2 
Harefield 0 0 
Leeds 13 4 
Leicester 0 0 
Liverpool 0 0 
London a 47 35 
London b 19 8 
Manchester 34 22 
Newcastle c 8 6 
Plymouth 0 0 
Sheffield 8 8 
Total 290 117 
a Anthony Nolan Research Institute, b Barts and The London; 
c Newcastle, which belonged to data from the 15th IHWS, was also considered in the analysis. 
 
Table 5.7 shows how often, in this short study, alleles which were previously considered 
as very rare or rare, were found. Not surprisingly, alleles that had been considered as 
rare prior to this study (i.e. found on 1-3 times excluding the initial sequence) were the 
main alleles found on several occasions.  
 
Table 5.7: Summary of alleles by number of times seen  
Number of alleles Previous Status Times reported 
1 1 R 11 
1 1 R 10 
2 2 R 7 
5 5 R 6 
2 2 R 5 
2 2 R 4 
12 3 VR, 9 R 3 
27 4 VR, 23 R 2 
117 30 VR, 87 R 1 
      Total 169   
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The contribution of data from UK laboratories in the confirmation of rare and very rare 
alleles is shown in Table 5.8. From the 169 different alleles reported by UK laboratories, 
the status of 34 very rare alleles was changed to rare, three alleles were changed from 
very rare to frequent, 114 rare alleles were changed from rare to frequent and 18 alleles 
remained rare. From this table one can conclude that by using data from different 
laboratories within the same country the number of rare and very rare alleles can be 
reduced significantly.  
 
Table 5.8: Number of changes in allele status after submissions by UK labs 
  
Previous status 
 
Changes 
 
Current status 
Locus Alleles VR R 
 
VR -> 
R 
VR -> 
F 
R -> 
F 
Remained 
R  
VR R 
Total 5,827 2,782 1,784   34 3 114 18   2,745 1,704 
A 1,518 770 451   7 0 24 4   763 434 
B 2,068 1,005 609   9 2 40 5   994 578 
C 1,016 520 341   4 0 26 0   516 319 
DRB1 873 341 285   6 0 15 4   335 276 
DQA1 35 7 12   1 0 0 0   6 13 
DQB1 144 76 42   0 0 6 2   76 36 
DPA1 28 12 6   0 0 0 1   12 6 
DPB1 145 51 38   7 1 3 2   43 42 
VR=Very rare allele, R=Rare allele, F=Frequent allele 
 
5.3.4 The rare allele search (RAS) 
 
Despite the previous suggested criteria to classify the rarity of HLA, a tool called Rare 
Allele Search (RAS) was developed and incorporated on the AFND website to allow 
investigators to decide whether an HLA allele should be considered as rare according to 
their own criteria (Figure 5.4). For instance, users can specify the allele or locus of 
interest and filter results by the number of times that the allele has been reported from 
the existing sources (e.g. IMGT/HLA Cells < 2, AFND < 2, NMDP < 2 and Labs < 
2). Also, these four data sources can be combined and filtered as shown in Figure 5.4. In 
the example shown, 1456 alleles from the HLA-B gene were found to be reported on 
less than four occasions combining the four datasets. Additionally, the search includes 
an option to filter results by the year in which the initial confirmation was submitted to 
the IMGT/HLA database. Furthermore, the output list can be also reduced by grouping 
alleles which are identical over exons 2 and 3 for Class I and exon 2 for Class II. 
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Figure 5.4: Example of the Rare Allele Search (RAS). 
In this figure, the example shows the list of HLA-B alleles found on less than 4 occasions in the different data 
sources. Hyphens (-) in „NMDP‟ indicate that the allele was not reported due to the level of resolution whereas 
hyphens in „Other Labs‟ were used for those alleles that have not been confirmed.  
 
The resulting list consisted of several columns describing the information provided by 
the different data sources. For example, data from IMGT/HLA included the official 
allele name, the ethnicity of the individual(s) in which the allele was found, year of the 
first sequence report, whether the sequence was confirmed or unconfirmed, the number 
of cells and groups and whether the allele was partially or fully sequenced. Data from 
AFND consisted of the number of confirmations submitted to the website, whether the 
allele was seen in a lower resolution in the database (e.g. B*18:01:02 may have been 
reported as B*18:01) and whether the allele belonged to a set of alleles that shared 
identical sequences (An example is shown in Figure 5.5). Data from NMDP and from 
individual laboratories consisted of the number of confirmations grouped by some of 
the ethnic origins provided by these two sources. Finally, an additional column was 
included to summarise the confirmations of the four datasets (IMGT/HLA, NMDP, 
AFND and other laboratories). Additionally, by clicking in the „Total Other lab‟ column, 
users can access the data content submitted by laboratories (Figure 5.6). 
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Figure 5.5: Example of identical HLA alleles over exons 2 and 3. 
The figure shows an example of HLA-B*18:01:03 which was reported as very rare. However, identical sequences of 
this allele over exons 2 and 3 contained several confirmations (e.g. B*18:01:01 reported eleven times in the AFND). 
 
 
Figure 5.6: Information provided by individual laboratories on rare alleles. 
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5.3.5 AFND and confirmations in the US 
 
A parallel project to identify the rarity of HLA alleles was initiated at the same time in 
the USA by the American Society for Histocompatibility and Immunogenetics (ASHI) 
(Cano et al. 2007). In that study, the acronym „C‟ was used to represent common alleles 
that contained a frequency greater than 0.001 in the USA population and the acronym 
„WD‟ used for alleles that are well documented in the literature. The published list consisted 
of 693 alleles for HLA-A, -B, -C, -DRB1, -DQB1, -DRB3/4/5, -DQA1 and -DPB1 
which were described as well-documented. The list was subsequently updated to include 
more alleles found in the literature and the addition of the HLA-DPA1 locus. Based on 
this list, an analysis was performed to determine whether the alleles reported as 
common and well documented (CWD) in USA populations were also reported as 
frequent according to data provided by IMGT/HLA, NMDP, AFND and individual 
laboratories. Table 5.9 shows a comparison between the two groups. 340 out of the 693 
well documented alleles were reported as common in the United States. Of these, only 
276 were described in release 3.3.0 of the IMGT/HLA database as the rest were 
subsequently split at a higher resolution. As expected, nearly all alleles considered as 
CWD which were in the 3.3.0 release were confirmed as frequent in the AFND after the 
compilation of the datasets. 
 
Table 5.9: Common and well-documented alleles and data in AFND   
Locus WD a CWD b 
CWD current 
nomenclature c 
Frequent in 
AFND d (%) 
All 732 340 276 267   
A 137 53 44 43 (97.7) 
B 252 118 83 79 (95.2) 
C 90 44 36 36 (100) 
DPA1 6 6 6 6 (100) 
DPB1 53 25 24 23 (95.8) 
DQA1 13 13 13 13 (100) 
DQB1 28 19 16 15 (93.8) 
DRB1 153 62 54 52 (96.3) 
a WD=Well documented alleles; b CWD=Common and well documented alleles; c Common and well documented 
alleles listed in the release 3.3.0 in the IMGT/HLA database; d Frequent=Alleles found more than three times in the 
Allele Frequency Net Database considering the four data sources (IMGT/HLA, AFND, NMDP and other 
laboratories). 
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5.3.6 Rare allele detector (RAD) 
 
As shown in the previous section (5.3.4), the RAS was only optimal when looking for a 
specific allele or a set of alleles that matched given criteria. To facilitate the analysis of 
large datasets (i.e. 1000 individuals typed) the Rare Allele Detector tool was developed and 
incorporated to the AFND website (Figure 5.7). This tool simplified the detection of 
alleles which were considered to be very rare, rare or frequent from submissions from 
individual laboratories which contained raw data (genotype of the individuals). In this 
module users can upload their own raw data file in a tab-separated text file or by 
inputting the allele(s) of interest directly into a text box as shown in Figure 5.7. The 
output list includes the detection of those alleles which were invalid according to the 
official nomenclature of the IMGT/HLA, whether the alleles were not considered in 
the analysis due to being typed at a lower resolution, and whether the alleles belonged to 
a very rare, rare or frequent category. 
 
 
Figure 5.7: Screenshot of the Rare Allele Detector (RAD) module. 
 
 
Chapter 5      A bioinformatics approach to ascertain the rarity of HLA alleles 
 
126 
 
5.4 Discussion 
 
The number of HLA alleles that have been sequenced and reported to the IMGT/HLA 
database in recent years has been immense. This has led to a problem in differentiating 
these alleles in Histocompatibility Laboratories. Some researchers have expressed 
scepticism whether all these alleles have been correctly determined. The results 
described in this chapter show that, despite a worldwide analysis which included four 
different datasets (NMDP, AFND, IMGT/HLA and individual laboratories) containing 
confirmations of HLA alleles, many alleles have not been confirmed after the initial 
sequence reported to the IMGT/HLA database. It is interesting to highlight that 47.1% 
of all alleles have only been reported once. This percentage shows an increase from 
previous results published in Tissue Antigens in 2009 (Middleton et al. 2009) which was 
40.6% at that time. The percentage was similar for the HLA Class I classical genes 
(HLA-A, -B and -C).  However, in Class II classical genes (HLA-DRB1, -DQA1, -
DQB1, -DPA1 and -DPB1) the percentages were more diverse. A possible reason was 
that the number of alleles in the Class II genes was considerable lower than in those of 
Class I and that very less diversity is observed for HLA-DR alleles.  
 
One of the outcomes of the 15th IHWS was the allocation of HLA alleles into three 
groups: very rare (only sequenced once), rare (found on one, two or three occasions in 
addition to the initial sequence) and frequent (found on more than three times excluding 
the initial sequence).  However, rather than presenting a specific status for each allele, an 
online searching mechanisms was included in the AFND website to allow individuals to 
decide the criteria for defining a rare allele. This online tool also provides an up-to-date 
resource for consultation of the alleles as it is automatically maintained by inputs from 
IMGT/HLA, NMDP, laboratories and submissions of populations in the AFND. 
 
At the beginning of this project, the majority of the confirmations were reported to 
NMDP, however, in recent years there was a significantly increase in the number of 
confirmatory sequences to the IMGT/HLA database which has implemented more 
requirements in the confirmation of alleles. However, the confirmations in the 
IMGT/HLA database are limited to sequence-based typing.  
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Many researches have argued that very rare and rare alleles may correspond to limitation 
of number of individuals typed. It is worth mentioning that although the number of 
confirmations from laboratories is yet lower than confirmations from NMDP, the 
number of submissions exceeded one thousand and it is expected that this number will 
increase considerably over the next years. Thus, the incorporation of data from large 
databases such as bone marrow donor registries and the analysis of the alleles at 
different levels, including a specific continent such as Europe (part of the HLA-NET 
project) or a specific country (United Kingdom) are expected to provide more evidence 
in the confirmation of the rarity of HLA alleles. In the future, when enough data is 
available, it will be possible to analyse the rarity of alleles by continents, geographic 
regions and eventually by countries. 
 
Another important factor to consider is that some individual laboratories may have 
reported the same data to more than one of the sources considered in this analysis.  For 
example, confirmation of a sequence may have been submitted to IMGT/HLA and the 
type submitted to NMDP. In these cases, it was not possible to validate duplications. 
However, for laboratory confirmations the genotype of the individual was required to 
alleviate the problem at least in this source of data. An ongoing process includes the 
validation of duplications in NMDP and IMGT/HLA which will be part of the rare 
project presented in the 16th IHWS in 2012.  
 
One of the issues that emerged during the presentation of the data in the 15th IHWS was 
that many of the alleles may have been reported in another allele sharing an identical 
sequence over exons 2 and 3 for Class I and exon 2 for Class II. However, Table 5.5 
indicated that 1752 alleles were still considered to be very rare taking into account this 
consideration.  
 
A parallel project about the rarity of HLA alleles was performed by Cano and colleagues 
to identify common HLA alleles based on the frequencies of the alleles observed in 
individuals from the United States (Cano et al. 2007). The analysis also included the 
report of alleles that were well-documented in the literature. One of the drawbacks of this 
study was that frequency analysis was restricted to individuals from the US. Thus, the 
data presented in this chapter corresponds to the most extensive analysis of rare alleles 
performed in worldwide populations. Additionally, the rare allele project has also helped 
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as a reference in the report of new alleles (Chu et al. 2010) and in the investigation of 
allele lineages (Martinez-Laso et al. 2011).  
 
Rare alleles may be the result of errors in the detection of alleles using a particular PCR 
method, mutations, genetic recombination, or the lack of enough data from a specific 
geographic location or population. Thus, the investigation of rare alleles requires an 
extensive analysis of which location these alleles may be found. One of the major 
problems from data reported in the IMGT/HLA database is that does not record the 
location/ethnicity in a standardised format. In the majority of the cases the ethnicity of 
the individual is stored using only 9 major categories which are difficult to interpret and 
in very few occasions the country is included in the report. Thus, future analysis will 
include the investigation of the rarity of alleles by ethnicity or geographic location which 
will require the standardisation of the name of the ethnic groups and geographic 
locations utilised in the NMDP, IMGT/HLA and AFND databases.  
 
One of the latest advances in the determination of HLA alleles has been the use of new 
techniques such as next-generation sequencing (Erlich et al. 2011). However, these 
technologies may be limited to a few laboratories due to the high-costs and large 
numbers for cost efficiency. The number of different populations tested may be 
effected by this as it is likely that second generation typing would be applied to registry 
typing. A significant effort would be needed to determine all possible alleles occurring in 
worldwide populations, if it ever occurs. Thus, it is expected that the AFND will serve 
as a primary source for the deposition of confirmatory sequences in the next future 
assisting in the investigation of HLA variants.  
 
5.5 Conclusions 
 
One of the most important contributions of this research was the analysis of the rarity 
of HLA alleles by examining large amount of data from different sources including 
reports in the AFND, data from the National Marrow Donor Program in the US and 
confirmations by individual laboratories. The structure of the AFND and the availability 
of the data in electronic format facilitated the compilation of such extensive amount of 
information. This study, which was presented as a project in the 15th IHWS in 2008, has 
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encouraged the active participation of individual laboratories and International 
organisations in the confirmation of rare alleles. A summary of results was described in 
this chapter including a suggested classification of alleles based on the number of 
confirmations by the different sources. Additionally, the chapter described a 
computational approach to ascertain the rarity of these alleles by including an up-to-date 
searching mechanism implemented in the AFND. The results presented in the current 
analysis indicated that nearly half of the alleles described in the IMGT/HLA database 
have never been found in any of the four different sources. This important finding 
encourages the continuous collaboration between the different databases to exchange 
data to increase the accuracy of information.  
 
  
 
 
Chapter 6  
KIR genes and genotype frequencies 
 
6.1 Introduction  
 
Chapters 4 and 5 presented an extensive analysis on the examination of HLA genes and 
their corresponding alleles in worldwide human populations. The analysis encompassed 
an overview of the frequency distribution of the HLA alleles among populations and 
described a computational approach as a method to analyse the rarity of the existing 
HLA alleles.  
 
This chapter describes a set of analyses that were performed in the Killer-cell 
Immunoglobulin-like Receptors (KIR) genes which are expressed in NK cells and a 
subset of T cells. As explained in Section 1.5, the products of some of the KIR genes 
are well known for their interactions with products of the HLA molecules and have 
been a topic of investigation by researchers. The genomic region comprising these genes 
has also been shown to present an elevated polymorphism with more than 600 alleles 
described in the IPD-KIR database as of release 2.4.0, April 2011. However, the 
observed polymorphism in the KIR genes is lower than that of the HLA system.  
 
The genes from the KIR family present a set of peculiarities which differ from the HLA 
system. One of the conspicuous differences is that an individual may possess the 
presence or absence of some of the KIR genes, termed the KIR genotype, which defines 
the gene content profile of the individual. Additionally, some of the KIR genes are 
considered to be habitually present and called framework genes, although a few 
individuals reported in some populations do not have these genes. As mentioned in 
Section 1.5.1, an individual‟s KIR genotype is formed by the combination of an A and B 
haplotype leading to the importance of investigating the structure of the KIR complex 
based on its gene content. Similarly to HLA, KIR genes also present wide variation 
among individuals from different populations bringing the attention of investigators to 
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examine the occurrence of genes and alleles among these groups. Therefore, in an 
endeavour to disseminate the known polymorphisms in the KIR gene cluster on a large 
scale, nearly two hundred KIR population samples listed in the AFND were analysed.  
 
This chapter presents an outline of the frequencies of the seventeen KIR genes which 
have been reported in the AFND. Furthermore, the chapter includes an overview of the 
KIR Genotype Frequency Database implemented in the AFND which contains the 
largest compilation of the KIR genotypes and their frequencies in worldwide 
populations. The results presented in this chapter provide an insight into the occurrence 
of KIR genes, their corresponding alleles and genotypes based on the analysis of the 
information using the AFND and tools included in the website. Finally, several tables 
and figures included in the chapter present an update of those results published as part 
of a review article in the Immunology Journal (Middleton & Gonzalez 2010). 
 
6.2 Materials and methods 
6.2.1 Population datasets 
 
A total of 194 population studies covering 23,204 unrelated healthy individuals with data 
on KIR frequencies collected by the AFND were included in this analysis. The 
compilation of datasets consisted of 161 population samples reported in fourteen peer-
review Journals from January 2001 to December 2010 and 33 unpublished datasets 
which were submitted directly to the AFND. The criteria applied for the selection of 
populations are described in Section 2.2.3. 75 out of the 194 population samples 
corresponded to individuals that were typed at allele level (3, 5 and/or 7 digits). 108 out 
of the 194 population samples contained genotype frequency information on 12,291 
individuals. In order to compare the frequency distribution of genotypes among 
different populations, samples were classified in ten geographical regions: Asia (ASIA), 
Australia (AUST), Eastern Europe (EEUR), Middle East (MIDE), North Africa 
(NAFR), North America (NAME), Pacific (PACI), Sub-Saharan Africa (SAFR), South 
and Central America (SCAM) and Western Europe (WEUR).  
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6.2.2 Frequency data and terminology  
 
Frequency datasets used for the analysis of KIR genes were available in two formats: (i) 
gene/allele frequencies and (ii) genotype frequencies.  
 
Gene/allele frequencies  
 
A total of 4,922 records containing data on frequencies at gene or allele level were 
included in the analysis. Frequency information for each KIR gene was given as gene 
frequency (percentage of individuals carrying the gene) or allele frequency (proportion of 
allele copies in the gene). Allele frequencies submitted to the AFND were given in four-
decimal format whereas gene frequencies were available in percentages with two 
decimals of precision.  
 
Genotype frequencies 
 
Genotype data comprised 2,600 genotype frequency records (percentage of individuals 
carrying the presence or absence of KIR genes) which were included in the analysis. 
KIR genotypes consisted of the presence or absence of the following genes: KIR2DL1, 
KIR2DL2, KIR2DL3, KIR2DL4, KIR2DL5, KIR2DP1, KIR2DS1, KIR2DS2, KIR2DS3, 
KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2, KIR3DL3, KIR3DP1 and KIR3DS1. 
 
6.2.3 Construction of the KIR genotype database 
 
The KIR genotype database was implemented in the AFND based on the concept of a 
genotype comparison performed by Rajalingam and colleagues which consisted of a 
preliminary list of 47 distinct genotypes from twelve different populations (Rajalingam 
et al. 2002). In 2008, the list was subsequently extended to include more data from 
which 179 distinct genotypes in 42 populations were reported and supplied as an Excel 
spreadsheet file (Rajalingam et al. 2008). In order to provide the scientific community 
with an up-to-date list and allow automated submission of new genotype findings, an 
online genotype capture module was developed and included in the AFND website 
(Figure 6.1). Additionally, all populations listed in the AFND which had been inputted 
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for gene/allele frequency data were verified for genotype data. Then, genotype data 
reported in literature were inputted via the online module. The first entries 
corresponded to the 179 genotypes in the 42 populations referenced in Rajalingam‟s 
publication (Rajalingam et al. 2008). KIR genotypes were identified in the AFND by the 
assignment of a consecutive identifier (ID) number. The ID numbers reported by 
Rajalingam and colleagues were used as a referencing index where possible. All 
genotypes included in the original list published by Rajalingam and colleagues were 
validated for duplications. During this step, eight genotypes were detected to present 
duplications and thus were excluded from the initial list. The IDs of the duplicated 
genotypes were subsequently occupied by novel genotypes submitted to the AFND. For 
each new genotype, a consecutive number was assigned to the new entry. Internally, 
genotypes were stored as binary data to indicate the presence (1) or absence of the gene 
(0). However, in some populations the typing of certain genes was not reported by 
authors. In these cases, a letter “n” was used to denote that the genotype was „not typed‟ 
at that particular locus.  
 
 
Figure 6.1: Screenshot of the KIR genotype submission form. 
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6.2.4 Data analysis 
 
Demographic and frequency datasets were administered using the MySQL database 
system which constitutes the back-end of the AFND. To investigate the frequency 
distribution of KIR genes, statistical analyses were carried out using the Predictive 
Analytics Software (PASW) Version 18. 
 
6.2.5 Data visualisation 
 
To illustrate the geographical location and occurrence of the KIR genes across the 
world, overlaid maps were automatically generated using the frequency distribution map 
tool described in Section 3.4.1. The automated maps were based on the coordinates 
available for each of the populations with KIR data. 
 
6.3 Results 
 
6.3.1 Summary of data available in the AFND for KIR 
 
To explore the availability and type of data submitted to the AFND, all 194 KIR 
population samples were classified according to the level of resolution (gene level or at 
alleles with 3, 5, 7 digits) employed in the allele determination. Table 6.1 shows the 
organisation of KIR data according to the number of populations and individuals typed 
by level of resolution. For instance, 166 population samples contained frequency data 
for the KIR2DL1 gene of which only nine populations had alleles determined at 3-digits 
resolution. KIR3DS1 was the locus with the most data available at gene level with 171 
population samples. Conversely, KIR2DL5A and KIR2DL5B were the genes containing 
the least data with only fourteen and fifteen population samples respectively. The low 
number of submissions for KIR2DL5A and KIR2DL5B can be explained by the fact 
that these genes are relatively new (in terms of allele detection) and submissions were 
reported in the past as KIR2DL5. Also, pseudogenes KIR2DP1 and KIR3DP1 were 
reported in less than a half of the populations due to many publications excluding the 
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analysis of these genes. KIR3DL1 and KIR3DS1 were the genes with more information 
at allele level, the main reason was due to one publication by Norman and colleagues 
being performed to investigate selection on the KIR3DL1 and KIR3DS1 genes using the 
data from twenty-eight populations (Norman et al. 2007). Interestingly, only five 
populations have included data on alleles typed at seven-digit resolution. Although 198 
different alleles with seven digits were described in the IPD-KIR database as of release 
2.4.0 (April 2011), only nineteen of these alleles have been reported in the AFND (data 
not shown in table). 
 
Table 6.1: KIR populations in the AFND by locus and level of resolution 
KIR locus 
Gene level  3-digits  5-digits  7-digits 
Pops 
Sample 
Size 
 Pops 
Sample 
Size 
 Pops 
Sample 
Size 
 Pops 
Sample 
Size 
 KIR2DL1  166 17,767  9 810  4 461  1 100 
 KIR2DL2  168 18,897  15 1,342  - -  - - 
 KIR2DL3  168 18,897  14 1,345  - -  - - 
 KIR2DL4  131 15,750  20 2,080  20 2,080  3 202 
 KIR2DL5  123 14,464  - -  - -  - - 
 KIR2DL5A  14 1,613  6 687  1 100  2 175 
 KIR2DL5B  15 1,713  6 687  1 100  2 175 
 KIR2DP1  95 10,666  - -  - -  - - 
 KIR2DS1  168 17,997  8 738  1 100  - - 
 KIR2DS2  168 17,997  2 175  2 175  - - 
 KIR2DS3  140 16,441  5 592  3 329  - - 
 KIR2DS4  136 16,132  17 1,989  12 1,321  - - 
 KIR2DS5  136 16,200  9 839  1 100  - - 
 KIR3DL1  167 18,852  54 7,408  54 7,408  - - 
 KIR3DL2  134 15,864  15 1,826  2 286  - - 
 KIR3DL3  120 14,658  2 169  2 169  - - 
 KIR3DP1  88 9,702  5 668  - -  - - 
 KIR3DS1  171 20,990  48 5,066  41 4,310  - - 
Data available in the AFND as of May 2011 
 
The analysis of data availability was extended to examine whether alleles described in 
release 2.4.0 of the IPD-KIR database (Robinson et al. 2005) were reported in the 
submissions to the AFND. Not surprisingly, only one third of the alleles described in 
release 2.4.0 were found in populations from AFND. KIR2DL5B and KIR3DS1 were 
the genes with more allele confirmations containing more than eighty percent of the 
alleles confirmed each (Table 6.2). On the contrary, KIR3DP1 and KIR2DP1 
pseudogenes contained the lowest number of confirmations. In the case of KIR2DP1 
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none of the alleles was confirmed in the AFND. The lack of allele information in 
several genes can be explained by the relatively new definition of many of the KIR 
alleles. For instance, the first release (1.0.0) generated in 2003 in the IPD-KIR database 
consisted of only 87 alleles (Marsh et al. 2003). However, in release 2.4.0, more than one 
hundred novel alleles were reported compared to the previous release 2.3.0 (August 
2010).  
 
Table 6.2: Confirmations of KIR alleles in the AFND 
KIR locus 
Number of alleles in 
IPD-KIR a 
Alleles reported to 
AFND b (%) 
KIR2DL1 43 28 (65.1) 
KIR2DL2 27 5 (18.5) 
KIR2DL3 32 7 (21.9) 
KIR2DL4 47 30 (63.8) 
KIR2DL5A 15 7 (46.7) 
KIR2DL5B 25 22 (88.0) 
KIR2DP1 22 0 (0.0) 
KIR2DS1 15 7 (46.7) 
KIR2DS2 22 7 (31.8) 
KIR2DS3 13 10 (76.9) 
KIR2DS4 30 14 (46.7) 
KIR2DS5 16 11 (68.8) 
KIR3DL1 70 47 (67.1) 
KIR3DL2 84 17 (20.2) 
KIR3DL3 101 51 (50.5) 
KIR3DP1 23 2 (8.7) 
KIR3DS1 16 13 (81.3) 
a Number of alleles reported as of release 2.4.0 April 2011 in the IPD-KIR database (Robinson et al. 2005);  
b Number of alleles confirmed in the AFND as of May 2011. 
 
6.3.2 Frequency distribution of KIR genes 
 
There is a wide variation in the frequencies of the KIR genes between worldwide 
populations. Based on this premise, gene frequencies (percentage of individuals carrying the 
gene) were compiled to examine the overall frequency distribution of the seventeen KIR 
genes. The analysis was divided into two sections: (i) estimation of the overall 
frequencies by gene and (ii) investigation of the occurrence of a particular gene by 
geographical region.  
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6.3.2.1 Overall frequency of KIR genes 
 
The first analysis consisted of the examination of frequencies of KIR genes (Figure 6.2). 
The analysis showed that framework genes (KIR2DL4, KIR3DL2, KIR3DL3 and 
KIR3DP1) were present in nearly all individuals with few exceptions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Overall gene frequencies in KIR populations on AFND. 
Figure showing the overall gene frequencies organised by gene type: inhibitory (blue), activating (light pink), 
framework gene (violet) or pseudogene (purple). Outliers (values outside range) are denoted by a circle (o) and the 
number of occurrences. Extreme values (values exceeding more than three times the inter-quartile range) are 
displayed as asterisks (*) along with the number of cases. For instance, in KIR2DL3, the majority of frequencies were 
between 83-99% with four cases of frequencies around 65%. 
 
As shown in Figure 6.2, inhibitory KIR genes KIR2DL1, KIR2DL3 and KIR3DL1 were 
found in the majority of the individuals whereas KIR2DL2 and KIR2DL5 (including 
KIR2DL5A and KIR2DL5B) contained the lowest frequencies among the inhibitory 
genes. Activating KIR genes (KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5 and 
KIR3DS1) showed great variation in the presence/absence in the populations studied. 
All activating genes presented overall frequencies below 60%, except KIR2DS4 which 
had frequencies over 90%. The high frequencies observed in KIR2DL1, KIR2DL3, 
KIR3DL1 and KIR2DS4 can be explained by the fact that these genes composed the A 
(%) 
Inhibitory Activating Framework Pseudogene 
Chapter 6      KIR genes and genotype frequencies 
 
138 
 
haplotype group which is present in all populations (See Section 6.3.3). Also of interest, 
the box-and-whisker diagram, shown in Figure 6.2, depicts certain genes such as 
KIR2DS1, KIR2DS2 and KIR3DS1 with many occurrences of outliers and/or extreme 
values (values outside the expected range) leading to the investigation of the possible 
origin of these frequencies. 
 
6.3.2.2 Frequency distribution of KIR genes by geographical region 
 
As frequencies for each specific gene may vary considerably between individuals from 
different populations, the analysis was further extended to estimate frequencies by 
grouping populations belonging to a similar geographical region. Simple statistical 
analyses based on the generation of histograms and box-and-whisker plots were used to 
examine the frequencies of each KIR gene.  
 
Inhibitory genes 
 
KIR2DL1 presented very high frequencies (90-100%) in more than eighty percent of 
the populations (Figure 6.3A). However, three populations submitted to the AFND 
contained low frequencies: one population from Taiwan (65.6%) (Yen et al. 2006), one 
population from Yucpa people in Venezuela (70.5%) (Gendzekhadze et al. 2006) and 
one population from Aboriginal people in Australia (72%) (Toneva et al. 2001). It can 
be observed from Figure 6.3A that two Australian populations had the lowest overall 
frequencies by geographical region. This also was illustrated after the generation of a 
map showing the occurrence of the KIR2DL1 gene (Figure 6.4A). KIR2DL2 gene 
showed great variation whereby the majority of frequencies (91 cases) were reported 
from 40-60% (Figure 6.3B). Low frequencies were principally observed in three Oriental 
populations – two populations from Japan with 8.5% and 11.4% (Single et al. 2007a; 
Yawata et al. 2006) and one population with Atayal people from the Taroko Region in 
Taiwan (Single et al. 2007a), which surprisingly, presented complete absence of this 
gene. On the other hand, Nasioi people from Papua New Guinea were reported to 
contain the highest frequency with 95.5% (Single et al. 2007a). A high variation in 
frequencies was observed in Asian populations as shown in (Figure 6.3B). This 
variability can also be graphically illustrated in Figure 6.4B in which low frequencies are 
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mainly observed in East Asia, contrary to the high frequencies reported in West Asia. 
KIR2DL3 was found to contain high frequencies (85-95%) in more than half of the 
populations reported in the database with this gene (Figure 6.3C). The two lowest 
frequencies were observed in two very geographically-distant populations: one 
population from Romania (56.5%) (Constantinescu et al. 2006) and the other in Nasioi 
individuals in Papua New Guinea (59.1%) (Single et al. 2007a). KIR2DL5 was found to 
present a wide range of frequencies, the higher incidences being in twenty-nine 
populations with frequencies from 55-60% (Figure 6.3D). The lowest frequencies were 
observed in a population from South Asian individuals (Indian) living in England (26%) 
(Cook, Moss & Briggs 2003) and a population from Uzbekistan (28.4%) (Unpublished 
data). The highest frequencies were found in populations from Kanikar, people from 
the Tamil Nadu State in India (86%) (Rajalingam et al. 2008), West Papua Province 
(formerly known as Irian Jaya) in the New Guinea Island (86%) (Velickovic et al. 2009) 
and the Amazon Region in Brazil (85%) (Ewerton et al. 2007). Despite the low data 
available for KIR2DL5A and KIR2DL5B, these loci were also included in the analysis to 
investigate possible patterns of these two similar structured genes (Figure 6.3E and 
Figure 6.3F). Most frequencies for KIR2DL5A were observed to vary from 30-40%, 
with the lowest frequencies found in two Sub-Saharan African populations – Comoros 
(13.0%) (Frassati et al. 2006) and Bubi people from Bioko Island in Equatorial Guinea 
(3.5%) (Unpublished data). The highest frequencies observed in this gene were found in 
one population from Uruguay (47.9%) (Unpublished data), and in one population from 
the Terceira Island in Azores (46.2%) (Fialho et al. 2009). KIR2DL5B was found to 
present frequencies from 20-30% in eight of the fifteen population samples containing 
data for this gene. The lowest frequency (5.8%) for the KIR2DL5B gene was found in 
Han individuals from the Zhejiang Province in China (Jiang et al. 2005) whereas the 
peak frequency (45.8%) was observed in Bubi people from Equatorial Guinea. Finally, 
KIR3DL1 was observed to present high frequencies (90-100%) in 132 of the 167 
populations with data on this gene (Figure 6.3G). However, low frequencies were found 
in one Australian and two Pacific Islands populations – Papua New Guinea Irian Jaya 
(46.0%) (Velickovic et al. 2009), Australia South Aborigine (55.0%) (Toneva et al. 2001) 
and Papua New Guinea Nasioi (59.1%) (Single et al. 2007a). 
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Activating genes 
 
Activating genes were observed to present a much wider range of frequencies. 
KIR2DS1 was found in 58 populations in a range from 35-45% (Figure 6.3H). As 
illustrated in Figure 6.4F, low frequencies were predominantly seen in African 
populations. In contrast, the highest frequencies were mainly reported in indigenous 
populations in Australia and Pacific Islands, in which Nasiois from Papua New Guinea 
presented the highest incidence with 90.9% (Single et al. 2007a). KIR2DS2 was found 
to vary from 40-60% in nearly half of the populations typed for this locus (Figure 6.3I). 
Several populations in East Asia presented the lowest frequencies as shown in Figure 
6.4G. For instance, a population from Japan reported the presence of this gene in 8.5% 
of the individuals (Single et al. 2007a). More outstanding was the report in the same 
study from a population of Taiwan in which the full absence of this gene was reported 
(Single et al. 2007a). The highest frequencies in the KIRDS2 gene were shown in one 
Australian and one Pacific Island populations – Australia South Aborigine (84.0%) 
(Toneva et al. 2001) and Papua New Guinea Nasioi (90.9%) (Single et al. 2007a). 
KIR2DS3 appeared to have much lower frequencies than the rest of the activating 
genes – with frequencies from seventy populations between 20-35% (Figure 6.3J). 
Interestingly, it was observed that four Amerindian populations presented the complete 
absence of this gene – two Venezuelan populations (Yucpa and Bari) (Gendzekhadze et 
al. 2006), one population from Argentina (Wichis from the Salta Region) (Unpublished 
data) and one population corresponding to Tarahumara people located in the North of 
Mexico (Gutierrez-Rodriguez et al. 2006). The highest frequency (81%) was observed in 
Aboriginal individuals living in the South of Australia (Toneva et al. 2001). KIR2DS4 
contained the highest frequencies reported in activating genes in which ninety-six 
populations reported frequencies over 90% (Figure 6.3K). Surprisingly, a very low 
frequency (31%) was observed in individuals from the Guanacaste Province in Costa 
Rica (Carrington et al. 2005). KIR2DS5 was mainly found in frequencies from 20-40% 
(Figure 6.3L). As shown in Figure 6.4J, the lower frequencies were found in South East 
Asia and in some Austronesian Islands, e.g. Borneo Kalimantan (10%) (Velickovic et al. 
2009). Higher frequencies were mainly presented in India and in the majority of the 
Amerindian populations, such as in individuals from the Amazon Region in Brazil 
which reported a frequency of 90% (Ewerton et al. 2007). In the case of KIR3DS1, 
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frequencies were generally found to range from 35-45% as reported by seventy-eight 
populations (Figure 6.3M). Lower frequencies were observed in all populations from 
Sub-Saharan Africa as depicted in Figure 6.4K. Conversely, highest frequencies 
corresponded to one population in Australia (78%)  (Toneva et al. 2001) and one 
population from Karitiana people from the Rondonia State in Brazil (80%) (Single et al. 
2007a). The extraordinary similarities of gene occurrence with the KIR2DS1 gene are 
graphically represented in the overlaid maps (Figure 6.4F and Figure 6.4K). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Frequency distribution of the KIR genes by geographical region. 
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Figure 6.3: Frequency distribution of the KIR genes by geographical region (Continued). 
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Figure 6.3: Frequency distribution of the KIR genes by geographical region (Continued). 
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Figure 6.3: Frequency distribution of the KIR genes by geographical region (Continued). 
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Figure 6.3: Frequency distribution of the KIR genes by geographical region (Continued). 
This figure shows the counts of frequencies in the KIR2DL1 gene (left) and the variation by geographical region 
(right). ASIA=Asia; AUST=Australia; EEUR=Eastern Europe; MIDE=Middle East; NAFR=North Africa; 
NAME=North America; PACI=Pacific; SAFR=Sub-Saharan Africa; SCAM=South and Central America; 
WEUR=Western Europe. In the case of KIR2DL5A and KIR2DL5B, gaps may be explained by limited number of 
populations typed for these two genes. 
 
Framework genes 
 
KIR2DL4, KIR3DL2, KIR3DL3 and KIR3DP1 framework genes have been recognised 
by their presence in nearly all individuals. However, several studies submitted to the 
AFND reported the absence of one of these genes in some individuals. Table 6.3 
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genes. From this table can be observed that the KIR2DL4 gene was found to be absent 
in ten individuals in seven populations, KIR3DL2 in fourteen individuals in six 
populations and KIR3DL3 in six individuals in five populations. Finally, the pseudogene 
KIR3DP1, which is also recognised as a framework gene presented the highest number 
of cases with gene absence with twenty-nine individuals in twelve populations.  
 
Table 6.3: Populations with the absence of a KIR framework gene 
Locus Population 
Sample 
Size 
Gene 
Frequency 
(%) 
Individuals 
with gene 
absence 
Reference 
2DL4 Poland KIR 690 99.7 2 (Majorczyk et al. 2007) 
2DL4 Trinidad South Asians KIR 108 99 1 (Norman et al. 2002) 
2DL4 Pakistan Karachi KIR 78 99 1 (Norman et al. 2002) 
2DL4 Brazil Rio de Janeiro Mixed KIR 166 99.4 1 (NR) 
2DL4 Turkey South KIR 200 99 2 (+) 
2DL4 Solomon Islands KIR 40 95 2 (Taniguchi & Kawabata 
2009) 
2DL4 Equatorial Guinea Bioko Island Bubi 
KIR 
95 99 1 (NR) 
3DL2 Japan Tokyo KIR 239 99.2 2 (Miyashita et al. 2006) 
3DL2 Brazil Amazon KIR 40 98 1 (Ewerton et al. 2007) 
3DL2 Japan Kyoto KIR 240 99.6 1 (Mogami et al. 2007) 
3DL2 Turkey South KIR 200 99.5 1 (+) 
3DL2 Azores Terceira Island KIR 117 95.7 5 (Fialho et al. 2009) 
3DL2 Taiwan KIR 96 95.8 4 (Yen et al. 2006) 
3DL3 Tokelau KIR 47 98 1 (Velickovic, Velickovic 
& Dunckley 2006) 
3DL3 Morocco Chaouya KIR 67 97 2 (NR) 
3DL3 Brazil Rio de Janeiro Mixed KIR 166 99.4 1 (NR) 
3DL3 Turkey South KIR 200 99.5 1 (+) 
3DL3 Venezuela Mestizo KIR 205 99.5 1 (Conesa et al. 2010) 
3DP1 France West KIR 108 97 3 (Denis et al. 2005) 
3DP1 Spain Basque KIR 71 99 1 (Santin et al. 2006) 
3DP1 Cook Islands KIR 48 94 3 (Velickovic, Velickovic 
& Dunckley 2006) 
3DP1 Samoa KIR 50 98 1 (Velickovic, Velickovic 
& Dunckley 2006) 
3DP1 Tokelau KIR 47 96 2 (Velickovic, Velickovic 
& Dunckley 2006) 
3DP1 Uzbekistan KIR 67 98.5 1 (NR) 
3DP1 Canada Iranian KIR 68 95.6 3 (NR) 
3DP1 Turkey South KIR 200 99 2 (+) 
3DP1 Solomon Islands KIR 40 95 2 (Taniguchi & Kawabata 
2009) 
3DP1 Macedonia KIR 214 99.5 1 (Djulejic et al. 2010) 
3DP1 Equatorial Guinea Bioko Island Bubi 
KIR 
95 99 1 (NR) 
3DP1 Azores Terceira Island KIR 117 92.3 9 (Fialho et al. 2009) 
NR=Populations submitted to the AFND with no associated bibliographic reference. +DOI: 10.1007/s11033-011-
0945-5 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                         
 
 
 
 
 
 
Figure 6.4: Ocurrence of KIR genes in worldwide populations. 
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Figure 6.4: Occurrence of KIR genes in worldwide populations (Continued). 
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Figure 6.4: Occurrence of KIR genes in worldwide populations (Continued). 
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6.3.3 The KIR genotype database 
 
A key concept in the investigation of the KIR gene content is the analysis of the 
genotypes (presence / absence of the gene) which are formed by the combination of A 
and/or B haplotypes. KIR haplotypes can be identified by familial studies. However, 
when the ability to perform such assays is not accessible, KIR genotypes can serve as a 
useful resource to understand the composition of an individual‟s profile. To investigate 
the KIR gene content organisation, 108 populations including 12,291 individuals with 
KIR genotype information were submitted to the AFND. From this compilation, a total 
of 396 different genotypes were identified. Figure 6.5 displays ten of the most common 
genotypes in the AFND representing 74.1% of the individuals tested. Based on the 
nomenclature adopted to identify the combination of haplotypes (AA and Bx), it was 
shown that one genotype AA (Genotype 1) was present in all populations in ~30% of 
individuals. The other nine common genotypes identified as Bx represented ~44% of 
the individuals.  
 
 
Figure 6.5: Most common KIR genotypes in worldwide populations 
KIR genotypes are displayed by the presence (grey) or absence (blank) of each gene. 
 
Despite the high percentage of individuals possessing one of these common 
combinations, 206 genotypes were identified to be unique occurring in only one 
individual in one population (Figure 6.6). Some of these genotypes could be the result of 
inaccurate typing. On the contrary, fifty-six genotypes representing ninety percent of the 
individuals typed were found in more than ten populations. Occasionally, AA genotypes 
had one of the genes normally present on an A haplotype missing (Figure 6.7). To aid 
the assessment of novel genotypes, the Genotype Frequency Search described in 
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Section 3.4.3 is used as a practical approach by displaying the closest genotypes (those 
differing in one gene) when an input profile is not listed after a search (See Figure 3.12). 
 
 
Figure 6.6: Occurrence of distinct genotypes in populations and individuals. 
Number of genotypes (bars) and individuals (lines) in different populations are shown in this figure. * 185 genotypes 
occurred in one individual, 15 genotypes in two, 5 in three and 1 in four individuals. 
 
 
Figure 6.7: Example of KIR AA genotypes with one gene missing. 
 
 
The analysis of genotype data was extended to examine the occurrence of these 
genotypes by geographical region (Table 6.4). Approximately 40% of the existing 
genotypes were reported in Asian individuals. Interestingly, the number of genotypes 
found in Eastern and Western Europe differed slightly (149 and 141 respectively) 
considering the number of populations reported in both regions (7 and 19 respectively). 
The number of unique genotypes was not necessarily proportional to the number of 
individuals tested. For example, twenty-three distinct genotypes were specific to 
* 
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Western Europe populations and twenty-two in populations from the Pacific despite 
nearly seven fold more individuals from Western Europe being typed. 
 
Table 6.4: Distribution of KIR genotypes by geographical region 
Geographical region Populations 
Total 
genotypes 
Unique 
genotypes 
Individuals 
Asia 24 160 34 2,326 
Australia 1 6  0 42 
Eastern Europe 7 149 37 1,267 
Middle East 11 122 29 1,390 
North Africa 1 22 2 67 
North America 13 111 17 1,536 
Pacific 9 92 22 427 
South and Central America 16 136 31 1,868 
Sub-Saharan Africa 7 60 11 461 
Western Europe 19 141 23 2,907 
Total 108   206 12,291 
 
 
Another analysis performed in the examination of the gene content was the 
investigation of the presence/absence of two KIR genes within a given genotype by 
pairwise comparisons. Figure 6.8 shows a summary of the analysis performed in the 
sixteen KIR genes (KIR2DL5A and KIR2DL5B data combined), according to the 
reports from genotype data. This figure presents an outline of the linkage disequilibrium 
found in the KIR gene cluster. For instance, in the 108 populations with KIR genotype 
frequency data, 47% of the times that KIR2DS2 was present, KIR2DL2 was also present 
(Figure 6.8A) and 50% of the times that KIR2DS2 was negative KIR2DL2 was also 
negative (Figure 6.8B) illustrating the high LD between these two genes [See reports of 
linkage disequilibrium in (Middleton 2005)]. As expected, the highest percentages were 
found in the framework genes KIR2DL4, KIR3DL2 and KIR3DL3, except KIR3DP1 
which was not determined in many of the populations. The analysis can also be 
extended to determine how many individuals had one gene and not the other. Thus, this 
tool can be useful for those individuals wishing to understand the LD between certain 
genes. Results displayed as percentages in this figure are available in the KIR 
breakdowns section in the AFND website at: 
 http://allelefrequencies.net/kir6004a.asp. 
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Figure 6.8: Linkage disequilibrium in the KIR genes. 
 
6.4 Discussion 
 
The design of a database to contain frequency data on the frequencies of KIR genes, 
complemented by searching mechanisms, has been shown to provide a convenient 
approach in the investigation of KIR genes among worldwide human populations. The 
KIR populations available in the AFND encompass the largest collection of frequency 
A) 
B) 
47% 2DS2 (+), 2DL2 (+) 
(+) 
(+) 
(-) 
(-) 
50% 2DS2 (-), 2DL2 (-) 
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data of this genomic region. These data has also assisted in the confirmation of KIR 
alleles described in the IPD-KIR database which stores the DNA sequence variants. 
Although it would be premature to use AFND to determine the rarity of KIR alleles, 
this resource can be considered as an initial approach to ascertain the presence of the 
existing alleles in the same fashion as in HLA alleles.  
 
In the last decade, researchers have performed several analyses to investigate the 
occurrence of genes in different populations. The most extensive analysis involving 
comparisons of different populations was a study carried out by Single and colleagues in 
which thirty populations across the world were genotyped to investigate diversity and 
coevolution between KIR genes and HLA ligands (Single et al. 2007a). Those 
populations were also submitted to the AFND and included in the analysis described in 
this chapter. The enrichment of the database with data from 194 populations has 
increased significantly the amount of information to perform wider analysis of KIR 
genes. The results presented in this section provided more evidence on the 
characteristics of certain genes such as the absence of framework genes (KIR2DL4, 
KIR3DL2, KIR3DL3 and KIR3DP1) observed in several individuals in various 
populations across the world (see Table 6.3). This information was used as a reference 
in a study by Nowak and colleagues in which a comparison of individuals lacking the 
KIR2DL4 gene was used to demonstrate that the absence of this gene is not essential 
for human reproduction (Nowak et al. 2011).  
 
One of the major outcomes from the results presented in this chapter was the Genotype 
Frequency Database, which represents an initial reference for those investigators 
interested in the analysis of the KIR gene content expressed in different individuals. 
Presented as a section in a review in Immunology (Middleton & Gonzalez 2010), the 
genotype list has been frequently adopted by researchers as a referencing index in the 
reporting of existing and novel genotypes (Djulejic et al. 2010; Shi et al. 2011; Zhu et al. 
2010; Zhu et al. 2011). It is expected that the use of genotype IDs specified in the 
AFND will be considered as official by international accreditation bodies in the future. 
Another interesting finding in the KIR Genotype Database was that from the 396 
genotypes reported, 206 were found to be unique to one population. These genotypes 
may be the product of an erroneous tissue typing, however it was not possible in this 
study to assess the accuracy of the typing of these genotypes. However, the GFS 
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described in Section 3.4.3 may help in the identification of false positive and false 
negative of KIR genes.  
 
Linkage disequilibrium in the KIR region has also been under investigation by scientists 
in recent years (Gourraud et al. 2010). Pairwise comparisons of KIR genes using the 
online tool described in Section 6.3.3 can be used as a complementary resource of the 
study performed by Gourraud and colleagues in which the use of familial data was 
employed to investigate the LD in individuals from Northern Ireland (Gourraud et al. 
2010). The LD analysis tool can also be expanded to include additional criteria such as 
geographical region, country, etc., increasing the usefulness of this automatic search. 
Also of interest was the analysis of the occurrence of KIR genes in the different 
geographical regions with the use of overlaid maps. These maps may be used as an 
illustrative representation of relationships between KIR genes such as the strong LD 
observed in KIR2DL2 and KIR2DS2 (Figure 6.4B and 6.4G). 
 
The KIR module has been used in a wide range of projects being cited in more than 
twenty peer-reviewed publications according to recent figures from the Web of 
Knowledge as of August 2011. Some of the studies included the investigation of the 
structure of ligand recognition by NK cells receptors (Joyce & Sun 2011), understanding 
the stratification and cell function in European populations (Guinan et al. 2010), among 
many others. 
 
Ongoing developments include the incorporation of virtual haplotypes into the KIR 
Genotype Database section. Based on data generated from a previous study in which 
KIR haplotypes were estimated using allele resolution from Northern Ireland families 
(Middleton, Meenagh & Gourraud 2007), this tool will allow users to enter their own 
genotype data and obtain the corresponding predicted haplotypes. Because gene content 
is suspected to have different effects in infectious and autoimmune diseases, the module 
will also provide analysis of these genotypes into frequencies of AA and Bx haplotype 
groups.  
 
Future work in the investigation of KIR genes includes the continuation of a project of 
the 15th IHWS which collected KIR genotypes and the corresponding HLA ligand from 
individuals in twenty three worldwide populations (Hollenbach et al. 2010). Although 
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KIR and HLA genes are on different chromosomes it appears that associations between 
the presence/absence of KIR genes and the corresponding presence/absence of the 
HLA ligand (Parham 2005b). Thus, the collection of these data and development of the 
corresponding modules will allow investigators to examine the linkage between KIR and 
HLA genes, through the analysis of raw data (KIR individual‟s genotypes) from 
worldwide populations.  
 
6.5 Conclusions 
 
This chapter described a set of analyses which were performed for the investigation of 
the frequencies of KIR genes among individuals from different populations. The results 
presented in this chapter provide an insight into the extensive variability presented in 
this genomic region. The analyses carried out in this investigation included the 
dissemination of data available in the AFND in different formats such as allele, gene 
and genotype frequency. The analysis of frequency data was strongly supported by the 
use of maps generated by tools available in the AFND website. Results described in the 
chapter provided a wide and up-to-date outline of the relationships found among the 
presence of KIR genes in different geographical regions. At present, the KIR section in 
the AFND encompasses the largest source of data related to this polymorphism.  
 
 
  
 
 
Chapter 7  
Other immune genes: MIC and 
Cytokine gene polymorphisms 
 
7.1 Introduction 
 
Chapters 4 and 6 presented an outline on the frequencies of two of the most 
polymorphic regions in the human genome, HLA and KIR. The information 
expounded in these two chapters described a compendium of the frequencies observed 
in genes and corresponding alleles among worldwide human populations.  
 
This chapter focuses on the investigation of two additional set of immune genes which 
were included in the AFND: (i) the major histocompatibility complex Class I chain- 
related genes (MIC) and (ii) several cytokine gene polymorphisms. The aim of this 
chapter is to present a similar synopsis on the frequencies of these genes among 
populations and describe a set of online modules that were implemented in the AFND 
website for the investigation of these genes. 
 
As mentioned in Section 1.6.1, MIC genes encode a set of proteins expressed at the 
surface of tissue cells and fibroblasts. The MIC genomic region comprises seven loci in 
which MICA and MICB are the only genes which encode for proteins. MICA and 
MICB genes also contain a considerable polymorphism with 73 and 31 alleles 
respectively as of release 3.3.0 in the IMGT/HLA database. Prior to the official 
nomenclature of MICA, alleles were classified into eight variants (A4, A5, A5.1, A6, A7, 
A9, A9.1 and A10) based on microsatellites differences at exon 5. Thus, the examination 
of the different types of MIC frequency data (microsatellites and official alleles) 
published in the literature has been a primary need for researchers. With the availability 
of sequence data provided in the IMGT/HLA database, the mapping of MICA 
microsatellites and MICA official alleles can be performed by examining the specific 
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codons within the sequence at exon 5. For instance, MICA A4 presents the same four 
Alanine repeats between codons 291-304 as the official MICA*001, *007:01, *007:03, 
*012:01, *018:01, *018:02, *029, *043, *045, *051 and *061 alleles. Therefore, a MIC 
module was implemented in the AFND to assist scientists in the analysis of 
microsatellites and official allele nomenclatures. Additionally, the analysis of several 
diseases has been expanded to investigate the relationships between MICA and HLA-B 
due to the proximity of these two loci in the chromosome. To provide scientists with a 
computational tool for the examination of MICA and HLA-B association frequencies, 
this chapter also includes an online searching mechanism to consult data reported in 
more than fifty worldwide human populations. 
 
To extend the polymorphism covered in the AFND, cytokine genes, which are protein 
molecules secreted by different cells in the human body, were also included in the 
database. As reviewed in Section 1.6.2, cytokines are believed to participate in the 
regulation of innate and adaptive immune response and are known to present high 
polymorphism in specific regions such as SNPs or microsatellites leading to the 
importance of investigating the variability of these genes in different individuals. 
Following a similar scheme for the investigation of gene polymorphisms as described in 
previous chapters, a module in the AFND was incorporated to examine the frequencies 
of cytokine gene polymorphism across worldwide populations. As such, this chapter 
includes a summary of the cytokine gene polymorphisms reported in more than one 
hundred populations and a set of online tools that were implemented in the AFND for 
the analysis of the polymorphisms. 
 
 
7.2 Materials and methods 
7.2.1 Population datasets 
 
The criteria applied for the selection of population datasets are described in the list of 
protocols reviewed in Section 2.2.3. Both datasets (MIC and Cytokine gene 
polymorphisms) were captured via the online submission form described in Section 
2.2.2. 
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MIC population samples 
 
Fifty-eight population samples covering 7,649 healthy unrelated individuals containing 
data on MIC frequencies were included in the analysis. The collection of datasets 
consisted of fifty-two populations reported in fifteen peer-review Journals from January 
1997 to December 2010, five populations available in the Proceedings of the 13th IHWS 
and one unpublished population directly submitted to the AFND. In order to compare 
the frequency distribution of MIC genes among different demographic groups, samples 
were classified in nine geographical regions: Asia (ASIA), Eastern Europe (EEUR), 
Middle East (MIDE), North Africa (NAFR), North America (NAME), Pacific (PACI), 
Sub-Saharan Africa (SAFR), South and Central America (SCAM) and Western Europe 
(WEUR). None of the populations submitted to the AFND contained data on 
individuals from Australia. 
 
MICA and HLA-B association datasets 
 
In order to examine the relationships between MICA and HLA-B, 20 of the 58 
populations containing data on MICA and HLA-B frequencies were submitted to the 
AFND. The compilation of MICA and HLA-B data consisted of 257 frequency records 
reported in 2,426 individuals. 
 
Cytokine population samples 
 
One hundred and thirteen population samples in 18,246 healthy unrelated individuals 
containing data on frequencies of cytokine polymorphisms were submitted to the 
AFND and included in the analysis. The assemblage of datasets corresponded to 
seventy-five publications from a review of fifteen peer-reviewed Journals from January 
2001 to December 2010, eighteen population samples from Proceedings from the 13th 
IHWS and twenty unpublished dataset. All populations containing cytokine frequency 
data were classified into ten geographical regions for further analysis: Asia (ASIA), 
Australia (AUST), Eastern Europe (EEUR), Middle East (MIDE), North Africa 
(NAFR), North America (NAME), Pacific (PACI), Sub-Saharan Africa (SAFR), South 
and Central America (SCAM) and Western Europe (WEUR). 
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7.2.2 MIC and cytokine gene frequency data  
 
Frequency datasets used in the analysis of MIC genes were available at microsatellite 
(e.g. A4, A5, A5.1, etc.) and/or allele level (e.g. MICA*001, MICA*002:01, MICB*001, 
etc). Frequency information for each MIC gene was given as genotype frequency (percentage 
of individuals carrying the allele/microsatellite variant) or allele frequency (proportion of 
allele/microsatellite variant copies in the gene). 709 of the 718 frequency records 
submitted to the AFND contained data on frequencies of MICA gene and only one 
population included the report of nine MICB alleles. 
 
The nomenclature used in the construction of the cytokine module consisted of three 
main components: (i) the gene name followed by a slash symbol (/), (ii) the nucleotide 
position of the SNP or microsatellite variant and (iii) the genotype generated by 
nucleotide combinations. For instance, the codes „AIF-1/-932CC‟, „AIF-1/-932CT‟ and 
„AIF-1/-932TT‟ were used to represent the genotype polymorphisms of the Allograft 
inflammatory factor 1 gene at position -932. Using this notation, a total of 27 cytokine 
genes comprising 51 genotype polymorphisms were submitted to the AFND. Names of 
cytokine genes were stored in the AFND based on the reports from literature, however, 
all cytokine genes were internally mapped to the current notation described in the 
Entrez Gene database (Table 7.1) (Maglott et al. 2011). 
 
Table 7.1: Cytokine names and references used in the AFND 
Cytokine name AFND ID 
Gene Entrez 
Name / ID 
Allograft inflammatory factor 1  AIF-1 AIF1 / 199 
Basic fibroblast growth factor 2 bFGF FGF2 / 2247 
Epidermal growth factor EGF EGF / 1950 
Colony stimulating factor 2 (granulocyte-macrophage) GM-CSF CSF2 / 1437 
Interferon gamma IFNgamma IFNG / 3458 
Insulin-like growth factor 1 IGF-1 IGF1 / 3479 
Interleukin 1 alpha IL-1alpha IL1A / 3552 
Interleukin 1 beta IL-1beta  IL1B / 3553 
Interleukin 1 receptor type I IL1R psti 1970 IL1R1 / 3554 
Interleukin 1 receptor type I IL1RA mspa 111100 IL1R1 / 3554 
Interleukin 2 IL-2 IL2 / 3558 
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Table 7.1: Cytokine names and references used in the AFND 
Cytokine name AFND ID 
Gene Entrez 
Name / ID 
Interleukin 4 IL-4 IL4 / 3565 
Interleukin 4 receptor IL-4R IL4R / 3566 
Interleukin 6 IL-6 IL6 / 3569 
Interleukin 10 IL-10 IL10 / 3586 
Interleukin 12A p35 IL-12 IL12A / 3592 
Interleukin 12B p40 IL-12p40 IL12B / 3593 
Interleukin 13 IL-13 IL13 / 3596 
Interleukin 15 IL-15 IL15 / 3600 
Interleukin 18 IL-18 IL18 / 3606 
Nerve growth factor NGF NGF / 4803 
Platelet-derived growth factor beta polypeptide PDGFB PDGFB / 5155 
Regulated upon Activation Normal T-cell Expressed 
and Secreted 
RANTES CCL5 / 6352 
Transforming growth factor beta 1 TGFbeta1 TGFB1 / 7040 
Tumour necrosis factor TNFalpha TNF / 7124 
Lymphotoxin alpha TNF superfamily member 1 TNFbeta LTA / 4049 
Vascular endothelial growth factor A  VEGF VEGFA / 7422 
 
Frequency data for cytokine gene polymorphisms was entered as genotype frequencies 
(number of individuals carrying the specific cytokine polymorphism genotype). The 
compilation of genotype frequency data consisted of 3,603 frequency records.  
 
7.3 Results 
7.3.1 Major histocompatibility Class I chain-related genes  
 
Three main subjects were investigated in the analysis of MIC frequency data: (i) the 
availability of MICA and MICB according to the level of resolution performed in the 
allele determination, (ii) the frequencies of MIC genes in different populations at allele 
and microsatellite level and (iii) the examination of the occurrence of MICA and HLA-B 
associations. 
 
Chapter 7      Other immune genes: MIC and cytokine gene polymorphisms 
 
162 
 
7.3.1.1 Availability of MIC data in the AFND 
 
After the submission of MIC frequency information in the AFND, all 58 population 
datasets were classified according to the level of resolution of allele typing. Table 7.2 
illustrates the availability of MICA and MICB data at microsatellite and allele level (3, 5 
or 7 digits). Not surprisingly, the vast majority of reports comprised data on MICA 
alleles. 25 of the 58 populations were found to contain frequency data at microsatellite 
level whereas 36 described frequencies using the official nomenclature. Three 
populations reported data at both levels (microsatellites and official alleles). Very limited 
data on MICB was found in the literature. The unique population reported in the 
AFND with MICB data consisted of a population from Thailand and the corresponding 
frequencies are described in this chapter in Section 7.3.1.2.  
 
Table 7.2: Availability of MIC data by level of resolution 
Locus 
Microsatellites  3 digits  5 digits  7 digits 
Pops Indiv  Pops Indiv  Pops Indiv  Pops Indiv 
MICA 25 3,319  36 4,733  21 2,503  N/A  N/A 
MICB  - -   1 100  1 100  - - 
N/A=Not available as MICA locus does not contain alleles at 7 digits. 
 
To extend the analysis of data available, all official alleles described in the IMGT/HLA 
database were examined according to the number of confirmations reported in the 
AFND. Approximately 74% (54/73) of the MICA alleles described in the IMGT/HLA 
database (as of release 3.3.0) was reported in the AFND whereas only six alleles of 54 
were found for MICB as of May 2011.  
7.3.1.2 Polymorphism and diversity of MIC genes among populations 
 
Overall frequencies of MICA microsatellites 
 
All twenty-five populations with MICA microsatellite data were analysed to estimate 
their overall frequencies. As shown in Figure 7.1, MICA A6 was observed to contain the 
highest incidence in that 13 of the 25 populations typed for MICA A6 were found to 
vary from 25-50%. Conversely, MICA A4 was the microsatellite with lowest frequencies 
(5.6-15% in 20 of the 25 populations). The mutational variant MICA A9.1 was reported 
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in only one individual who was from Korea (Sohn et al. 2010), similarly to MICA A10 
which was also found in only one individual from the Hunan Province in China (Tian et 
al. 2006). The A7 microsatellite, which was originally found in a Spanish individual from 
a cohort of celiac disease subjects (Rueda et al. 2002), was not found in information 
submitted to the AFND. Interestingly, MICA*050, the allele counterpart of A7 
microsatellite, was also reported in one individual from Murcia in Spain from a sample 
of 154 healthy unrelated individuals (Lucas et al. 2008).   
 
 
Figure 7.1: Frequency distribution of MICA microsatellites. 
 
 
MICA microsatellites by geographical region 
 
To examine the occurrence of MICA microsatellites by geographical location, all 
populations were grouped in only four regions due to limited data available (Figure 7.2). 
In this figure a consistency can be observed in frequencies of MICA A4 and A9 in all 
four geographical regions. However, the uniformity in frequencies of these two 
microsatellites contrasts with the significant variation shown in MICA A5, A5.1 and A6.  
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Figure 7.2: Frequency distribution of MICA microsatellites by geographical region. 
This figure shows the overall allele frequencies by geographical region. Number of populations considered in the 
analysis is indicated with an „n‟. ASIA=Asia; Geographical regions: EEUR=Eastern Europe; MIDE=Middle East; 
WEUR=Western Europe.  
MICA A4 MICA A5 
MICA A5.1 MICA A6 
MICA A9 
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For instance, in Figure 7.2 it can be observed that Asian populations presented very 
high frequencies for MICA A5 compared to those reported in Eastern and Western 
Europe and Middle East. Likewise, MICA A6 was found to be much more frequent 
(~50%) in the two populations from Middle East than in the rest of geographical 
regions. These high frequencies may be associated to the fact that in these two Middle 
East populations the number of individuals sampled was very small (n=18). 
 
Overall frequencies of MICA alleles 
 
A third analysis was carried out to examine the occurrence of MICA alleles reported in 
the AFND using the official nomenclature. Results were organised according to the 
number of reports in the AFND which are shown in Figure 7.3. MICA*004 and 
MICA*010 were the more prevalent alleles with 36 and 30 reports respectively. 
However, in terms of frequencies, the highest frequencies corresponded to the 
MICA*002:01 and MICA*008:01 alleles whereas the lowest frequencies of the top 10 
seen alleles were found in MICA*016 and MICA*011 alleles.  
 
 
Figure 7.3: Frequency distribution of top 10 MICA alleles. 
The first two lines in the x-axis legend correspond to the MICA official allele name and their corresponding 
microsatellite equivalence. Numbers of populations considered in the analysis are indicated with an „n‟. 
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As expected, the top ten official MICA alleles reported in the AFND corresponded to 
the most frequent MICA microsatellites: A4 (MICA*007, *012), A5 (MICA*010, *016, 
*027), A5.1 (MICA*008:01), A6 (MICA*004, *009:01, *011) and A9 (MICA*002:01). 
Using this approach data in the past containing microsatellite variants can be linked to 
the most likely official allele by examining the corresponding allelic equivalence at exon 
5 and the frequency of the allele in a given population.  
 
Frequencies of MICB alleles 
 
Data on MICB frequencies was narrowed to only one population from Thailand 
containing nine frequencies: MICB*002 (59%), MICB*003 (1%), MICB*004 (23%), 
MICB*005:01 (0%), MICB*005:02 (62%), MICB*005:03 (6%), MICB*008 (17%), 
MICB*013 (4%), MICB*014 (7%) (Jumnainsong et al. 2008).  
 
Software to aid the examination of MICA and MICB alleles 
 
In order to allow users the examination of MICA/MICB alleles and MICA 
microsatellite frequencies, an online search was implemented in the AFND. The 
searching tool was based on the structure of the allele frequency search described in 
Chapter 3 in Section 3.4.1.  The tool can be accessed using the following link:  
http://www.allelefrequencies.net/mic6001a.asp 
 
7.3.1.3 Occurrence of MICA and HLA-B associations among populations 
 
To aid the examination of MICA and HLA-B relationships, an online module was 
implemented in the AFND website under the MIC section (Figure 7.4). Following a 
similar scheme of multi-filters as in the HLA haplotype frequency search described in 
Section 3.4.2, this searching mechanism allows users to input a particular MICA or 
HLA-B allele and find the strongest relationships from 257 records available in the 
AFND. For instance, Figure 7.4 shows 10 of the 37 records with associations between 
MICA*004 and any HLA-B allele. From this figure it can be observed that the highest 
frequency match corresponded to the allele HLA-B*42:01 which was observed in seven 
of the 39 individuals typed in a sample of African Americans in the United States (Tian 
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et al. 2003). As shown in Figure 7.4, the frequency of MICA and HLA-B associations 
may vary considerably depending in the ethnicity/geographical location of the 
individuals. For example, all three populations from Spain displayed in Figure 7.4 were 
found to present high associations (7.3-12.1%) with the HLA-B*44 allele, similar to two 
Korean (8.3-11.5%) and one Moroccan (10.6%) populations. In Efik individuals from 
Nigeria, the highest “MICA*004-HLA-B*” frequency association (10.9%) was observed 
with the HLA-B*49:01 allele. Thus, by using the HLA-MIC association frequency tool 
researchers can examine the most likely occurrences within MICA and HLA-B loci. 
 
 
Figure 7.4: MICA and HLA-B association frequency search. 
 
7.3.2 Cytokine gene polymorphisms 
 
The analysis of cytokine gene polymorphisms was divided into two main categories: (i) 
dissemination of the availability of frequency data by cytokine gene polymorphism and 
geographical region and (ii) the implementation of an online searching mechanism for 
the investigation of polymorphisms among worldwide populations.  
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7.3.2.1 Availability of Cytokine data in the AFND 
 
The initial analysis for the investigation of cytokine gene polymorphisms consisted of 
the classification of all 113 cytokine population frequency datasets grouping the 
populations by geographical region and gene. As shown in Table 7.3, frequency data was 
available for all geographical regions with at least one population reporting 
polymorphism frequencies. From data compilation, 51 cytokine gene polymorphisms 
were found in the submissions. The majority of the submissions corresponded to the 
report of Interleukin 6 (IL-6), Transforming Growth Factor beta 1 (TGFbeta1) and 
Tumour Necrosis Factor (TNFalpha).  
 
Table 7.3: Availability of cytokine gene polymorphisms by geographical region 
Gene / Polymorphism 
Geographical region 
ASIA EEUR MIDE NAFR NAME SAFR SCAM WEUR 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
AIF-1/ 
  -932 (C|T) 
        2/395 
 
      
bFGF/ 
  223 (C|T) 
              1/500 
EGF/ 
  61 (A|G) 
              2/760 
GM-CSF/ 
  -677 (A|C) 
  -1916 (C|T) 
              1/500 
IFNgamma/ 
  874 (A|T) 
  utr5644 (A|T) 
9/506 14/1387 7/583   19/2698   7/776 14/3103 
IGF-1/ 
  -383 (C|T) 
  -1089 (C|T) 
              1/500 
IL-10/ 
  -592 (A|C) 
  -819 (C|T) 
  -1082 (A|G) 
13/1039 15/1487 8/741   22/4163 1/86 8/878 23/6102 
IL-12/ 
  -1188 (A|C) 
9/506 9/846 6/535       1/99 8/1288 
IL-12p40/ 
  -1287 (C|T) 
              1/220 
IL-13/ 
  -1055 (C|T) 
  -1459 (A|C) 
              2/720 
IL-15/ 
  3utr (A|T) 
  5utr (C|T) 
              1/500 
IL-18/ 
  -137 (C|G) 
  -607 (A|C) 
  -656 (G|T) 
  1248 (A|G) 
1/143       2/395     1/220 
IL-1alpha/ 
  -889 (C|T) 
9/506 10/946 6/535     2/233 1/99 11/1640 
IL-1beta/ 
  -31 (C|T) 
  -511 (C|T) 
  3962 (C|T) 
10/690 9/846 6/535   3/1574   1/99 11/1678 
IL1R/ 
  PstI 1970 (C|T) 
9/506 9/846 6/535       1/99 5/831 
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Table 7.3: Availability of cytokine gene polymorphisms by geographical region (Continued) 
 
Gene / Polymorphism 
Geographical region 
ASIA EEUR MIDE NAFR NAME SAFR SCAM WEUR 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
Pops/ 
Indiv 
IL1RA/ 
  MspA1I 11100 (C|T) 
9/506 9/846 6/535       1/99 6/938 
IL-2/ 
  -330 (G|T) 
  166 (G|T) 
10/589 11/1151 6/575   4/608 1/86 1/99 12/2170 
IL-4/ 
  -33 (C|T) 
  -34 (C|T) 
  -589 (C|T) 
  -590 (C|T) 
  -1098 (G|T) 
11/1241 11/1151 5/495   4/1747 2/233 1/99 12/2384 
IL-4Ralpha/ 
  223 (A|G) 
  1092 (A|G) 
9/506 9/846 6/535   3/322 2/233 1/99 7/1158 
IL-6/ 
  -174 (C|G) 
  565 (A|G) 
11/1158 16/1692 7/623   23/4312 3/319 8/878 20/3355 
NGF/ 
  -198 (C|T) 
              1/500 
PDGF B/ 
  1135 (A|C) 
              1/500 
RANTES/ 
  -109 (C|T) 
              1/500 
TGFbeta1/ 
  -509 (C|T) 
  -800 (A|G) 
  codon10 (C|T) 
  codon25 (C|T) 
11/706 11/1064 6/543   18/2591 2/233 8/878 11/1946 
TNFalpha/ 
  -238 (A|G) 
  -308 (A|G) 
  -857 (C|T) 
  -863 (A|C) 
  -1031 (C|T) 
15/2087 17/1853 8/741 1/157 26/4630 3/319 8/878 25/4308 
TNFbeta/ 
  252 (A|G) 
1/83 3/331 1/80 1/157 3/255 1/86   4/705 
VEGF/ 
  -7 (C|T) 
  -1001 (C|G) 
  -1154 (A|G) 
  -1455 (C|T) 
  -2578 (A|C) 
        3/364     3/2860 
Asia (ASIA), Australia (AUST), Eastern Europe (EEUR), Middle East (MIDE), North Africa (NAFR), North 
America (NAME), Pacific (PACI), Sub-Saharan Africa (SAFR), South and Central America (SCAM) and Western 
Europe (WEUR).  
 
7.3.2.2 Diversity of cytokine gene polymorphisms among populations 
 
To assess the variation of the different cytokine gene polymorphisms among 
populations across the world, an online searching mechanism was implemented in the 
AFND website. Figure 7.5 shows an example of the frequency search displaying twelve 
of the 309 records containing data for the Tumour necrosis factor (TNFalpha) gene 
with a polymorphism being reported at the -308 nucleotide position. In the example, the 
polymorphism consists of genotype combinations of Adenine (A) and Guanine (G). 
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From the figure it can be observed that the first four populations ordered alphabetically, 
presented very low frequencies (≤2%) for the genotype AA contrary to the other two 
genotypes AG (9.3-26.2%) and GG (73.8-90.7%). The output results include the 
cytokine gene polymorphism, the name of the population, the genotype frequency (in 
percentages) and sample size of the population. Additionally, a reference to the Entrez-
Gene database was incorporated in the output list to provide users with the ability to 
examine the gene sequence. Moreover, a hyperlink was added to the results to generate 
automatic overlaid maps based on frequency data. The frequency map tool, which was 
also implemented in each of the polymorphic regions available in the AFND, represents 
comparisons of frequencies of cytokine gene polymorphism across the world. Figure 7.6 
shows an example of the variation present in the genotype AG at -308 nucleotide 
position of the TNFalpha gene. The figure illustrates that the highest frequencies for 
this genotype were mainly found in populations of Caucasian origin whereas the lowest 
corresponded principally to populations in North and South America. 
 
 
Figure 7.5: Example of the frequency search for cytokine gene polymorphisms. 
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Figure 7.6: Frequency distribution of the ‘TNFalpha/-308 AG’ polymorphism. 
 
7.4 Discussion 
 
The use of computational approaches implemented in the AFND has been shown to 
provide a useful resource for the analysis of frequency data. This chapter described the 
analysis of the polymorphisms observed in two additional set of immune genes, MIC 
and cytokine genes. The analysis consisted in the examination of frequencies reported in 
the literature in different formats (allele, microsatellite and genotype). Although the 
polymorphism present in these two set of genes is not as extensive as HLA and KIR, 
the implementation of the searching mechanisms in a similar fashion allows the 
evaluation of a generic software framework to investigate other immune genes of 
interest. 
 
In the case of MIC genes, the design of a new module to contain MIC frequency data 
provides researchers with a valuable electronic resource for the investigation of 
frequencies at allele and/or microsatellite level. A review presented by Collins and 
colleagues in 2004 showed the comparisons of frequencies of MICA microsatellites and 
official alleles in eleven population samples from six different ethnic groups reported in 
the literature at that time (Collins 2004). Thus, the results described in this chapter 
correspond to a wider and up-to-date analysis of MIC frequencies comprising data from 
fifty-eight populations available in the AFND.  
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One of the drawbacks of the old MICA microsatellite nomenclature was that exons 2-4 
(encoding the extracellular domains) were not considered in the analysis of populations, 
limiting the examination of frequencies to allelic variability at exon 5 only. However, 
with the emergence of the official nomenclature for MIC alleles, further studies have 
reported the analysis of populations using alleles described in the IMGT/HLA database. 
Therefore, with the availability of sequence data, investigators are able to compare 
frequency data of microsatellites to the corresponding equivalences of official alleles by 
examining the polyalanine repeats in the protein sequence at exon 5. The searching 
methods used in the online tools were developed to cover both formats (microsatellite 
and official alleles). Additionally, data and searching options available in the AFND 
provides a convenient approach to investigate the presence of very rare variants. For 
instance, in the review by Stephens, an enquiry was raised concerning the high 
frequencies of the MICA*008 (A5.1), which corresponds to an „aberrant‟ allele 
(Stephens 2001). This topic was also followed in the review by Collins who compared 
different population including one South American population which, interestingly, was 
found to present a very low frequency for MICA*008 (Collins 2004). Low frequencies 
in South American populations were subsequently confirmed by Oliveira (Oliveira et al. 
2008). These findings can be clearly illustrated using the online tool for generating 
overlaid maps 
(http://www.allelefrequencies.net/mic6004a.asp?mic_allele=MICA*008:01). Also of 
interest, is that the MICA microsatellite variant A8 which was reported to present eight 
GTC (Alanine) repeats (Gambelunghe et al. 2006), was not found in any of the reports 
submitted to the AFND including the official allele counterpart (MICA*055). Originally, 
the A8 variant was found in one individual from a cohort of 1100 Italian subjects 
leading to the possibility of a wrong sequence or that more studies are needed to clarify 
the existence of this variation.  
 
The number of MIC alleles has increased in the last years but not comparable to the 
numbers presented in HLA and KIR. The first release in the IMGT/HLA database 
describing MIC sequences in January 2001 comprised 51 MICA alleles. The list was 
updated to 73 alleles as of release 3.3.0, January 2011 (Robinson et al. 2001). Limited 
data had previously been reported for MICB, possibly due to the lack of an official 
nomenclature. MICB official alleles were initially incorporated in April 2005 containing 
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18 of the 31 alleles reported in release 3.3.0. However, it is expected that in the coming 
years more data will be available for MICB. 
Due to the proximity of MICA and HLA-B within the chromosome, a number of 
studies have focussed on the investigation of associations of these two loci to several 
diseases (Stephens 2001). However, few reports with frequencies of other ethnicities 
have been reported in the literature. Therefore, data available in the AFND may be 
valuable for further analysis. Additionally, sizes of several samples in the association 
studies described in previous publications were small leading to the 
over/underestimation of „real‟ values, thus, the increase of the amount of data in 
associations may result in better insights into the relationships between the MICA and 
HLA-B loci.  
 
In the case of cytokines, the study of the gene polymorphism has been an important 
topic in the analysis of the mechanisms involved in the immune response. The lack of a 
central source to collect frequency data led to the incorporation of a module in the 
AFND. An online bibliographic reference published in 1999 by Bidwell provided an 
extraordinary resource comprising more than 1000 cytokine reviews for cytokine 
associations in human diseases (Bidwell et al. 1999), however the resource was 
discontinued in recent years. Additionally, the study of cytokine gene polymorphism 
frequencies was not included in that repository. 
 
This chapter included the description of cytokine gene polymorphism frequency data 
from a compilation of more than one hundred populations. Different studies have been 
carried out to investigate the polymorphism present in populations from different 
continents (Delaney et al. 2004; Larcombe et al. 2005; Middleton et al. 2002). The 
creation of an electronic cytokine gene polymorphism warehouse may help in the 
analysis of variations in these genes. The Cytokine Polymorphism Frequency tool 
described in the chapter may provide a useful resource in the assistance of population 
comparisons at large scale.  
 
In cytokine gene polymorphisms the number of citations to the website is considerably 
lower than in HLA and KIR (6 citations as of August 2011). Currently, this section has 
been principally used for referencing a given population. However, it is expected that 
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the addition of novel tools for the analysis of more than one hundred cytokine 
populations may increase the usability of this section.  
 
Although at present there is not a standardised nomenclature for representing cytokine 
gene polymorphisms, a suggested nomenclature was presented in this chapter based on 
of the name of cytokine genes described in the Gene-Entrez database (Maglott et al. 
2011). Future work will include the dissemination of a standardised notation and the 
incorporation of more polymorphism in cytokine genes. 
 
7.5 Conclusions 
 
This chapter described an outline on the frequencies of two additional set of immune 
genes, MIC and cytokine gene polymorphisms. Two modules were implemented in the 
AFND to store the information of each polymorphism and provide the scientific 
community with an online resource for the analysis of the occurrence of the 
polymorphisms in worldwide human populations. The chapter included the 
dissemination of the information available for MIC and cytokine genes comprising data 
available at various formats: microsatellite, allele and genotype level. In this chapter, an 
analysis was presented to examine the different MICA microsatellites and most frequent 
official MICA alleles from a compilation of 58 population samples. The results included 
in the chapter can be used as a useful resource in the ascertaining of a given allele in a 
particular geographical region or ethnicity. Cytokine gene polymorphism frequency data 
was also analysed and summarised in the chapter by classifying data available in each 
polymorphism. In addition, a set of online tools for the analysis and visualisation of 
frequency data was also described in this section.  
  
 
 
Chapter 8  
Discussion, general conclusions and 
future work 
 
 
The aim of this chapter is to summarise the content of this thesis, extend the discussion 
of the analysis carried out in each chapter and describe ongoing projects and future 
work related to this research. Finally, general conclusions of this work are outlined at 
the end of this chapter. 
 
8.1 Summary of thesis 
 
This thesis was focussed on the development of a database to provide the scientific 
community with an electronic resource for the investigation of the frequencies of 
several immune genes such as HLA, KIR, MIC and cytokine genes across worldwide 
populations. The work carried out in this research can be summarised in three main 
components: first, the compilation of immune gene frequencies and the design of the 
AFND for the storage of frequency data at allele, haplotype and genotype level, second, 
the development of customised searching mechanisms and other software applications 
for the examination of data and, third, the description of several analyses that were 
performed to outline the extensive polymorphism found in these immune genes. 
 
Chapter 1 provided an insight into several genes involved in the immune response and 
introduced the reader to the field of immunogenetics and bioinformatics as a means to 
investigate the genetic basis and function of these genes. The immune genes analysed in 
this research included the most polymorphic region in the human genome: the HLA 
system. Additionally, other extremely polymorphic regions such as KIR, MIC and 
several cytokine gene polymorphisms were also included in this study. To analyse such 
extraordinary polymorphisms in human populations, Chapter 2 described a database 
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schema developed to contain frequencies available in different formats: allele, haplotype 
and genotype level. In addition, Chapter 2 included a full description of the criteria and 
methods applied for the input and validation of datasets. Chapter 3 described a set of 
bioinformatics online tools that were implemented in the AFND website for the 
examination of data. Based on a multi-filter scheme, these tools allow flexibility in the 
retrieval of information performed by users. The generic model implemented in the 
searching mechanisms allowed the replication of the same technique for the analysis of 
additional genes. In Chapter 4, the analysis of the frequencies of HLA alleles and 
haplotypes was carried out with the use of software applications implemented in the 
AFND website to estimate the overall frequencies by geographical region, country or 
ethnic group. Despite the polymorphism present in genes of the HLA system 
comprising more than 6,000 alleles as of January 2011, many of these alleles were not 
reported in the compilation of HLA datasets. Thus, the rarity of the HLA alleles was 
examined in Chapter 5 by collecting data from other electronic sources such as the 
IMGT/HLA database, the NMDP database and from individual laboratories. Rivalling 
the polymorphism of HLA, the variability present in KIR genes was examined in 
Chapter 6. The analysis carried out in KIR genes included the examination of gene 
frequencies and the investigation of the organisation of KIR genes by inspecting the 
presence or absence of the gene in an individual‟s profile (KIR genotype). The latter led 
to the most extensive compilation of KIR genotype data in the world. Finally, in 
Chapter 7 other polymorphic regions such as MIC and several cytokine polymorphisms 
that were submitted to the AFND were also examined. The incorporation of these two 
additional set of genes allowed the enrichment of immune gene data and confirmed the 
design of the database schema as a generic model for the storage of other immune genes 
in the future. 
 
8.2 Discussion 
 
This section includes an extension of the discussion described in each chapter and 
includes a critical appraisal of alternative methodologies, techniques and other resources 
available for the investigation of similar immune genes.  
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8.2.1 The Allele Frequency Net Database  
 
The vast amount of information available on the occurrence of several immune genes 
and their corresponding alleles and its significance in different fields of research were 
the motivations for the development of the AFND. The AFND comprises the most 
extensive electronic archive for the investigation of immune genes across worldwide 
human populations. The compilation of data in electronic format has provided the 
research community with a valuable instrument to perform meta-analysis which would 
not be feasible without this resource. The applications described in this thesis have 
increased the versatility in the examination of data. It is expected that the range of 
functionalities will assist expert and non-specialist users in the investigation of data. 
Several case studies were described in the „Discussion‟ section in each chapter. One of 
the most recent analysis using data from AFND was a study published in Science by Abi-
Rached and colleagues, led by Peter Parham FRS, who compared the HLA-B*73 allele 
between archaic and modern humans demonstrating the admixture across these species 
(Abi-Rached et al. 2011). 
 
8.2.2 Alternative approaches in the design of immune gene databases 
 
The first objective of this research was to utilise a software engineering approach in the 
development of a freely accessible web-based interface to assist researchers in the 
analysis of immune genes in an interactive manner. To facilitate the consultation of such 
large amount of data, multiple filter options were implemented in all searching 
mechanisms in the AFND. The addition of customised searching options allows users 
to optimise their queries and obtain the closest matching results. As reviewed in Chapter 
1, several technologies are available for the design of web-based repositories. In this 
work, all software applications were implemented using CSS and XHTML standards to 
guarantee the correct visualisation in any operating system used in the client machine. In 
terms of the selection of the programming language, it was decided that ASP would 
cover the requirements for data querying and it would speed the development of the 
different modules. Presently, ASP has covered all the needs for the development of the 
current searching tools including the analysis of data at amino acid level implemented in 
the AFAAT tool described in Section 3.5. However, more advanced queries/analyses 
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may require the use of other programming languages for optimal performance of the 
analysis such as Java or C++. This is particularly important when the DBMS cannot 
cover the initial query request and a secondary process needs to be executed on the 
server/client machine before the display of results. Nevertheless, one of the advantages 
of the web-based approach employed in this research is that there is no restriction on 
the implementation of secondary interfaces. For instance, additional interfaces can be 
implemented in alternative platforms (e.g. operating system and/or programming 
language) and data can be accessed via a particular connection protocol. In the case of 
the AFND, MySQL, which has been used as the back-end, includes supporting 
connections for the most of the popular programming languages. Also, the use of a web 
service that can process the information on an external server can be used as an 
alternative approach. In this scenario, users of the database would send a job (i.e. data 
for a given analysis) to the secondary server and processed data would be sent back to 
the server and subsequently displayed in the client machine.  
 
Data annotation 
 
In recent years, one implementation that has been introduced in the design of biological 
repositories is the inclusion of websites called wikis. These websites facilitate the review 
process by providing online tools for edition and management of the information 
(Brohee, Barriot & Moreau 2010). In the case of the AFND, the use of wikis may help 
in the validation of current datasets listed in the website by allowing investigators to 
perform annotations on a specific population. As discussed in Chapter 2, at present, 
users rely on data available in the AFND which has normally followed a peer-reviewed 
process. However, on some occasions, different queries concerning data accuracy are 
sent to curators of the database by e-mail. Thus, it is important to allow users the 
incorporation of queries, annotations or the inclusion of supplementary material which 
may help in the evaluation of the current datasets and serve others in the interpretation 
of their data and/or analyses performed.  
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8.2.3 Use of relational models and DBMS 
 
The relational model approach used in the implementation of the AFND has allowed 
the management and query of data in an easy and interactive way. The simplicity and 
robustness of this methodology has improved significantly the management of datasets. 
The use of MySQL as the relational DBMS has various advantages, first, the flexibility 
of this software to interact with other design tools such as MySQL Workbench and 
PowerDesigner in the generation of the database schemas and the definition of rules 
and constraints of the data, second, the excellent performance in the implementation of 
simple and complex queries and, third, the distribution of this software as a cross-
platform application released under the GNU General Public License.  
 
8.2.4 Archive of raw data 
 
One of the characteristics that distinguish AFND from other immune gene frequency 
databases (dbMHC and ALFRED) is the ability to allow users the submission of their 
own data. To do this, an online submission form for data input was created. However, 
less than ten percent of data available in the AFND has been entered by users only, 
possibly due to the fact that users do not directly receive any credit for their submission, 
as they would for a published paper. Therefore, future plans in the AFND include the 
design of an online journal for the compilation of raw data which will serve to two 
purposes: first, it should increase the number of individuals submitting their own data 
and, second, the incorporation of raw data will increase the types of analysis that can be 
performed in the AFND. Due to the lack of raw data, at present, it is not possible to 
ascertain how individuals analysed their data, which protocols they used in the 
publication of their results, the level of resolution employed in the calculation of 
frequencies, etc. Thus, the addition of raw data is expected to provide better 
understanding of how frequency data has been compiled. 
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8.2.5 Standards in immune gene frequencies 
 
The use of controlled vocabulary and definition of standards for data exchange plays an 
important role in the development of biological repositories. One example of the 
application of data standards has been in the field of proteomics performed by the 
Human Proteome Organisation via the Proteomics Standards Initiative which is in 
charge of the definition of standards to facilitate the exchange, comparison and analysis 
of proteomics data (Orchard, Hermjakob & Apweiler 2003). In the case of HLA, KIR, 
MIC and cytokine gene polymorphisms the definition of standards is in the early stages. 
Several attempts to produce standard formats have been under development in recent 
years. For instance, the NMDP bioinformatics group has designed a XML-based 
prototype called HML (Histoimmunogenetics Markup Language) to report HLA testing 
results. However, the HML project has not had recent modifications and the version 
0.3, which is the most recent version available, has not been distributed or recognised in 
the field of immunogenetics. Recently, two international groups, the HLA European 
Network (HLA-NET) and the Immunogenomics Data-Analysis Working Group 
(IDAWG), have initiated the definition of standards and minimal data recommended in 
the reporting of HLA data. Due to the AFND comprising the largest repository of HLA 
data, this research work has been in continuous interaction with these initiatives via the 
formulation of examples of the heterogeneity of data reported by investigators.  
 
8.3 Future work  
 
There are a number of ongoing and future projects that will be implemented in the 
AFND. The addition of these modules is expected to increase the usefulness of the 
website and may help investigators better understand the function of the immune genes. 
 
8.3.1 Quality control 
 
Quality control is perhaps the most important concern in the collection of immune gene 
frequency data. To date, there has been a lack of standardisation in recording HLA, 
KIR, MIC and cytokine gene polymorphisms results. For instance, in HLA, data is often 
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produced from individual laboratories using different methodologies which do not 
necessarily detect the same alleles and/or the same resolution, and individuals make 
different non-documented assumptions to record typing data. Thus, analysis of data 
may be prone to errors in the absence of a standardised approach for documenting data. 
Future implementations include the collection of raw data and a software pipeline to 
verify allele frequency calculations and request a standard set of metadata to improve 
consistency for analyses. Datasets will be validated automatically to ensure that the 
information submitted comply with the minimal standard guidelines. To define the 
required minimal metadata, the AFND project will actively participate with international 
organisations, such as the HLA-NET the IDAWG groups for the standardisation and 
validation of frequency datasets, controlled vocabulary (e.g. ethnic origins, geographical 
regions, etc.), database schemas and data exchange.  
 
8.3.2 Software toolkit for data sharing and complementary analysis 
 
To extend the set of tools provided in the AFND, future developments include the 
incorporation of statistical routines to allow users to apply advanced analyses for all 
populations available. This will be done by the integration of AFND output formats 
into external programs such as PyPop (Lancaster et al. 2003), GENEPOP (Rousset 
2008) and Arlequin (Excoffier, Laval & Schneider 2005) for test of Hardy-Weinberg and 
neutrality, and PHYLIP (Retief 2000) for the display of dendrograms and phylogenetic 
trees. In the context of data sharing, future developments will include data portability in 
XML format. This will be done by the implementation of a standardised XML layer and 
definition of controlled vocabularies. Additionally, a minimum reporting requirements 
document will be also generated to ensure that all studies deposited in AFND are 
described consistently.  
 
8.3.3 KIR and HLA ligands 
 
Ongoing developments include the implementation of the display of KIR gene 
frequencies correlated with their HLA ligand frequencies as a continuation of the KIR 
anthropology component of the 15th IHWS (Hollenbach et al. 2010) and a section for 
the collection of KIR and disease studies. It is believed that the addition of these 
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software applications on the website will be invaluable to researchers interested in the 
investigation of KIR genes.  
 
8.4 General conclusions 
 
The Allele Frequency Net Database has provided an important resource for the 
histocompatibility and immunogenetics community. The design of the database to store 
immune gene frequencies in different populations has moved the analysis of immune 
genes from publication-driven into digital resources. The development of novel 
mechanisms of querying and the incorporation of new polymorphisms have enriched 
the examination of the genes available. Acting as a primary source, the AFND contains 
the most extensive archive of immune gene frequencies. As of August 2011, 168 peer-
reviewed publications have cited the website according to the records in the Web of 
Knowledge (http://apps.webofknowledge.com/). From 4 August 2010 to 4 August 
2011, the website was accessed by 15,784 distinct users from 2,758 cities in 136 
countries, demonstrating the large international user base. To date, the users are spread 
across domains in clinical, biomedical and biological research and future developments 
should further increase the international impact, especially for fundamental immunology 
research, human genetics and groups working to understand host responses to 
infectious disease.  
 
The nature of databases involves continuous maintenance of datasets and 
implementations of new modules for the coverage of new methods and techniques 
which are constantly published by researchers. Perhaps, the problem with databases 
such as AFND is that they are usually the work of one individual or one group and the 
success of the databases on many occasions depends on the interest of Research 
Councils to fund the costs. However, it is expected that the design and structure 
presented on this work may serve a wide community interested in the analyses of these 
genes for more years. Full details of searches and datasets can be freely explored by 
accessing the www.allelefrequencies.net website. 
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Appendix A  
 
Schemas of the Allele Frequency Net 
Database  
 
The following set of diagrams represents the logical and physical model schemas that 
were generated for the design of the AFND. Additionally, the SQL schema which can 
be used for the generation of the database is also included in this section. 
 
Logical Data Model 
Demographic data 
 
 
Figure A.1: Logical data model of the AFND: Demographic data. 
formed
constituted
contains
posseses
continen
con_code
con_name
con_index
con_status
con_code <pi>
geogreg
geo_code
con_code
geo_name
geo_index
geo_status
geo_code <pi>
country
cou_code
geo_code
cou_name
cou_code_2_digits
cou_population
cou_area
cou_status
cou_code <pi>
ethnic
eth_code
eth_name
eth_reference
eth_status
eth_code <pi>
populat
pop_id
cou_code
eth_code
pol_code
pop_name
pop_subregion
pop_linguistic
pop_center
pop_origin
pop_urban_rural
pop_family
pop_source
pop_lat1_deg
pop_lat1_min
pop_lat1_card
pop_size
pop_samplesize
pop_sampleyear
pop_method_freq
pop_notes
pop_dataset
pop_article
pop_authors
pop_correspondence
pop_email
pop_journal
pop_year
pop_volumen
pop_issue
pop_pages
pop_method
pop_status
identifier_1 <pi>
Appendix A       Schemas of the AFND 
 
202 
 
 
Frequency data 
 
 
 
Figure A.2: Logical data model of the AFND: Frequency data. 
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DNA sequence data 
 
 
 
Figure A.3: Logical data model of the AFND: DNA sequence data. 
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Rare allele data 
 
 
Figure A.4: Logical data model of the AFND: Rare allele data 
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Users and Security Access 
 
 
Figure A.5: Logical data model of the AFND: Users and security access 
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Physical Data Model 
 
Demographic data 
 
 
 
Figure A.6: Physical data model of the AFND: Demographic data 
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Frequency Data 
 
 
 
Figure A.7: Physical data model of the AFND: Frequency data 
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Figure A.8: Physical data model of the AFND: DNA sequence data 
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Rare allele data 
 
 
Figure A.9: Physical data model of the AFND: Rare allele data 
 
 
 
FK_allexlab
FK_is_classified
FK_rare_rel
FK_ipd_rel
FK_imgt_rel
FK_ashi_rel
FK_confirmed
FK_ashi_dict
FK_imgt_dict
FK_ipd_dict
FK_ashi_allele
FK_imgt_allele
FK_ipd_allele
alleles
all_name
loc_name
all_family
all_common
all_documented
all_cells
all_groups
all_confirmed
all_partial
all_length
all_year
all_levels
all_level1
all_level2
all_level3
all_level4
all_clevel1
all_clevel2
all_clevel3
all_clevel4
all_order
all_status
char(20)
char(10)
char(4)
char(4)
char(4)
decimal(6,0)
decimal(6,0)
char(1)
char(10)
decimal(4,0)
decimal(4,0)
decimal(4,0)
decimal(4,0)
decimal(4,0)
decimal(4,0)
decimal(4,0)
char(4)
char(4)
char(4)
char(4)
decimal(8,0)
char(1)
<pk>
<fk2>
rareall
all_name
rel_code
rel_version
rar_web
rar_nmdp
rar_labs
rar_status
...
char(20)
char(8)
char(20)
decimal(8,0)
decimal(8,0)
decimal(8,0)
char(1)
<fk1>
<fk2>
<fk2>
releases
rel_code
rel_version
rel_date
rel_file
rel_desc
rel_status
...
char(8)
char(20)
datetime
char(100)
char(40)
char(1)
<pk>
<pk>
ext_ashi_rares
rel_code
rel_version
all_name
ashi_common
ashi_documented
ashi_update
char(8)
char(20)
char(20)
char(2)
char(2)
date
<fk1>
<fk1>
<fk2>
ext_imgt_confirm
rel_code
rel_version
all_name
imgt_cells
imgt_groups
imgt_confirmed
imgt_partial
imgt_ethnicity
...
char(8)
char(20)
char(20)
decimal(6,0)
decimal(6,0)
char(15)
char(10)
char(200)
date
<fk1>
<fk1>
<fk2>
ext_ipd_kir
rel_code
rel_version
all_name
ipd_update
char(8)
char(20)
char(20)
date
<fk1>
<fk1>
<fk2>
ext_labs_rares
all_name
labs_bla
labs_cau
labs_mes
labs_his
labs_oth
labs_total
char(20)
decimal(9,0)
decimal(9,0)
decimal(9,0)
decimal(9,0)
decimal(9,0)
decimal(9,0)
<fk>
allexlab
all_name
usr_login
axlab_id
axlab_ethnicity
axlab_population
axlab_indiv_type
axlab_indiv_type_registry
axlab_haplotype
axlab_notes
axlab_other_member
axlab_indiv_same_resol
axlab_methods
axlab_phenotype
axlab_haplotype1
axlab_haplotype2
axlab_line
axlab_source
axlab_status
...
char(20)
char(20)
decimal(8,0)
char(50)
char(50)
char(30)
char(40)
char(40)
char(40)
char(40)
decimal(9,0)
char(60)
char(200)
char(200)
char(200)
decimal(9,0)
char(1)
char(1)
<pk,fk1>
<pk,fk2>
<pk>
Appendix A       Schemas of the AFND 
 
210 
 
Users and Security Access 
 
 
Figure A.10: Physical data model of the AFND: Users and security access 
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SQL schema of the AFND 
 
CREATE TABLE alldesig( 
 alld_allele nvarchar(20) Not NULL, 
 alld_type nvarchar(20) NULL, 
 alld_code nvarchar(20) NULL, 
 alld_polyreg nvarchar(255) Not NULL, 
    CONSTRAINT PK_alldesig PRIMARY KEY CLUSTERED  
    ( 
     alld_allele Asc, 
     alld_polyreg Asc 
    ) 
) 
 
CREATE TABLE allefreq( 
 allf_popid decimal(8, 0) Not NULL, 
 allf_polyreg nvarchar(10) Not NULL, 
 allf_locus nvarchar(20) Not NULL, 
 allf_allele nvarchar(20) Not NULL, 
 allf_line decimal(4, 0) NULL, 
 allf_gene_freq nvarchar(10) NULL, 
 allf_pheno_freq nvarchar(10) NULL, 
 allf_added datetime NULL, 
 allf_updated datetime NULL, 
 allf_user nvarchar(20) NULL, 
 allf_status nvarchar(1) NULL, 
 allf_indiv decimal(9, 0) NULL, 
 allf_chrom decimal(9, 0) NULL, 
 allf_sample_size decimal(9, 0) NULL, 
 allf_notes nvarchar(250) NULL, 
    CONSTRAINT PK_allefreq PRIMARY KEY CLUSTERED  
    ( 
     allf_popid Asc, 
     allf_polyreg Asc, 
     allf_locus Asc, 
     allf_allele Asc 
    ) 
) 
 
CREATE TABLE alleles( 
 all_name nvarchar(20) Not NULL, 
 all_name2 nvarchar(20) NULL, 
 all_region nvarchar(10) NULL, 
 all_locus nvarchar(20) NULL, 
 all_family nvarchar(4) NULL, 
 all_ethnic_origin nvarchar(Max) NULL, 
 all_class nvarchar(15) NULL, 
 all_common nvarchar(4) NULL, 
 all_documented nvarchar(4) NULL, 
 all_cells decimal(6, 0) NULL, 
 all_groups decimal(6, 0) NULL, 
 all_confirmed nvarchar(12) NULL, 
 all_start decimal(6, 0) NULL, 
 all_end decimal(6, 0) NULL, 
 all_partial nvarchar(10) NULL, 
 all_updated datetime NULL, 
 all_pops decimal(9, 0) NULL, 
 all_total_nmdp decimal(9, 0) NULL, 
 all_total_labs decimal(9, 0) NULL, 
 all_total_identical_cell decimal(9, 0)     
                                   NULL, 
  all_total_identical_group decimal(9, 0)                    
                                    NULL, 
 all_total_identical_pops decimal(9, 0)  
                                   NULL, 
 all_total_identical_nmdp decimal(9, 0)  
                                   NULL, 
 all_total_identical_labs decimal(9, 0)   
                                    NULL, 
 all_length decimal(4, 0) NULL, 
 all_status nvarchar(1) NULL, 
 all_year decimal(4, 0) NULL, 
 all_levels decimal(4, 0) NULL, 
 all_level1 decimal(4, 0) NULL, 
 all_level2 decimal(4, 0) NULL, 
 all_level3 decimal(4, 0) NULL, 
 all_level4 decimal(4, 0) NULL, 
 all_clevel1 nvarchar(4) NULL, 
 all_clevel2 nvarchar(4) NULL, 
 all_clevel3 nvarchar(4) NULL, 
 all_clevel4 nvarchar(4) NULL, 
 all_order decimal(8, 0) NULL, 
    CONSTRAINT PK_alleles PRIMARY KEY CLUSTERED  
    ( 
     all_name Asc 
    ) 
) 
 
CREATE TABLE allexlab( 
 axlab_allele nvarchar(20) Not NULL, 
 axlab_indiv_id nvarchar(20) Not NULL, 
 axlab_user nvarchar(20) Not NULL, 
 axlab_ethnicity nvarchar(50) NULL, 
 axlab_population nvarchar(50) NULL, 
 axlab_indiv_type nvarchar(30) NULL, 
 axlab_indiv_type_registry nvarchar(40)    
                                              NULL, 
 axlab_indiv_type_other nvarchar(40) NULL, 
 axlab_haplotype nvarchar(40) NULL, 
 axlab_notes nvarchar(40) NULL, 
 axlab_other_member nvarchar(40) NULL, 
 axlab_indiv_same_resol decimal(9, 0) NULL, 
 axlab_methods nvarchar(60) NULL, 
 axlab_sbt nvarchar(1) NULL, 
 axlab_ssp nvarchar(1) NULL, 
 axlab_sso nvarchar(1) NULL, 
 axlab_seq nvarchar(255) NULL, 
 axlab_oth nvarchar(1) NULL, 
 axlab_type nvarchar(200) NULL, 
 axlab_phenotype nvarchar(200) NULL, 
 axlab_haplotype1 nvarchar(200) NULL, 
 axlab_haplotype2 nvarchar(10) NULL, 
 axlab_hap1_hla_a nvarchar(30) NULL, 
 axlab_hap2_hla_a nvarchar(30) NULL, 
 axlab_hap1_hla_b nvarchar(30) NULL, 
 axlab_hap2_hla_b nvarchar(30) NULL, 
 axlab_hap1_hla_c nvarchar(30) NULL, 
 axlab_hap2_hla_c nvarchar(30) NULL, 
 axlab_hap1_hla_dra1 nvarchar(30) NULL, 
 axlab_hap2_hla_dra1 nvarchar(30) NULL, 
 axlab_hap1_hla_drb1 nvarchar(30) NULL, 
 axlab_hap2_hla_drb1 nvarchar(30) NULL, 
 axlab_hap1_hla_dqa1 nvarchar(30) NULL, 
 axlab_hap2_hla_dqa1 nvarchar(30) NULL, 
 axlab_hap1_hla_dqb1 nvarchar(30) NULL, 
 axlab_hap2_hla_dqb1 nvarchar(30) NULL, 
 axlab_hap1_hla_dpa1 nvarchar(30) NULL, 
 axlab_hap2_hla_dpa1 nvarchar(30) NULL, 
 axlab_hap1_hla_dpb1 nvarchar(30) NULL, 
 axlab_hap2_hla_dpb1 nvarchar(30) NULL, 
 axlab_date_added datetime NULL, 
 axlab_line decimal(9, 0) NULL, 
 axlab_status nvarchar(1) NULL, 
 axlab_authors nvarchar(200) NULL, 
 axlab_add1 nvarchar(80) NULL, 
 axlab_add2 nvarchar(80) NULL, 
 axlab_city nvarchar(20) NULL, 
 axlab_county nvarchar(20) NULL, 
 axlab_country nvarchar(4) NULL, 
 axlab_postcode nvarchar(10) NULL, 
 axlab_fax nvarchar(25) NULL, 
 axlab_email nvarchar(60) NULL, 
 axlab_ihw nvarchar(1) NULL, 
    CONSTRAINT PK_allexlab PRIMARY KEY CLUSTERED  
    ( 
     axlab_allele Asc, 
 axlab_indiv_id Asc, 
 axlab_user Asc 
    ) 
) 
 
CREATE TABLE allidend( 
 idd_code nvarchar(20) Not NULL, 
 idd_allele nvarchar(20) Not NULL, 
idd_status nvarchar(1) NULL, 
    CONSTRAINT PK_allidend PRIMARY KEY CLUSTERED  
    ( 
 idd_code Asc, 
 idd_allele Asc 
    ) 
) 
 
CREATE TABLE allidenr( 
 idr_allele nvarchar(20) Not NULL, 
 idr_identical nvarchar(20) Not NULL, 
    CONSTRAINT PK_allidenr PRIMARY KEY CLUSTERED  
    ( 
     idr_allele Asc, 
     idr_identical Asc 
    ) 
) 
 
CREATE TABLE allident( 
 ide_code nvarchar(20) Not NULL, 
 ide_name nvarchar(20) Not NULL, 
 ide_status nvarchar(1) NULL, 
    CONSTRAINT PK_allident PRIMARY KEY CLUSTERED  
    ( 
     ide_code Asc, 
     ide_name Asc 
    ) 
) 
 
CREATE TABLE allseq( 
 aseq_allele nvarchar(20) Not NULL, 
 aseq_protein nvarchar(Max) NULL, 
 aseq_genomic nvarchar(Max) NULL, 
 aseq_size decimal(8, 0) NULL, 
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    CONSTRAINT PK_allseq PRIMARY KEY CLUSTERED  
    ( 
     aseq_allele Asc 
    ) 
) 
 
CREATE TABLE allseqd( 
 aseqd_allele nvarchar(20) Not NULL, 
 aseqd_line decimal(4, 0) Not NULL, 
 aseqd_type nvarchar(2) Not NULL, 
 aseqd_from decimal(6, 0) NULL, 
 aseqd_to decimal(6, 0) NULL, 
 aseqd_order decimal(4, 0) NULL, 
    CONSTRAINT PK_allseqd PRIMARY KEY CLUSTERED  
    ( 
     aseqd_allele Asc, 
     aseqd_line Asc, 
     aseqd_type Asc 
    ) 
) 
 
CREATE TABLE allsynon( 
 asyn_parent nvarchar(20) Not NULL, 
 asyn_child nvarchar(20) Not NULL, 
 asyn_parent_size decimal(4, 0) NULL, 
 asyn_child_size decimal(4, 0) NULL, 
    CONSTRAINT PK_allsynon PRIMARY KEY CLUSTERED  
    ( 
     asyn_parent Asc, 
     asyn_child Asc 
    ) 
) 
 
CREATE TABLE cellline( 
 cell_id decimal(8, 0) Not NULL, 
 cell_dna_no nvarchar(20) NULL, 
 cell_ihw_no nvarchar(20) NULL, 
 cell_ipd_code nvarchar(20) NULL, 
 cell_consang nvarchar(1) NULL, 
 cell_2dl1_1 nvarchar(20) NULL, 
 cell_2dl1_2 nvarchar(20) NULL, 
 cell_2dp1_1 nvarchar(20) NULL, 
 cell_2dl3_1 nvarchar(20) NULL, 
 cell_2dl3_2 nvarchar(20) NULL, 
 cell_2ds4_1 nvarchar(20) NULL, 
 cell_2ds4_2 nvarchar(20) NULL, 
 cell_3dl1_1 nvarchar(20) NULL, 
 cell_3dl1_2 nvarchar(20) NULL, 
 cell_3dl1_1_s nvarchar(20) NULL, 
 cell_3dl1_2_s nvarchar(20) NULL, 
 cell_3ds1_1 nvarchar(20) NULL, 
 cell_3ds1_1_s nvarchar(20) NULL, 
 cell_2ds1_1 nvarchar(20) NULL, 
 cell_2ds2_1 nvarchar(20) NULL, 
 cell_2ds3_1 nvarchar(20) NULL, 
 cell_2ds3_2 nvarchar(20) NULL, 
 cell_2ds5_1 nvarchar(20) NULL, 
 cell_2dl2_1 nvarchar(20) NULL, 
 cell_2dl2_2 nvarchar(20) NULL, 
 cell_2dl5a_1 nvarchar(20) NULL, 
 cell_2dl5a_2 nvarchar(20) NULL, 
 cell_2dl5a_s nvarchar(20) NULL, 
 cell_2dl5b_1 nvarchar(20) NULL, 
 cell_2dl5b_2 nvarchar(20) NULL, 
 cell_2dl5b_s nvarchar(20) NULL, 
 cell_2dl4_1 nvarchar(20) NULL, 
 cell_2dl4_2 nvarchar(20) NULL, 
 cell_3dl2_1 nvarchar(20) NULL, 
 cell_3dl2_2 nvarchar(20) NULL, 
 cell_3dl3_1 nvarchar(20) NULL, 
 cell_3dp1_1 nvarchar(20) NULL, 
 cell_status nvarchar(1) NULL, 
    CONSTRAINT PK_cellline PRIMARY KEY CLUSTERED  
    ( 
     cell_id Asc 
    ) 
) 
 
CREATE TABLE codons( 
 cod_id decimal(4, 0) Not NULL, 
 cod_aminoacid nvarchar(20) NULL, 
 cod_letter nvarchar(1) NULL, 
 cod_3letter nvarchar(3) NULL, 
 cod_rna nvarchar(3) NULL, 
 cod_dna nvarchar(3) NULL, 
 cod_polarity nvarchar(5) NULL, 
    CONSTRAINT PK_codons PRIMARY KEY CLUSTERED  
    ( 
     cod_id Asc 
    ) 
) 
 
CREATE TABLE continen( 
 con_code nvarchar(4) Not NULL, 
 con_name nvarchar(20) NULL, 
 con_index nvarchar(2) NULL, 
 con_status nvarchar(1) NULL, 
    CONSTRAINT PK_continen PRIMARY KEY CLUSTERED  
    ( 
     con_code Asc 
    ) 
) 
 
CREATE TABLE country( 
 cou_code nvarchar(3) Not NULL, 
 geo_code nvarchar(4) Not NULL, 
 cou_name nvarchar(60) NULL, 
 cou_code2 nvarchar(2) NULL, 
 cou_number decimal(6, 0) NULL, 
 cou_name2 nvarchar(60) NULL, 
 cou_tld nvarchar(6) NULL, 
 cou_timezone nvarchar(60) NULL, 
 cou_phone_code nvarchar(5) NULL, 
 cou_population decimal(18, 0) NULL, 
 cou_pop_date datetime NULL, 
 cou_pop_source nvarchar(60) NULL, 
 cou_area decimal(12, 2) NULL, 
 cou_area_date datetime NULL, 
 cou_area_source nvarchar(60) NULL, 
 cou_capital nvarchar(60) NULL, 
 cou_latitude nvarchar(40) NULL, 
 cou_longitude nvarchar(40) NULL, 
 cou_status nvarchar(1) NULL, 
    CONSTRAINT PK_country PRIMARY KEY CLUSTERED  
    ( 
     cou_code Asc 
    ) 
) 
 
CREATE TABLE couxgeo( 
 cogr_geo_region_code nvarchar(4) Not NULL, 
 cogr_country_code nvarchar(3) Not NULL, 
 cogr_geo_region_name nvarchar(25) NULL, 
 cogr_country_name nvarchar(60) NULL, 
 cogr_status nvarchar(1) NULL, 
    CONSTRAINT PK_couxgeo PRIMARY KEY CLUSTERED  
    ( 
     cogr_geo_region_code Asc, 
     cogr_country_code Asc 
    ) 
) 
 
CREATE TABLE cytofreq( 
 cytf_popid decimal(8, 0) Not NULL, 
 cytf_gene nvarchar(20) Not NULL, 
 cytf_cytokine nvarchar(25) Not NULL, 
 cytf_line decimal(4, 0) NULL, 
 cytf_freq decimal(8, 4) NULL, 
 cytf_added datetime NULL, 
 cytf_updated datetime NULL, 
 cytf_user nvarchar(20) NULL, 
 cytf_order decimal(12, 4) NULL, 
 cytf_status nvarchar(1) NULL, 
 cytf_indiv decimal(9, 0) NULL, 
 cytf_sample_size decimal(9, 0) NULL, 
    CONSTRAINT PK_cytofreq PRIMARY KEY CLUSTERED  
    ( 
     cytf_popid Asc, 
     cytf_gene Asc, 
     cytf_cytokine Asc 
    ) 
) 
 
CREATE TABLE cytokine( 
 cyt_name nvarchar(25) Not NULL, 
 cyt_gene nvarchar(15) NULL, 
 cyt_group nvarchar(6) NULL, 
 cyt_updated datetime NULL, 
 cyt_index nvarchar(10) NULL, 
 cyt_status nvarchar(1) NULL, 
    CONSTRAINT PK_cytokine PRIMARY KEY CLUSTERED  
    ( 
     cyt_name Asc 
    ) 
) 
 
CREATE TABLE ethnalle( 
 etha_allele nvarchar(20) Not NULL, 
 etha_ethnic_origin nvarchar(200) NULL, 
 etha_first nvarchar(4) NULL, 
    CONSTRAINT PK_ethnalle PRIMARY KEY CLUSTERED  
    ( 
     etha_allele Asc 
    ) 
) 
 
CREATE TABLE ethnic( 
 eth_code nvarchar(4) Not NULL, 
 eth_name nvarchar(25) NULL, 
 eth_status nvarchar(1) NULL, 
 eth_reference nvarchar(40) NULL, 
    CONSTRAINT PK_ethnic PRIMARY KEY CLUSTERED  
    ( 
     eth_code Asc 
    ) 
) 
 
CREATE TABLE ethxcou( 
 ethc_country_code nvarchar(3) Not NULL, 
 ethc_ethnic_code nvarchar(4) Not NULL, 
 ethc_country_name nvarchar(60) NULL, 
 ethc_ethnic_name nvarchar(25) NULL, 
 ethc_status nvarchar(1) NULL, 
    CONSTRAINT PK_ethxcou PRIMARY KEY CLUSTERED  
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    ( 
     ethc_country_code Asc, 
     ethc_ethnic_code Asc 
    ) 
) 
 
CREATE TABLE ethxgeo( 
 ethg_geo_region_code nvarchar(4) Not NULL, 
 ethg_ethnic_code nvarchar(4) Not NULL, 
 ethg_geo_region_name nvarchar(25) NULL, 
 ethg_ethnic_name nvarchar(25) NULL, 
 ethg_status nvarchar(1) NULL, 
    CONSTRAINT PK_ethxgeo PRIMARY KEY CLUSTERED  
    ( 
     ethg_geo_region_code Asc, 
     ethg_ethnic_code Asc 
    ) 
) 
 
CREATE TABLE event( 
 eve_id decimal(8, 0) Not NULL, 
 eve_event nvarchar(20) NULL, 
 eve_description nvarchar(40) NULL, 
 eve_user nvarchar(20) NULL, 
 eve_program nvarchar(8) NULL, 
 eve_date datetime NULL, 
 eve_time decimal(6, 0) NULL, 
 eve_extra nvarchar(40) NULL, 
    CONSTRAINT PK_event PRIMARY KEY CLUSTERED  
    ( 
     eve_id Asc 
    ) 
) 
 
 
CREATE TABLE ext_ashi_rares( 
 ashi_allele nvarchar(20) Not NULL, 
 ashi_release nvarchar(10) Not NULL, 
 ashi_common nvarchar(2) NULL, 
 ashi_documented nvarchar(2) NULL, 
 ashi_update datetime NULL, 
    CONSTRAINT PK_ext_ashi_rares PRIMARY KEY 
CLUSTERED  
    ( 
     ashi_allele Asc, 
     ashi_release Asc 
    ) 
) 
 
CREATE TABLE ext_imgt_confirm( 
 imgt_allele nvarchar(20) Not NULL, 
 imgt_release nvarchar(10) Not NULL, 
 imgt_cells decimal(6, 0) NULL, 
 imgt_groups decimal(6, 0) NULL, 
 imgt_confirmed nvarchar(15) NULL, 
 imgt_start decimal(6, 0) NULL, 
 imgt_end decimal(6, 0) NULL, 
 imgt_partial nvarchar(10) NULL, 
 imgt_ethnicity nvarchar(200) NULL, 
 imgt_update datetime NULL, 
    CONSTRAINT PK_ext_imgt_confirm PRIMARY KEY 
CLUSTERED  
    ( 
     imgt_allele Asc, 
     imgt_release Asc 
    ) 
) 
 
CREATE TABLE ext_ipd_kir( 
 ipd_allele nvarchar(20) Not NULL, 
 ipd_release nvarchar(10) Not NULL, 
 ipd_update datetime NULL, 
    CONSTRAINT PK_ext_ipd_kir PRIMARY KEY CLUSTERED  
    ( 
     ipd_allele Asc, 
     ipd_release Asc 
    ) 
) 
 
CREATE TABLE ext_labs_rares( 
 labs_allele nvarchar(20) Not NULL, 
 labs_bla decimal(9, 0) NULL, 
 labs_cau decimal(9, 0) NULL, 
 labs_mes decimal(9, 0) NULL, 
 labs_his decimal(9, 0) NULL, 
 labs_oth decimal(9, 0) NULL, 
 labs_total decimal(9, 0) NULL, 
    CONSTRAINT PK_ext_labs_rares PRIMARY KEY 
CLUSTERED  
    ( 
     labs_allele Asc 
    ) 
) 
 
CREATE TABLE ext_nmdp_rares( 
 nmdp_allele nvarchar(20) Not NULL, 
 nmdp_release nvarchar(10) Not NULL, 
 nmdp_afa decimal(6, 0) NULL, 
 nmdp_api decimal(6, 0) NULL, 
 nmdp_cau decimal(6, 0) NULL, 
 nmdp_his decimal(6, 0) NULL, 
 nmdp_nam decimal(6, 0) NULL, 
 nmdp_oth decimal(6, 0) NULL, 
 nmdp_total decimal(9, 0) NULL, 
 nmdp_rare nvarchar(1) NULL, 
 nmdp_zero nvarchar(1) NULL, 
 nmdp_update datetime NULL, 
    CONSTRAINT PK_ext_nmdp_rares PRIMARY KEY 
CLUSTERED  
    ( 
     nmdp_allele Asc, 
     nmdp_release Asc 
    ) 
) 
 
CREATE TABLE extratbl( 
 ext_table nvarchar(4) Not NULL, 
 ext_code nvarchar(4) Not NULL, 
 ext_value nvarchar(60) NULL, 
 ext_value2 nvarchar(60) NULL, 
 ext_status nvarchar(1) NULL, 
    CONSTRAINT PK_extratbl PRIMARY KEY CLUSTERED  
    ( 
     ext_table Asc, 
     ext_code Asc 
    ) 
) 
 
CREATE TABLE genofred( 
 genfd_popid decimal(8, 0) Not NULL, 
 genfd_polyreg nvarchar(4) Not NULL, 
 genfd_genotype decimal(8, 0) Not NULL, 
 genfd_locus nvarchar(20) Not NULL, 
 genfd_line_h decimal(4, 0) NULL, 
 genfd_line decimal(4, 0) NULL, 
 genfd_value nvarchar(2) NULL, 
 genfd_status nvarchar(1) NULL, 
    CONSTRAINT PK_genofred PRIMARY KEY CLUSTERED  
    ( 
     genfd_popid Asc, 
     genfd_polyreg Asc, 
     genfd_genotype Asc, 
     genfd_locus Asc 
    ) 
) 
 
CREATE TABLE genofreq( 
 genf_popid decimal(8, 0) Not NULL, 
 genf_polyreg nvarchar(10) Not NULL, 
 genf_genotype decimal(8, 0) Not NULL, 
 genf_line decimal(4, 0) NULL, 
 genf_phenotype nvarchar(10) NULL, 
 genf_genotype_b2 nvarchar(20) NULL, 
 genf_genotype_b3 nvarchar(50) NULL, 
 genf_freq decimal(8, 4) NULL, 
 genf_added datetime NULL, 
 genf_updated datetime NULL, 
 genf_status nvarchar(1) NULL, 
 genf_individuals decimal(9, 0) NULL, 
 genf_sample_size decimal(9, 0) NULL, 
    CONSTRAINT PK_genofreq PRIMARY KEY CLUSTERED  
    ( 
     genf_popid Asc, 
     genf_polyreg Asc, 
     genf_genotype Asc 
    ) 
) 
 
CREATE TABLE geogreg( 
 geo_code nvarchar(4) Not NULL, 
          con_code nvarchar(4) NULL, 
 geo_name nvarchar(25) NULL, 
 geo_index nvarchar(6) NULL, 
 geo_status nvarchar(1) NULL, 
    CONSTRAINT PK_geogreg PRIMARY KEY CLUSTERED  
    ( 
     geo_code Asc 
    ) 
) 
 
CREATE TABLE gracolor( 
 gcol_gene nvarchar(20) Not NULL, 
 gcol_range nvarchar(10) Not NULL, 
 gcol_color nvarchar(10) NULL, 
 gcol_color_value nvarchar(10) NULL, 
 gcol_bar nvarchar(10) NULL, 
 gcol_minv decimal(4, 0) NULL, 
 gcol_maxv decimal(4, 0) NULL, 
    CONSTRAINT PK_gracolor PRIMARY KEY CLUSTERED  
    ( 
     gcol_gene Asc, 
     gcol_range Asc 
    ) 
) 
 
CREATE TABLE gradient( 
 gra_value decimal(4, 0) Not NULL, 
 gra_min decimal(4, 0) NULL, 
 gra_max decimal(4, 0) NULL, 
    CONSTRAINT PK_gradient PRIMARY KEY CLUSTERED  
    ( 
     gra_value Asc 
    ) 
) 
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CREATE TABLE hallele( 
 hla_allele nvarchar(20) Not NULL, 
 hla_locus nvarchar(10) NULL, 
 hla_level1 decimal(4, 0) NULL, 
 hla_level2 decimal(4, 0) NULL, 
 hla_level3 decimal(4, 0) NULL, 
 hla_level4 decimal(4, 0) NULL, 
 hla_order decimal(8, 0) NULL, 
    CONSTRAINT PK_hallele PRIMARY KEY CLUSTERED  
    ( 
     hla_allele Asc 
    ) 
) 
 
CREATE TABLE hallele2( 
 hla2_allele nvarchar(20) Not NULL, 
 hla2_allele2 nvarchar(20) NULL, 
 hla2_locus nvarchar(10) NULL, 
 hla2_length decimal(3, 0) NULL, 
 hla2_source nvarchar(4) NULL, 
 hla2_resol nvarchar(1) NULL, 
 hla2_level1 decimal(4, 0) NULL, 
 hla2_level2 decimal(4, 0) NULL, 
 hla2_level3 decimal(4, 0) NULL, 
 hla2_level4 decimal(4, 0) NULL, 
 hla2_order decimal(8, 0) NULL, 
    CONSTRAINT PK_hallele2 PRIMARY KEY CLUSTERED  
    ( 
     hla2_allele Asc 
    ) 
) 
 
CREATE TABLE hapldet( 
 hapd_popid decimal(8, 0) Not NULL, 
 hapd_line decimal(4, 0) Not NULL, 
 hapd_allele nvarchar(20) Not NULL, 
 hapd_locus nvarchar(10) Not NULL, 
 hapd_info nvarchar(20) NULL, 
    CONSTRAINT PK_hapldet PRIMARY KEY CLUSTERED  
    ( 
     hapd_popid Asc, 
     hapd_line Asc, 
     hapd_allele Asc, 
     hapd_locus Asc 
    ) 
) 
 
 
CREATE TABLE haplfreq( 
 hapf_popid decimal(8, 0) Not NULL, 
 hapf_region nvarchar(10) Not NULL, 
 hapf_line decimal(4, 0) Not NULL, 
 hapf_haplotype nvarchar(100) Not NULL, 
 hapf_haplotype2 nvarchar(100) Not NULL, 
 hapf_freq decimal(8, 4) NULL, 
 hapf_added datetime NULL, 
 hapf_updated datetime NULL, 
 hapf_user nvarchar(20) NULL, 
 hapf_status nvarchar(1) NULL, 
 hapf_loci decimal(4, 0) NULL, 
    CONSTRAINT PK_haplfreq PRIMARY KEY CLUSTERED  
    ( 
     hapf_popid Asc, 
     hapf_region Asc, 
     hapf_line Asc, 
     hapf_haplotype Asc, 
     hapf_haplotype2 Asc 
    ) 
) 
 
CREATE TABLE hladict( 
 hlad_allele nvarchar(20) Not NULL, 
 hlad_expert nvarchar(20) NULL, 
 hlad_who nvarchar(20) NULL, 
 hlad_status nvarchar(1) NULL, 
    CONSTRAINT PK_hladict PRIMARY KEY CLUSTERED  
    ( 
     hlad_allele Asc 
    ) 
) 
 
CREATE TABLE hlaprot( 
 hlap_allele nvarchar(20) Not NULL, 
 hlap_line decimal(8, 0) NULL, 
 hlap_sequence nvarchar(Max) NULL, 
 hlap_reference nvarchar(Max) NULL, 
    CONSTRAINT PK_hlaprot PRIMARY KEY CLUSTERED  
    ( 
     hlap_allele Asc 
    ) 
) 
 
CREATE TABLE kallele( 
 kir_allele nvarchar(20) Not NULL, 
    CONSTRAINT PK_kallele PRIMARY KEY CLUSTERED  
    ( 
     kir_allele Asc 
    ) 
) 
 
CREATE TABLE kallele2( 
 kir2_allele nvarchar(20) Not NULL, 
 kir2_locus nvarchar(20) NULL, 
 kir2_length decimal(3, 0) NULL, 
 kir2_source nvarchar(4) NULL, 
 kir2_resol nvarchar(1) NULL, 
    CONSTRAINT PK_kallele2 PRIMARY KEY CLUSTERED  
    ( 
     kir2_allele Asc 
    ) 
) 
 
CREATE TABLE kirgeno( 
 kgen_id decimal(8, 0) Not NULL, 
 kgen_3dl1 nvarchar(2) NULL, 
 kgen_2dl1 nvarchar(2) NULL, 
 kgen_2dl3 nvarchar(2) NULL, 
 kgen_2ds4 nvarchar(2) NULL, 
 kgen_2dl2 nvarchar(2) NULL, 
 kgen_2dl5 nvarchar(2) NULL, 
 kgen_3ds1 nvarchar(2) NULL, 
 kgen_2ds1 nvarchar(2) NULL, 
 kgen_2ds2 nvarchar(2) NULL, 
 kgen_2ds3 nvarchar(2) NULL, 
 kgen_2ds5 nvarchar(2) NULL, 
 kgen_2dl4 nvarchar(2) NULL, 
 kgen_3dl2 nvarchar(2) NULL, 
 kgen_3dl3 nvarchar(2) NULL, 
 kgen_2dp1 nvarchar(2) NULL, 
 kgen_3dp1 nvarchar(2) NULL, 
 kgen_group_a nvarchar(1) NULL, 
 kgen_group_b nvarchar(1) NULL, 
 kgen_type nvarchar(2) NULL, 
 kgen_order nvarchar(20) NULL, 
 kgen_status nvarchar(1) NULL, 
 kgen_phenotype nvarchar(10) NULL, 
 kgen_pops decimal(9, 0) NULL, 
 kgen_individuals decimal(12, 0) NULL, 
 kgen_a_genes decimal(4, 0) NULL, 
 kgen_b_genes decimal(4, 0) NULL, 
 kgen_pseudo_genes decimal(4, 0) NULL, 
 kgen_total_genes decimal(4, 0) NULL, 
    CONSTRAINT PK_kirgeno PRIMARY KEY CLUSTERED  
    ( 
     kgen_id Asc 
    ) 
) 
 
CREATE TABLE locus( 
 loc_region nvarchar(10) Not NULL, 
 loc_name nvarchar(20) Not NULL, 
 loc_chrom_name nvarchar(20) NULL, 
 loc_chrom_number decimal(2, 0) NULL, 
 loc_chrom_position nvarchar(1) NULL, 
 loc_chrom_band decimal(3, 0) NULL, 
 loc_chrom_subband decimal(3, 0) NULL, 
 loc_chrom_ending nvarchar(4) NULL, 
 loc_hla_class nvarchar(10) NULL, 
 loc_hla_type nvarchar(20) NULL, 
 loc_kir_domains decimal(2, 0) NULL, 
 loc_kir_cyto_tail nvarchar(10) NULL, 
 loc_kir_gene_number nvarchar(2) NULL, 
 loc_kir_type nvarchar(10) NULL, 
 loc_kir_code nvarchar(4) NULL, 
 loc_order nvarchar(4) NULL, 
 loc_status nvarchar(1) NULL, 
    CONSTRAINT PK_locus PRIMARY KEY CLUSTERED  
    ( 
     loc_region Asc, 
     loc_name Asc 
    ) 
) 
 
CREATE TABLE mallele( 
 mic_allele nvarchar(20) Not NULL, 
 mic_locus nvarchar(10) NULL, 
 mic_level1 decimal(4, 0) NULL, 
 mic_level2 decimal(4, 0) NULL, 
 mic_level3 decimal(4, 0) NULL, 
 mic_level4 decimal(4, 0) NULL, 
 mic_order decimal(8, 0) NULL, 
    CONSTRAINT PK_mallele PRIMARY KEY CLUSTERED  
    ( 
     mic_allele Asc 
    ) 
) 
 
CREATE TABLE mallele2( 
 mic2_allele nvarchar(20) Not NULL, 
 mic2_allele2 nvarchar(20) NULL, 
 mic2_locus nvarchar(10) NULL, 
 mic2_length decimal(4, 0) NULL, 
 mic2_source nvarchar(4) NULL, 
 mic2_resol nvarchar(1) NULL, 
 mic2_level1 decimal(4, 0) NULL, 
 mic2_level2 decimal(4, 0) NULL, 
 mic2_level3 decimal(4, 0) NULL, 
 mic2_level4 decimal(4, 0) NULL, 
 mic2_order decimal(8, 0) NULL, 
    CONSTRAINT PK_mallele2 PRIMARY KEY CLUSTERED  
    ( 
     mic2_allele Asc 
    ) 
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) 
 
CREATE TABLE metadata( 
 met_type nvarchar(4) Not NULL, 
 met_table nvarchar(30) Not NULL, 
 met_number decimal(6, 0) Not NULL, 
 met_name nvarchar(40) NULL, 
 met_namedisp nvarchar(20) NULL, 
 met_desc nvarchar(40) NULL, 
 met_datatype nvarchar(20) NULL, 
 met_length nvarchar(8) NULL, 
 met_mask nvarchar(20) NULL, 
 met_help nvarchar(40) NULL, 
 met_common nvarchar(1) NULL, 
 met_upper nvarchar(1) NULL, 
 met_order decimal(6, 0) NULL, 
 met_status nvarchar(1) NULL, 
    CONSTRAINT PK_metadata PRIMARY KEY CLUSTERED  
    ( 
     met_type Asc, 
     met_table Asc, 
     met_number Asc 
    ) 
) 
 
 
CREATE TABLE polyreg( 
 pol_code nvarchar(10) Not NULL, 
 pol_name nvarchar(20) NULL, 
 pol_desc nvarchar(50) NULL, 
 pol_index nvarchar(6) NULL, 
 pol_status nvarchar(1) NULL, 
    CONSTRAINT PK_polyreg PRIMARY KEY CLUSTERED  
    ( 
     pol_code Asc 
    ) 
) 
 
CREATE TABLE poplocus( 
 popl_poly nvarchar(20) Not NULL, 
 popl_popid decimal(8, 0) Not NULL, 
 popl_locus nvarchar(20) Not NULL, 
    CONSTRAINT PK_poplocus PRIMARY KEY CLUSTERED  
    ( 
     popl_poly Asc, 
     popl_popid Asc, 
     popl_locus Asc 
    ) 
) 
 
CREATE TABLE popshla( 
 phla_popid decimal(8, 0) Not NULL, 
 phla_population nvarchar(50) NULL, 
 phla_a decimal(6, 0) NULL, 
 phla_b decimal(6, 0) NULL, 
 phla_cw decimal(6, 0) NULL, 
 phla_drb1 decimal(6, 0) NULL, 
 phla_dqb1 decimal(6, 0) NULL, 
 phla_dqa1 decimal(6, 0) NULL, 
 phla_dpa1 decimal(6, 0) NULL, 
 phla_dpb1 decimal(6, 0) NULL, 
 phla_others decimal(6, 0) NULL, 
 phla_total decimal(6, 0) NULL, 
 phla_hap decimal(6, 0) NULL, 
 phla_a_p decimal(6, 0) NULL, 
 phla_b_p decimal(6, 0) NULL, 
 phla_cw_p decimal(6, 0) NULL, 
 phla_drb1_p decimal(6, 0) NULL, 
 phla_dqb1_p decimal(6, 0) NULL, 
 phla_dqa1_p decimal(6, 0) NULL, 
 phla_dpa1_p decimal(6, 0) NULL, 
 phla_dpb1_p decimal(6, 0) NULL, 
 phla_others_p decimal(6, 0) NULL, 
 phla_total_p decimal(6, 0) NULL, 
    CONSTRAINT PK_popshla PRIMARY KEY CLUSTERED  
    ( 
     phla_popid Asc 
    ) 
) 
 
CREATE TABLE popskir( 
 pkir_popid decimal(8, 0) Not NULL, 
 pkir_population nvarchar(50) NULL, 
 pkir_2dl1 decimal(6, 0) NULL, 
 pkir_2dl2 decimal(6, 0) NULL, 
 pkir_2dl3 decimal(6, 0) NULL, 
 pkir_2dl4 decimal(6, 0) NULL, 
 pkir_2dl5 decimal(6, 0) NULL, 
 pkir_2dl5a decimal(6, 0) NULL, 
 pkir_2dl5b decimal(6, 0) NULL, 
 pkir_2ds1 decimal(6, 0) NULL, 
 pkir_2ds2 decimal(6, 0) NULL, 
 pkir_2ds3 decimal(6, 0) NULL, 
 pkir_2ds4 decimal(6, 0) NULL, 
 pkir_2ds5 decimal(6, 0) NULL, 
 pkir_3ds1 decimal(6, 0) NULL, 
 pkir_3dl1 decimal(6, 0) NULL, 
 pkir_3dl2 decimal(6, 0) NULL, 
 pkir_3dl3 decimal(6, 0) NULL, 
 pkir_2dp1 decimal(6, 0) NULL, 
 pkir_3dp1 decimal(6, 0) NULL, 
 pkir_total decimal(6, 0) NULL, 
 pkir_geno decimal(6, 0) NULL, 
    CONSTRAINT PK_popskir PRIMARY KEY CLUSTERED  
    ( 
     pkir_popid Asc 
    ) 
) 
 
CREATE TABLE populat( 
 pop_id decimal(8, 0) Not NULL, 
 pop_polyreg nvarchar(20) Not NULL, 
 pop_name nvarchar(60) NULL, 
 pop_name2 nvarchar(60) NULL, 
 pop_country nvarchar(50) NULL, 
 pop_geog_region nvarchar(25) NULL, 
 pop_subregion nvarchar(50) NULL, 
 pop_ethnic_origin nvarchar(50) NULL, 
 pop_linguistic nvarchar(50) NULL, 
 pop_center nvarchar(50) NULL, 
 pop_origin nvarchar(50) NULL, 
 pop_urban_rural nvarchar(50) NULL, 
 pop_family nvarchar(50) NULL, 
 pop_source nvarchar(50) NULL, 
 pop_isolated nvarchar(1) NULL, 
 pop_admixture nvarchar(1) NULL, 
 pop_lat1_deg decimal(3, 0) NULL, 
 pop_lat1_min decimal(2, 0) NULL, 
 pop_lat1_card nvarchar(1) NULL, 
 pop_long1_deg decimal(3, 0) NULL, 
 pop_long1_min decimal(2, 0) NULL, 
 pop_long1_card nvarchar(1) NULL, 
 pop_coord_conf nvarchar(1) NULL, 
 pop_size decimal(10, 0) NULL, 
 pop_samplesize decimal(9, 0) NULL, 
 pop_sampleyear nvarchar(6) NULL, 
 pop_method_analysis nvarchar(20) NULL, 
 pop_notes nvarchar(250) NULL, 
 pop_verified nvarchar(1) NULL, 
 pop_status nvarchar(1) NULL, 
 pop_submited_date datetime NULL, 
 pop_submited_by nvarchar(20) NULL, 
 pop_reviewed_date datetime NULL, 
 pop_reviewed_by nvarchar(20) NULL, 
 pop_update datetime NULL, 
 pop_alleles decimal(6, 0) NULL, 
 pop_phenotypes decimal(6, 0) NULL, 
 pop_genotypes decimal(6, 0) NULL, 
 pop_haplotypes decimal(6, 0) NULL, 
 pop_loci_test_hap decimal(6, 0) NULL, 
 pop_main_author nvarchar(250) NULL, 
 pop_reference1 nvarchar(250) NULL, 
 pop_reference2 nvarchar(50) NULL, 
 pop_reference3 nvarchar(250) NULL, 
 pop_dataset nvarchar(20) NULL, 
 pop_article nvarchar(250) NULL, 
 pop_authors nvarchar(250) NULL, 
 pop_correspondence nvarchar(100) NULL, 
 pop_email nvarchar(50) NULL, 
 pop_journal nvarchar(250) NULL, 
 pop_year decimal(4, 0) NULL, 
 pop_volumen nvarchar(10) NULL, 
 pop_issue nvarchar(10) NULL, 
 pop_pages nvarchar(20) NULL, 
 pop_doi nvarchar(50) NULL, 
 pop_pubmed nvarchar(20) NULL, 
 pop_file_name nvarchar(100) NULL, 
 pop_method nvarchar(25) NULL, 
 pop_ssp nvarchar(1) NULL, 
 pop_ssop nvarchar(1) NULL, 
 pop_sscp nvarchar(1) NULL, 
 pop_sbt nvarchar(1) NULL, 
 pop_seq nvarchar(1) NULL, 
 pop_rsca nvarchar(1) NULL, 
 pop_rflp nvarchar(1) NULL, 
 pop_oth nvarchar(1) NULL, 
 pop_country_lab nvarchar(50) NULL, 
 pop_dna_origin nvarchar(20) NULL, 
 pop_kit nvarchar(50) NULL, 
 pop_certify nvarchar(6) NULL, 
 pop_reference4 nvarchar(250) NULL, 
 pop_has_alleles nvarchar(1) NULL, 
 pop_has_haplotypes nvarchar(1) NULL, 
 pop_has_cytokines nvarchar(1) NULL, 
    CONSTRAINT PK_populat PRIMARY KEY CLUSTERED  
    ( 
     pop_id Asc, 
     pop_polyreg Asc 
    ) 
) 
 
CREATE TABLE programs( 
 prg_code nvarchar(8) Not NULL, 
 prg_desc nvarchar(80) NULL, 
 prg_desc2 nvarchar(Max) NULL, 
 prg_desc3 nvarchar(80) NULL, 
 prg_desc4 nvarchar(40) NULL, 
 prg_desc5 nvarchar(40) NULL, 
 prg_type nvarchar(4) NULL, 
 prg_module nvarchar(20) NULL, 
 prg_status nvarchar(1) NULL, 
 prg_author nvarchar(8) NULL, 
 prg_created datetime NULL, 
 prg_last_update datetime NULL, 
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 prg_user_update nvarchar(8) NULL, 
 prg_version nvarchar(10) NULL, 
 prg_display nvarchar(1) NULL, 
 prg_web nvarchar(1) NULL, 
    CONSTRAINT PK_programs PRIMARY KEY CLUSTERED  
    ( 
     prg_code Asc 
    ) 
) 
 
CREATE TABLE rareall( 
 rar_allele nvarchar(20) Not NULL, 
 rar_release nvarchar(10) Not NULL, 
 rar_web decimal(8, 0) NULL, 
 rar_nmdp decimal(8, 0) NULL, 
 rar_labs decimal(8, 0) NULL, 
 rar_status nvarchar(1) NULL, 
    CONSTRAINT PK_rareall PRIMARY KEY CLUSTERED  
    ( 
     rar_allele Asc, 
     rar_release Asc 
    ) 
) 
 
CREATE TABLE releases( 
 rel_code nvarchar(8) Not NULL, 
 rel_name nvarchar(20) Not NULL, 
 rel_date datetime NULL, 
 rel_ftp nvarchar(100) NULL, 
 rel_file nvarchar(100) NULL, 
 rel_http nvarchar(100) NULL, 
 rel_desc nvarchar(40) NULL, 
 rel_total_rows nvarchar(20) NULL, 
 rel_status nvarchar(1) NULL, 
    CONSTRAINT PK_releases PRIMARY KEY CLUSTERED  
    ( 
     rel_code Asc, 
     rel_name Asc 
    ) 
) 
 
CREATE TABLE resolut( 
 res_parent nvarchar(20) Not NULL, 
 res_child nvarchar(20) Not NULL, 
 res_parent_size decimal(2, 0) NULL, 
 res_child_size decimal(2, 0) NULL, 
    CONSTRAINT PK_resolut PRIMARY KEY CLUSTERED  
    ( 
     res_parent Asc, 
     res_child Asc 
    ) 
) 
 
CREATE TABLE securacc( 
 sec_user nvarchar(20) Not NULL, 
 sec_program nvarchar(8) Not NULL, 
 sec_password nvarchar(20) NULL, 
 sec_master_ins nvarchar(1) NULL, 
 sec_master_del nvarchar(1) NULL, 
 sec_master_mod nvarchar(1) NULL, 
 sec_detail_ins nvarchar(1) NULL, 
 sec_detail_del nvarchar(1) NULL, 
 sec_detail_mod nvarchar(1) NULL, 
 sec_print nvarchar(1) NULL, 
 sec_apply nvarchar(1) NULL, 
 sec_undo nvarchar(1) NULL, 
 sec_open nvarchar(1) NULL, 
 sec_cancel nvarchar(1) NULL, 
 sec_lock nvarchar(1) NULL, 
 sec_unlock nvarchar(1) NULL, 
 sec_export nvarchar(1) NULL, 
 sec_page1 nvarchar(1) NULL, 
 sec_page2 nvarchar(1) NULL, 
 sec_page3 nvarchar(1) NULL, 
 sec_page4 nvarchar(1) NULL, 
 sec_page5 nvarchar(1) NULL, 
 sec_page6 nvarchar(1) NULL, 
 sec_page7 nvarchar(1) NULL, 
 sec_page8 nvarchar(1) NULL, 
 sec_page9 nvarchar(1) NULL, 
 sec_page10 nvarchar(1) NULL, 
    CONSTRAINT PK_securacc PRIMARY KEY CLUSTERED  
    ( 
     sec_user Asc, 
     sec_program Asc 
    ) 
) 
 
CREATE TABLE statshla( 
 shla_locus nvarchar(20) Not NULL, 
 shla_imgt decimal(9, 0) NULL, 
 shla_website decimal(9, 0) NULL, 
 shla_entries decimal(9, 0) NULL, 
    CONSTRAINT PK_statshla PRIMARY KEY CLUSTERED  
    ( 
     shla_locus Asc 
    ) 
) 
 
CREATE TABLE statskir( 
 skir_locus nvarchar(20) Not NULL, 
 skir_ipd decimal(9, 0) NULL, 
 skir_website decimal(9, 0) NULL, 
 skir_entries decimal(9, 0) NULL, 
    CONSTRAINT PK_statskir PRIMARY KEY CLUSTERED  
    ( 
     skir_locus Asc 
    ) 
) 
 
CREATE TABLE statsmic( 
 smic_locus nvarchar(10) Not NULL, 
 smic_imgt decimal(9, 0) NULL, 
 smic_website decimal(9, 0) NULL, 
 smic_entries decimal(9, 0) NULL, 
    CONSTRAINT PK_statsmic PRIMARY KEY CLUSTERED  
    ( 
     smic_locus Asc 
    ) 
) 
 
CREATE TABLE statspop( 
 spop_polyreg nvarchar(10) Not NULL, 
 spop_pops decimal(9, 0) NULL, 
 spop_alleles decimal(9, 0) NULL, 
 spop_haplotypes decimal(9, 0) NULL, 
 spop_genotypes decimal(9, 0) NULL, 
 spop_family decimal(9, 0) NULL, 
 spop_both decimal(9, 0) NULL, 
    CONSTRAINT PK_statspop PRIMARY KEY CLUSTERED  
    ( 
     spop_polyreg Asc 
    ) 
) 
 
CREATE TABLE tblallele( 
 tall_popid decimal(8, 0) Not NULL, 
 tall_polyreg nvarchar(10) Not NULL, 
 tall_locus nvarchar(10) Not NULL, 
 tall_allele nvarchar(20) Not NULL, 
 tall_line decimal(10, 0) NULL, 
 tall_gene_freq nvarchar(10) NULL, 
 tall_status nvarchar(1) NULL, 
 tall_user nvarchar(15) NULL, 
 tall_pheno_freq nvarchar(10) NULL, 
 tall_added datetime NULL, 
 tall_updated datetime NULL, 
 tall_gene_has_data nvarchar(1) NULL, 
 tall_gene_freq_num decimal(8, 4) NULL, 
 tall_freq_has_data nvarchar(1) NULL, 
 tall_pheno_freq_num decimal(8, 4) NULL, 
 tall_has_data nvarchar(1) NULL, 
 tall_indiv decimal(8, 0) NULL, 
 tall_chrom decimal(8, 0) NULL, 
 tall_samplesize decimal(8, 0) NULL, 
 tall_notes nvarchar(250) NULL, 
    CONSTRAINT PK_tblallele PRIMARY KEY CLUSTERED  
    ( 
     tall_popid Asc, 
     tall_polyreg Asc, 
     tall_locus Asc, 
     tall_allele Asc 
    ) 
) 
 
 
CREATE TABLE tblcytokines( 
 tcyt_popid decimal(8, 0) Not NULL, 
 tcyt_gene nvarchar(20) Not NULL, 
 tcyt_cytokine nvarchar(25) Not NULL, 
 tcyt_genotype nvarchar(4) Not NULL, 
 tcyt_line decimal(10, 0) NULL, 
 tcyt_order decimal(8, 4) NULL, 
 tcyt_freq decimal(8, 4) NULL, 
 tcyt_added datetime NULL, 
 tcyt_update datetime NULL, 
 tcyt_status nvarchar(1) NULL, 
 tcyt_user nvarchar(20) NULL, 
 tcyt_indiv decimal(9, 0) NULL, 
 tcyt_sample_size decimal(9, 0) NULL, 
    CONSTRAINT PK_tblcytokines PRIMARY KEY CLUSTERED  
    ( 
     tcyt_popid Asc, 
     tcyt_gene Asc, 
     tcyt_cytokine Asc, 
     tcyt_genotype Asc 
    ) 
) 
 
CREATE TABLE tblhaplotypes( 
 thap_popid decimal(8, 0) Not NULL, 
 thap_region nvarchar(20) Not NULL, 
 thap_haplotype nvarchar(90) Not NULL, 
 thap_line decimal(10, 0) NULL, 
 thap_haplotype2 nvarchar(90) NULL, 
 thap_frequency decimal(8, 4) NULL, 
 thap_status nvarchar(1) NULL, 
 thap_loci decimal(4, 0) NULL, 
    CONSTRAINT PK_tblhaplotypes PRIMARY KEY 
CLUSTERED  
    ( 
     thap_popid Asc, 
     thap_region Asc, 
     thap_haplotype Asc 
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    ) 
) 
 
CREATE TABLE tmpmatrix( 
 tmp_user nvarchar(20) Not NULL, 
 tmp_allele nvarchar(20) Not NULL, 
 tmp_pos decimal(4, 0) Not NULL, 
 tmp_letter nvarchar(1) NULL, 
 tmp_freq decimal(8, 4) NULL, 
    CONSTRAINT PK_tmpmatrix PRIMARY KEY CLUSTERED  
    ( 
     tmp_user Asc, 
     tmp_allele Asc, 
     tmp_pos Asc 
    ) 
) 
 
CREATE TABLE tmpmatrix2( 
 tmp2_user nvarchar(20) Not NULL, 
 tmp2_value nvarchar(20) Not NULL, 
 tmp2_position decimal(8, 0) NULL, 
    CONSTRAINT PK_tmpmatrix2 PRIMARY KEY CLUSTERED  
    ( 
     tmp2_user Asc, 
     tmp2_value Asc 
    ) 
) 
 
CREATE TABLE tmpmatrix3( 
 tmp3_user nvarchar(20) Not NULL, 
 tmp3_value decimal(8, 0) Not NULL, 
 tmp3_position decimal(8, 0) NULL, 
    CONSTRAINT PK_tmpmatrix3 PRIMARY KEY CLUSTERED  
    ( 
 tmp3_user Asc, 
 tmp3_value Asc 
    ) 
) 
 
CREATE TABLE tmptab02( 
 tmp2_popid decimal(8, 0) Not NULL, 
 tmp2_allele nvarchar(20) Not NULL, 
 tmp2_pfreq nvarchar(10) NULL, 
 tmp2_afreq nvarchar(10) NULL, 
 tmp2_notes nvarchar(Max) NULL, 
    CONSTRAINT PK_tmptab02 PRIMARY KEY CLUSTERED  
    ( 
     tmp2_popid Asc, 
 tmp2_allele Asc 
    ) 
) 
 
CREATE TABLE tsession( 
 ses_user nvarchar(20) Not NULL, 
 ses_last_event nvarchar(8) NULL, 
 ses_status nvarchar(1) NULL, 
 ses_date datetime NULL, 
 ses_time decimal(6, 0) NULL, 
    CONSTRAINT PK_tsession PRIMARY KEY CLUSTERED  
    ( 
     ses_user Asc 
    ) 
) 
 
CREATE TABLE typehla( 
 thla_user nvarchar(20) Not NULL, 
 thla_indiv nvarchar(20) Not NULL, 
 thla_locus nvarchar(20) Not NULL, 
 thla_copy nvarchar(1) Not NULL, 
 thla_allele nvarchar(20) Not NULL, 
 thla_code nvarchar(40) NULL, 
 thla_mark nvarchar(1) NULL, 
 thla_status nvarchar(1) NULL, 
    CONSTRAINT PK_typehla PRIMARY KEY CLUSTERED  
    ( 
 thla_user Asc, 
     thla_indiv Asc, 
     thla_locus Asc, 
     thla_copy Asc, 
     thla_allele Asc 
    ) 
) 
 
CREATE TABLE users( 
 usr_login nvarchar(20) Not NULL, 
 usr_password nvarchar(20) NULL, 
 usr_lastname nvarchar(40) NULL, 
 usr_firstname nvarchar(40) NULL, 
 usr_title nvarchar(4) NULL, 
 usr_sex nvarchar(1) NULL, 
 usr_date_of_birth datetime NULL, 
 usr_email nvarchar(60) NULL, 
 usr_status nvarchar(1) NULL, 
 usr_profile nvarchar(8) NULL, 
 usr_add1 nvarchar(80) NULL, 
 usr_add2 nvarchar(80) NULL, 
 usr_city nvarchar(20) NULL, 
 usr_county nvarchar(4) NULL, 
 usr_country nvarchar(4) NULL, 
 usr_postcode nvarchar(10) NULL, 
 usr_tel1 nvarchar(25) NULL, 
 usr_tel2 nvarchar(25) NULL, 
 usr_fax nvarchar(25) NULL, 
 usr_mobile nvarchar(25) NULL, 
 usr_url nvarchar(60) NULL, 
 usr_association nvarchar(60) NULL, 
 usr_interests nvarchar(60) NULL, 
 usr_notify nvarchar(1) NULL, 
 usr_date_added datetime NULL, 
    CONSTRAINT PK_users PRIMARY KEY CLUSTERED  
    ( 
        usr_login Asc 
    ) 
) 
 
CREATE TABLE usrconf( 
 ucfg_user nvarchar(20) Not NULL, 
 ucfg_program nvarchar(20) Not NULL, 
 ucfg_event nvarchar(40) Not NULL, 
 ucfg_value nvarchar(20) NULL, 
    CONSTRAINT PK_usrconf PRIMARY KEY CLUSTERED  
    ( 
 ucfg_user Asc, 
 ucfg_program Asc, 
 ucfg_event Asc 
    ) 
) 
 
CREATE TABLE websetup( 
 web_name nvarchar(40) Not NULL, 
 web_name2 nvarchar(40) NULL, 
 web_add1 nvarchar(40) NULL, 
 web_add2 nvarchar(40) NULL, 
 web_city nvarchar(20) NULL, 
 web_county nvarchar(4) NULL, 
 web_country nvarchar(4) NULL, 
 web_postcode nvarchar(10) NULL, 
 web_tel1 nvarchar(25) NULL, 
 web_tel2 nvarchar(25) NULL, 
 web_fax nvarchar(25) NULL, 
 web_mobile nvarchar(25) NULL, 
 web_server nvarchar(15) NULL, 
 web_alias_db nvarchar(20) NULL, 
 web_image nvarchar(40) NULL, 
 web_icon nvarchar(40) NULL, 
 web_domain nvarchar(40) NULL, 
 web_library nvarchar(40) NULL, 
 web_release nvarchar(30) NULL, 
 web_email nvarchar(50) NULL, 
 web_header nvarchar(Max) NULL, 
 web_footer nvarchar(Max) NULL, 
 web_homepage nvarchar(40) NULL, 
 web_path nvarchar(80) NULL, 
    CONSTRAINT PK_websetup PRIMARY KEY CLUSTERED  
    ( 
 web_name Asc 
    ) 
) 
 
 
 
 
  
 
 
Appendix B 
 
Metadata and data dictionary  
 
This section includes the description of the tables and views that were used in the 
implementation of the AFND.  
 
Tables and Views 
 
Table B 1: Tables and views in the AFND 
Table Description Type Records 
alldesig Catalogue of alleles for mapping old and 
new nomenclature 
Catalogue 5,140 
allefreq Allele frequencies Frequency data 92,506 
alleles Catalogue of alleles Catalogue 6,891 
allexlab Rare alleles submitted by laboratories Catalogue 1,182 
allidend Details of identical alleles Catalogue 591 
allidenr Relationships of identical alleles  Catalogue 3,110 
allident Group of identical alleles Catalogue 164 
allseq Amino acid sequences of alleles Catalogue 6,186 
allseqd Details of amino acid sequences Catalogue 21,135 
allsynon  Synonymous alleles Catalogue 15,114 
cellline  Catalogue of cell lines Catalogue 132 
codons Catalogue of codons Catalogue 64 
continen Catalogue of continents Catalogue 7 
country Catalogue of countries Catalogue 243 
couxgeo Countries by geographical region Catalogue 243 
cytofreq Cytokine frequencies Frequency data 3,603 
cytokine Catalogue of cytokines Catalogue 189 
ethnalle Alleles by ethnic groups Catalogue 3,193 
ethnic Catalogue of ethnic groups Catalogue 24 
ethxcou Ethnic origins by country View / Report 151 
ethxgeo Ethnic origins by geographical region View / Report 53 
event Event monitor Settings 70,393 
ext_ashi_rares Allele confirmations by ASHI External data 764 
ext_imgt_confirm Allele confirmations by IMGT/HLA External data 61,039 
ext_ipd_kir Allele confirmations by IPD-KIR External data 1,645 
ext_labs_rares Allele confirmations by other laboratories External data 585 
ext_nmdp_rares Allele confirmations by NMDP External data 16,107 
extratbl Additional tables Catalogue 110 
genofred Detail of genotype frequencies Frequency data 41,776 
genofreq Genotype frequencies Frequency data 2,600 
geogreg Catalogue of geographical regions Catalogue 10 
gracolor Temporary table for colour gradients Temporary table 40 
gradient Temporary table for general gradients Temporary table 11 
hallele List of existing hla alleles View / Report 4,108 
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Table B 2: Tables and views in the AFND (Continued) 
Table Description Type Records 
hallele2 HLA alleles dictionary at different level of 
resolution 
Catalogue 6,738 
hapldet Detail of haplotype frequencies Frequency data 25,414 
haplfreq Haplotype frequencies Frequency data 9,173 
hladict HLA dictionary Catalogue 2,130 
hlaprot Coding sequence of HLA alleles Catalogue 5,010 
kallele List of existing KIR alleles View / Report 263 
kallele2 KIR allele dictionary at different resolution Catalogue 644 
kirgeno Catalogue of KIR genotypes Catalogue 438 
locus Catalogue of locus Catalogue 87 
mallele List of existing MIC alleles View / Report 76 
mallele2 MIC allele dictionary at different resolution Catalogue 122 
metadata Catalogue of metadata Catalogue 38 
polyreg Catalogue of polymorphic regions Catalogue 8 
poplocus Locus typed by population View / Report 2,600 
popshla HLA alleles by population View / Report 836 
popskir KIR alleles by population View / Report 188 
populat Catalogue of populations Catalogue 1,212 
programs Catalogue of programs Settings 49 
rareall Rare allele releases Catalogue 1,700 
releases Catalogue of releases from external 
websites 
Catalogue 32 
resolut Catalogue of alleles at low-resolution Catalogue 7,914 
securacc User grants Settings 26 
statshla HLA breakdowns View / Report 34 
statskir KIR breakdowns View / Report 18 
statsmic MIC breakdowns View / Report 2 
statspop Population breakdowns View / Report 4 
tblallele Kardex of allele frequencies Kardex 92,488 
tblcytokines Kardex of cytokine frequencies Kardex 3,603 
tblhaplotypes Kardex of haplotype frequencies Kardex 9,173 
tmpmatrix Temporary table for differences in amino 
acids 
Temporary table 120 
tmpmatrix2 Temporary table for differences in alleles Temporary table 1,000 
tmpmatrix3  Temporary table for differences in 
populations 
Temporary table 100 
tmptab02  Temporary table for frequency entries Temporary table 6,890 
tsession  User sessions Settings 1 
typehla  HLA typing data Catalogue 1,132 
users Catalogue of users Catalogue 5,074 
usrconf  User settings by program Settings 8 
websetup  Website settings Settings 1 
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Data dictionary 
 
Table B 3: Data dictionary of the AFND 
Table Attribute Description Example 
        
alldesig alld_allele Allele name according to 
previous nomenclature 
A*01010101 
 alld_type Type of generation (Automatic 
or manual) 
AUT1, AUT2, AUT3, 
MAN1 
 alld_code Allele name A*01:01:01:01 
 alld_polyreg Polymorphic region HLA, KIR, MIC, Cyt 
allefreq allf_popid Population ID 1212 
 allf_polyreg Polymorphic region HLA, KIR, MIC, Cyt 
 allf_locus Locus name A, B, C, DRB1, … 
 allf_allele Allele name A*01:01:01:01, … 
 allf_line Consecutive number 1, 2, 3, … 
 allf_gene_freq Allele frequency 0.0001, … 
 allf_pheno_freq Phenotype frequency 18.50, … 
 allf_added Date added 01/01/2010 
 allf_updated Last update 01/01/2010 
 allf_user User who entered the 
frequency 
… 
 allf_status Status A=Active, P=Pending 
for submission 
 allf_indiv Number of individuals who 
carry the allele 
50 
 allf_chrom Number of copies with the 
allele 
20 
 allf_sample_size Sample size 200 
 allf_notes Additional notes … 
alleles all_name Allele name A*01:01:01:01 
 all_name2 Name of the allele according 
to previous nomenclature 
A*01010101 
 all_region Polymorphic region HLA, KIR, MIC, Cyt 
 all_locus Locus name A, B, C, DRB1, … 
 all_family Allele family  01, 02, 03, … 
 all_ethnic_origin Ethnic origin(s) in which the 
allele was found in 
IMGT/HLA 
Oriental - Taiwan, Asia, 
… 
 all_class HLA Class Class I, Class II, … 
 all_common Common allele in USA 
(ASHI) 
C = Common 
 all_documented Well-documented allele 
(ASHI) 
WD = Well-
documented 
 all_cells Number of cells/sources that 
have been sequenced 
(IMGT/HLA) 
1, 2, 3, … 
 all_groups Number of groups which have 
reported the allele 
1, 2, 3, … 
 all_confirmed Confirmation of the allele by 
groups (IMGT/HLA) 
Confirmed / 
Unconfirmed 
 all_start Start position of CDS 1 
 all_end End position of CDS 200 
 all_partial CDS confirmed Partial / Full 
 all_updated Last update 01/01/2010 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
alleles all_pops Number of pops in which the 
allele has been reported 
1 
 all_total_nmdp Number of times in NMDP 1 
 all_total_labs Number of times in other 
laboratories 
1 
 all_total_identical_cell Number of cells considering 
identical alleles 
1 
 all_total_identical_group Number of groups considering 
identical alleles 
1 
 all_total_identical_pops Number of times in website 
including identical alleles 
1 
 all_total_identical_nmdp Number of times in NMDP 
including identical alleles 
1 
 all_total_identical_labs Number of times in labs 
including identical alleles 
1 
 all_length Allele length 4, 6, 8, ... 
 all_status Allele status A=Active, D=Deleted 
 all_year Year in which the allele was 
first reported 
1990, 2000, … 
 all_levels Level of resolution 1, 2, 3, 4 
 all_level1 Value first level 1 
 all_level2 Value second level 1 
 all_level3 Value third level 1 
 all_level4 Value fourth level 1 
 all_clevel1 Code at first level 01 
 all_clevel2 Code at second level 01 
 all_clevel3 Code at third level 01 
 all_clevel4 Code at fourth level 01 
 all_order Order 1, 2, 3, … 
allexlab axlab_allele Allele name A*01:01:01:01 
 axlab_indiv_id ID of individual possessing 
the allele 
HAN-1002, … 
 axlab_user User who submitted the allele  … 
 axlab_ethnicity Ethnic origin Caucasoid, … 
 axlab_population Population name Brazilian, … 
 axlab_indiv_type Individual type Bone Marrow Patient, 
… 
 axlab_indiv_type_registry Registry name Brazilian Bone Marrow, 
… 
 axlab_indiv_type_other Specification for other 
association 
Coord blood donor 
 axlab_haplotype Haplotype confirmation Confirmed by family 
studies 
 axlab_notes Additional notes … 
 axlab_other_member Family member with a similar 
rare allele 
Sibling of HAN-1002 
 axlab_indiv_same_resol Individuals typed at the same 
level of resolution 
1, 2, 3, … 
 axlab_methods Methods used to detect allele SBT, SSOP, … 
 axlab_sbt SBT method Y/N 
 axlab_ssp SSP method Y/N 
 axlab_sso SSO method Y/N 
 axlab_seq Sequencing method Y/N 
 axlab_oth Other typing method Y/N 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
allexlab axlab_type Phenotype of the individual A*01:01:01:02N / 
01:01:01:01; 
B*35:03/44:03:02; 
DRB1*07/13:64 
 axlab_phenotype Phenotype of the individual 
validated 
A*01:01:01:02N / 
01:01:01:01; 
B*35:03/44:03:02; 
DRB1*07/13:64 
 axlab_haplotype1 First haplotype of the 
individual 
A*01:01:01:02N- 
B*35:03- DRB1*07 
 axlab_haplotype2 Second haplotype of the 
individual 
A*01:01:01:01-
B*44:03:02-
DRB1*16:64 
 axlab_hap1_hla_a Haplotype 1 HLA-A A*01:01:01:02N 
 axlab_hap2_hla_a Haplotype 2 HLA-A A*01:01:01:01 
 axlab_hap1_hla_b Haplotype 1 HLA-B B*35:03 
 axlab_hap2_hla_b Haplotype 2 HLA-B B*44:03:02 
 axlab_hap1_hla_c Haplotype 1 HLA-C  
 axlab_hap2_hla_c Haplotype 2 HLA-C  
 axlab_hap1_hla_dra Haplotype 1 HLA-DRA  
 axlab_hap2_hla_dra Haplotype 2 HLA-DRA  
 axlab_hap1_hla_drb1 Haplotype 1 HLA-DRB1 DRB1*07 
 axlab_hap2_hla_drb1 Haplotype 2 HLA-DRB1 DRB1*16:64 
 axlab_hap1_hla_dqa1 Haplotype 1 HLA-DQA1  
 axlab_hap2_hla_dqa1 Haplotype 2 HLA-DQA1  
 axlab_hap1_hla_dqb1 Haplotype 1 HLA-DQB1  
 axlab_hap2_hla_dqb1 Haplotype 2 HLA-DQB1  
 axlab_hap1_hla_dpa1 Haplotype 1 HLA-DPA1  
 axlab_hap2_hla_dpa1 Haplotype 2 HLA-DPA1  
 axlab_hap1_hla_dpb1 Haplotype 1 HLA-DPB1  
 axlab_hap2_hla_dpb1 Haplotype 2 HLA-DPB1  
 axlab_date_added Date added 01/01/2010 
 axlab_line Counter 1, 2, 3, … 
 axlab_status Status A=Active, P=Pending 
 axlab_authors Contributor Name 
 axlab_add1 Address 1 Address 
 axlab_add2 Address 2 Address 
 axlab_city City of contributor City 
 axlab_county County of contributor County 
 axlab_country Country of contributor Country 
 axlab_postcode Postcode Postcode 
 axlab_fax Fax of contributor Fax 
 axlab_email Email of contributor Email 
 axlab_ihw Participant of the 15 IHWS Y/N 
allidend idd_code Internal code for identical 
alleles 
A-G01 
 idd_allele Allele name A*01:01:01:01 
 idd_status Status of the allele A=Active 
allidenr idr_allele Allele name A*01:01:01:01 
 idr_identical Identical allele A*01:01:01:02N 
allident ide_code Internal code for identical 
alleles 
A-G01 
 ide_name Allele name A*01:01:01:01 
 ide_status Status of the allele A=Active 
allseq aseq_allele Allele name A*01:01:01:01 
 aseq_protein Protein sequence MAVMAPR…. 
 aseq_genomic Genomic sequence GCCAGGCC…. 
 aseq_size Size of the coding sequence 3503, … 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
allseqd aseqd_allele Allele name A*01:01:01:01 
 aseqd_line Line number 1,2,3…  
 aseqd_type Type of sequence  EX=Exon, … 
 aseqd_from Initial position  1 
 aseqd_to End position of CDS  246 
 aseqd_order Order  1, 2, 3, … 
allsynon asyn_parent Parent allele  DQB1*03:01:03 
 asyn_child Child allele  DQB1*01:01:01 
 asyn_parent_size Size of the parent allele  3 
 asyn_child_size Size of the child allele  3 
cellline cell_id Cell line id  1 
 cell_dna_no DNA code of the cell line  AMAI 
 cell_ihw_no Code of the IH Workshop  9010 
 cell_ipd_code Code in IPD-KIR database  10246 
 cell_consang Consanguineous  C=Consanguineous 
 cell_2dl1_1 Allele present in the gene  002 
 cell_2dl1_2 Allele present in the gene  001v 
 cell_2dp1_1 Allele present in the gene  + 
 cell_2dl3_1 Allele present in the gene  002 
 cell_2dl3_2 Allele present in the gene  005 
 cell_2ds4_1 Allele present in the gene  003 
 cell_2ds4_2 Allele present in the gene   
 cell_3dl1_1 Allele present in the gene  00101 
 cell_3dl1_2 Allele present in the gene   
 cell_3dl1_1_s Allele present in the gene   
 cell_3dl1_2_s Allele present in the gene   
 cell_3ds1_1 Allele present in the gene  - 
 cell_3ds1_1_s Allele present in the gene   
 cell_2ds1_1 Allele present in the gene  -  
 cell_2ds2_1 Allele present in the gene   
 cell_2ds3_1 Allele present in the gene  - 
 cell_2ds3_2 Allele present in the gene   
 cell_2ds5_1 Allele present in the gene  - 
 cell_2dl2_1 Allele present in the gene  - 
 cell_2dl2_2 Allele present in the gene   
 cell_2dl5a_1 Allele present in the gene  - 
 cell_2dl5a_2 Allele present in the gene   
 cell_2dl5a_s Allele present in the gene   
 cell_2dl5b_1 Allele present in the gene  - 
 cell_2dl5b_2 Allele present in the gene   
 cell_2dl5b_s Allele present in the gene   
 cell_2dl4_1 Allele present in the gene  00202 
 cell_2dl4_2 Allele present in the gene   
 cell_3dl2_1 Allele present in the gene  001 
 cell_3dl2_2 Allele present in the gene   
 cell_3dl3_1 Allele present in the gene  + 
 cell_3dp1_1 Allele present in the gene  + 
 cell_status Cell line status  A=Active 
codons cod_id Codon id  1 
 cod_aminoacid Amino acid name  Phenylalanine 
 cod_letter Amino acid code  F 
 cod_3letter Amino acid three letter code  Phe 
 cod_rna Rna equivalence  UUU 
 cod_dna Dna equivalence  TTT 
 cod_polarity Polarity  Non polar   
continen con_code Continent code  AFR 
 con_name Continent name  Africa 
 con_index Continent order  1 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
continen con_status Continent status  A=Active 
country cou_code Country code  ARG 
 geo_code Geographical region code  SCAM 
 cou_name Country name  Argentina 
 cou_code2 Country code two digits  AR 
 cou_number Country UN number  32 
 cou_name2 Country name in caps  ARGENTINA 
 cou_tld Country internet ending  .ar    
 cou_timezone Country time zone  GMT - 3 hrs 
 cou_phone_code Country phone code  54    
 cou_population Country population  40301927 
 cou_pop_date Country population last 
update 
 15/10/2008 
 cou_pop_source Country population source UN estimate  
 cou_area Country area  2780400 
 cou_area_date Country area last update  15/10/2008 
 cou_area_source Country area source   
 cou_capital Country capital  Buenos Aires 
 cou_latitude Country latitude  34‟36 S 
 cou_longitude Country longitude  58‟22 W 
 cou_status Country status  A=Active, I=Inactive 
couxgeo cogr_geo_region_code Geographical region code  ASIA 
 cogr_country_code Country code  AAE 
 cogr_geo_region_name Geographical region name  Asia                      
 cogr_country_name Country name  Myanmar                                                      
 cogr_status Relationship status  A 
cytofreq cytf_popid Population ID  1366 
 cytf_gene Locus or gene  IL-10/ 
 cytf_cytokine Cytokine name  IL-10/ - 1082 AA 
 cytf_line Row number  1, 2, 3… 
 cytf_freq Phenotype frequency  19.4000 
 cytf_added Date added  01/01/2008 
 cytf_updated Last update  01/01/2008 
 cytf_user Username  … 
 cytf_order Order  1085.1000 
 cytf_status Status  A=Active, I=Inactive 
 cytf_indiv Number of individuals who 
carry the allele 
 19 
 cytf_sample_size Sample size of the population  100 
cytokine cyt_name Cytokine name  AIF-1/ -932 CC 
 cyt_gene Cytokine gene  AIF-1/ 
 cyt_group Cytokine group  CC     
 cyt_updated Cytokine update  01/02/2008 
 cyt_index Cytokine order or index  1200.1 
 cyt_status Cytokine status  A 
ethnalle etha_allele Allele name  A*01:01:01:01 
 etha_ethnic_origin Ethnic origins where the allele 
has been seen 
 Caucasoid, … 
 etha_first First ethnic origin sequenced  Caucasoid 
ethnic eth_code Ethnic origin code  ASTN 
 eth_name Ethnic origin name  Austronesian 
 eth_status Ethnic origin status  A 
 eth_reference Ethnic origin reference  Pacific Islanders 
ethxcou ethc_country_code Country code  AAH 
 ethc_ethnic_code Ethnic group code  CAUC 
 ethc_country_name Country name  Serbia                                                       
 ethc_ethnic_name Ethnic group name  Caucasoid                 
 ethc_status Relationship status  A 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
ethxgeo ethg_geo_region_code Geographical region code  AUST 
 ethg_ethnic_code Ethnic group code  AUST 
 ethg_geo_region_name Geographical region name  Australia                                   
 ethg_ethnic_name Ethnic group name  Australian Aboriginal     
 ethg_status Relationship status  A 
event eve_id Monitor id number 19671 
 eve_event Monitor event LOG 
 eve_description Monitor description Login to website 
 eve_user Monitor user … 
 eve_program Monitor program Main 
 eve_date Monitor date 25/03/2009 
 eve_time Monitor time 102346 
 eve_extra Monitor extra comments Login… 
ext_ashi_rares ashi_allele Allele name  A*01:01:01:01 
 ashi_release Release  1.0.0      
 ashi_common Flag to identify a common 
allele 
 C=Common 
 ashi_documented Flag to identify a well-
documented allele 
 WD=Well-
documented 
 ashi_update Release 25/09/2008 
ext_imgt_confirm imgt_allele Allele name  B*35:31 
 imgt_release Release  2.28.0 
 imgt_cells Number of cells/sources 
which have been sequenced 
the allele 
 3 
 imgt_groups Number of submitters who 
have sequenced the allele 
 2 
 imgt_confirmed Confirmation for the allele  Confirmed 
 imgt_start Nucleotide start position of 
the sequence compared to the 
CDS of the reference 
sequence 
 1 
 imgt_end Nucleotide end position of the 
sequence compared to the 
CDS of the reference 
sequence 
 1089 
 imgt_partial CDS sequenced  Full 
 imgt_ethnicity First ethnic origin sequenced  Caucasoid 
 imgt_update Last update  17/02/2010 
ext_ipd_kir ipd_allele Allele name  2DL1*001 
 ipd_release Release  2.0.0 
 ipd_update Last update  31/07/2008 
ext_labs_rares labs_allele Allele name  A*01:01:01:02N 
 labs_bla Total for black ethnicity  0 
 labs_cau Total for caucasian ethnicity  0 
 labs_mes Total for mestizo ethnicity  0 
 labs_his Total for hispanic ethnicity  0 
 labs_oth Total for other ethnicity  1 
 labs_total Total alleles  1 
ext_nmdp_rares nmdp_allele Allele name  B*15:94N 
 nmdp_release Release  2.16.0     
 nmdp_afa African american  0 
 nmdp_api Asian or pacific islanders  0 
 nmdp_cau Caucasian  0 
 nmdp_his Hispanic race  0 
 nmdp_nam Native american  0 
 nmdp_oth Multiple, unknown or decline  0 
 nmdp_total Total  0 
 nmdp_rare Rare allele  X 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
ext_nmdp_rares nmdp_zero Absent confirmation  X 
 nmdp_update Last update  01/01/2007 
extratbl ext_table Extra table name  JOU 
 ext_code Extra table code  0001 
 ext_value Extra table value 1  Transplant 
Immunology 
 ext_value2 Extra table value 2  Additional comment 
 ext_status Extra table status  A=Active, I=Inactive 
genofred genfd_popid Population ID  1618 
 genfd_polyreg Polymorphic region  KIR 
 genfd_genotype Genotype ID  9 
 genfd_locus Locus  2DL1 
 genfd_line_h Row number (header)  6 
 genfd_line Row number  2 
 genfd_value Type  1 
 genfd_status Status  A=Active, I=Inactive 
genofreq genf_popid Population ID  2444 
 genf_polyreg Polymorphic region  KIR 
 genf_genotype Genotype ID  112 
 genf_line Row number  9 
 genf_phenotype Phenotype code   
 genf_genotype_b2 Genotype (base = 2)   
 genf_genotype_b3 Genotype (base = 3)   
 genf_freq Genotype frequency  0.6 
 genf_added Date added  06/06/2008 
 genf_updated Last update  06/06/2008 
 genf_status Status  A=Active, I=Inactive 
 genf_individuals Number of individuals who 
carry the genotype 
 1 
 genf_sample_size Sample size of the population  166 
geogreg geo_code Geographical region code  ASIA 
 con_code Continent ASI 
 geo_name Geographical region name  Asia 
 geo_index Geographical region index  01 
 geo_status Geographical region status  01 
gracolor gcol_gene Name of gene to draw  2DL1 
 gcol_range Range  60-79 
 gcol_color Name of colour  P 
 gcol_color_value Colour value  #993399 
 gcol_bar Type of bar  6 
 gcol_minv Minimum value  60 
 gcol_maxv Maximum value  80 
gradient gra_value Gradient value  1 
 gra_min Minimum value  1 
 gra_max Maximum value  10 
hallele hla_allele Allele Name A*01:01:01:01 
 hla_locus Locus name A, B, C, DRB1, … 
 hla_level1 First level 1, 2, 15, … 
 hla_level2 Second level 1, 2, 15, … 
 hla_level3 Third level 1, 2, 15, … 
 hla_level4 Fourth level 1, 2, 15, … 
 hla_order Order 1, 2, 3, … 
hallele2 hla2_allele Allele Name A*01:01:01:01 
 hla2_allele2 Last nomenclature A*01010101 
 hla2_locus Locus name A, B, C, DRB1, … 
 hla2_length Level of digits of resolution 1, 2, 3, 4 
 hla2_source Source of generation MAN1, AUT1 … 
AUT4 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
hallele2 hla2_resol Level of resolution H = High, L = Low 
 hla2_level1 First level 1, 2, 15, … 
 hla2_level2 Second level 1, 2, 15, … 
 hla2_level3 Third level 1, 2, 15, … 
 hla2_level4 Fourth level 1, 2, 15, … 
 hla2_order Order 1, 2, 3, … 
hapldet hapd_popid Population ID  1216 
 hapd_line Reference line to haplotypes  1 
 hapd_allele Allele name  A*02:01 
 hapd_locus Locus name  A 
 hapd_info Allele variant  02:01 
haplfreq hapf_popid Population ID  1481 
 hapf_region Polymorphic region  HLA 
 hapf_line Row number  52 
 hapf_haplotype Haplotype  B*50:01-C*06:02 
 hapf_haplotype2 Past nomencl Haplotype  B*5001-Cw*0602 
 hapf_freq Haplotype frequency  2.1000 
 hapf_added Date added  01/02/2008 
 hapf_updated Last update  01/02/2008 
 hapf_user Username  … 
 hapf_status Status  A 
 hapf_loci Number of loci  2 
hladict hlad_allele Allele name  A*01:01 
 hlad_expert Expert assigned type  A1 
 hlad_who WHO assigned type  A1 
 hlad_status Status  A 
hlaprot hlap_allele Allele name  A*24:02:31 
 hlap_line Line number  843 
 hlap_sequence Protein sequence  ---------V-… 
 hlap_reference Reference sequence  MAVMAPRT… 
kallele kir_allele Allele name for all resolutions  2DL1*001 
kallele2 kir2_allele Allele name  2DL1*001             
 kir2_locus Locus name  2DL1 
 kir2_length Length of the allele  3 
 kir2_source Source of generation  AUT1 
 kir2_resol Level of resolution  L=Low, H=High 
kirgeno kgen_id KIR genotype ID  1 
 kgen_3dl1 Gene value  1 
 kgen_2dl1 Gene value  1 
 kgen_2dl3 Gene value  1 
 kgen_2ds4 Gene value  1 
 kgen_2dl2 Gene value  0 
 kgen_2dl5 Gene value  0 
 kgen_3ds1 Gene value  0 
 kgen_2ds1 Gene value  0 
 kgen_2ds2 Gene value  0 
 kgen_2ds3 Gene value  0 
 kgen_2ds5 Gene value  0 
 kgen_2dl4 Gene value  1 
 kgen_3dl2 Gene value  1 
 kgen_3dl3 Gene value  1 
 kgen_2dp1 Gene value  1 
 kgen_3dp1 Gene value  1 
 kgen_group_a Belongs to group A  1 
 kgen_group_b Belongs to group B  0 
 kgen_type KIR genotype type  AA 
 kgen_order KIR genotype order  1 
 kgen_status KIR genotype status  A=Active, I=Inactive 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
kirgeno kgen_phenotype KIR phenotype  A 
 kgen_pops Pops with this genotype  108 
 kgen_individuals Number of individuals who 
carry the genotype 
 3686 
 kgen_a_genes Number of A genes present in 
the genotype 
 4 
 kgen_b_genes Number of B genes present in 
the genotype 
 0 
 kgen_pseudo_genes Number of Pseudogenes 
present in the genotype 
 2 
 kgen_total_genes Total genes in the genotype  9 
locus loc_region Polymorphic region code  HLA        
 loc_name Locus name  A 
 loc_chrom_name Locus chromosome name   
 loc_chrom_number Locus chromosome number  6 
 loc_chrom_position Locus position on 
chromosome 
 6.23 
 loc_chrom_band Locus chromosome band   
 loc_chrom_subband Locus chromosome sub-band   
 loc_chrom_ending Locus chromosome ending   
 loc_hla_class Locus HLA class  Class I 
 loc_hla_type Locus HLA type  Classical 
 loc_kir_domains Locus KIR domains  2 
 loc_kir_cyto_tail Locus KIR cytoplasmic tail  Large 
 loc_kir_gene_number Locus KIR gene number  1 
 loc_kir_type Locus KIR type  Type I 
 loc_kir_code Locus KIR code  A    
 loc_order Locus order  02 
 loc_status Locus status  A=Active, I=Inactive 
mallele mic_allele MIC allele name MICA*001 
 mic_locus Locus name MICA, MICB 
 mic_level1 First level 1, 2, 15, … 
 mic_level2 Second level 1, 2, 15, … 
 mic_level3 Third level 1, 2, 15, … 
 mic_level4 Fourth level 1, 2, 15, … 
 mic_order Order 1, 2, 3, … 
mallele2 mic2_allele Allele Name MICA*001:01 
 mic2_allele2 Last nomenclature MICA*00101 
 mic2_locus Locus name A, B, C, DRB1, … 
 mic2_length Level of digits of resolution 1, 2, 3, 4 
 mic2_source Source of generation MAN1, AUT1 … 
AUT4 
 mic2_resol Level of resolution H = High, L = Low 
 mic2_level1 First level 1, 2, 15, … 
 mic2_level2 Second level 1, 2, 15, … 
 mic2_level3 Third level 1, 2, 15, … 
 mic2_level4 Fourth level 1, 2, 15, … 
 mic2_order Order 1, 2, 3, … 
metadata met_type Metadata type  FLD=Field 
 met_table Table Name  kirgeno 
 met_number Entry order  1 
 met_name Metadata name  kgen_id 
 met_namedisp Name to display  Genotype ID 
 met_desc Metadata description  KIR genotype ID 
 met_datatype Field datatype  Numeric 
 met_length Field length  8,0 
 met_mask Field mask  zzzzzzz9 
 met_help Field help  Comments 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
metadata met_common Display as a common field  Y 
 met_upper Field to uppercase  N 
 met_order Field order  2 
 met_status Field status  A=Active, I=Inactive 
polyreg pol_code Polymorphic region code  001 
 pol_name Polymorphic region name  HLA 
 pol_desc Polymorphic region 
description 
 Human Leukocyte 
Antigens 
 pol_index Polymorphic region index  01 
 pol_status Polymorphic region status  A 
poplocus popl_poly Polymorphic region  HLA 
 popl_popid Population id  1212 
 popl_locus Locus name  A 
popshla phla_popid Population id  1212 
 phla_population Population name  Scotland Orkney 
 phla_a Number of alleles in locus  39 
 phla_b Number of alleles in locus  40 
 phla_c Number of alleles in locus  19 
 phla_drb1 Number of alleles in locus  26 
 phla_dqa1 Number of alleles in locus  0 
 phla_dqb1 Number of alleles in locus  9 
 phla_dpa1 Number of alleles in locus  0 
 phla_dpb1 Number of alleles in locus  0 
 phla_others Number of alleles in locus  0 
 phla_total Number of alleles in locus  133 
 phla_hap Number of alleles in locus  0 
 phla_a_p Number of alleles in locus  13 
 phla_b_p Number of alleles in locus  20 
 phla_c_p Number of alleles in locus  11 
 phla_drb1_p Number of alleles in locus  26 
 phla_dqb1_p Number of alleles in locus  0 
 phla_dqa1_p Number of alleles in locus  9 
 phla_dpa1_p Number of alleles in locus  0 
 phla_dpb1_p Number of alleles in locus  0 
 phla_others_p Number of alleles in locus  0 
 phla_total_p Number of alleles in 
population 
 79 
popskir pkir_popid Population id  1429 
 pkir_population Population name  Ireland Northern KIR 
 pkir_2dl1 Number of alleles in gene  1 
 pkir_2dl2 Number of alleles in gene  1 
 pkir_2dl3 Number of alleles in gene  7 
 pkir_2dl4 Number of alleles in gene  10 
 pkir_2dl5 Number of alleles in gene  1 
 pkir_2dl5a Number of alleles in gene  0 
 pkir_2dl5b Number of alleles in gene  0 
 pkir_2ds1 Number of alleles in gene  1 
 pkir_2ds2 Number of alleles in gene  1 
 pkir_2ds3 Number of alleles in gene  1 
 pkir_2ds4 Number of alleles in gene  6 
 pkir_2ds5 Number of alleles in gene  1 
 pkir_3ds1 Number of alleles in gene  6 
 pkir_3dl1 Number of alleles in gene  12 
 pkir_3dl2 Number of alleles in gene  13 
 pkir_3dl3 Number of alleles in gene  7 
 pkir_2dp1 Number of alleles in gene  1 
 pkir_3dp1 Number of alleles in gene  1 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
popskir pkir_total Number of alleles in 
population 
 64 
 pkir_geno Number of genotypes in the 
population 
 26 
populat pop_id Population id 2000 
 pop_polyreg Polymorphic region HLA, KIR, … 
 pop_name Population name Scotland Orkney, … 
 pop_name2 Population name Orkneys, … 
 pop_country Population country Scotland 
 pop_geo_region Population geographical 
region 
Western Europe, … 
 pop_subregion Population sub geographical 
region 
Western Europe, … 
 pop_ethnic_origin Population ethnic origin Caucasoid 
 pop_linguistic Population linguistic family Caucasoid 
 pop_center Population linguistic family Caucasoid 
 pop_origin     
 pop_urban_rural Population type (Urban/Rural) Urban, Rural, Urban 
and Rural 
 pop_family Population family Parents live at same 
location, … 
 pop_source Source of population Anthropology study, … 
 pop_isolated Population was isolated  Y/N 
 pop_admixture Population contains admixture  Y/N 
 pop_lat1_deg Latitude degrees 58 
 pop_lat1_min Latitude minutes 59 
 pop_lat1_card Latitude orientation (Cardinal 
position) 
N 
 pop_long1_deg Longitude degrees 3 
 pop_long1_min Longitude minutes 11 
 pop_long1_card Longitude orientation 
(Cardinal position) 
W 
 pop_coord_conf Confirmation of coordinate Y, N 
 pop_size Population size, if known 10 000  
 pop_samplesize Population sample size 99 
 pop_sampleyear Population sample year 2000 
 pop_method_analysis Type of method used for the 
estimation 
Direct counting, 
resampling, etc. 
 pop_notes Population notes Additional comments 
 pop_verified Flag to indicate if population 
was verified 
Y, N 
 pop_status Population status A = Active, P = 
Pending 
 pop_submited_date Population submited date 04/07/2002 
 pop_submited_by Population submited by Username 
 pop_reviewed_date Population reviewed date 07/10/2008 
 pop_reviewed_by Population reviewed by Username 
 pop_update Last update 07/10/2008 
 pop_alleles Number of alleles in the 
population 
1, 2, 3, … 
 pop_phenotypes Number of phenotypes in the 
population 
1, 2, 3, … 
 pop_genotypes Number of genotypes in the 
population 
1, 2, 3, … 
 pop_haplotypes Number of haplotypes in the 
population 
1, 2, 3, … 
 pop_loci_test_hap Number of loci tested for 
haplotypes 
1, 2, 3, … 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
populat pop_main_author Population author Bodmer 
 pop_reference1 Population reference 1 Bodmer et al 
 pop_reference2 Population reference 2 E-mail 
 pop_reference3 Population reference 3 Not able to 
distinguish… 
 pop_dataset Type of dataset Literature 
 pop_article Title of the publication Title 
 pop_authors Authors included in the 
publication 
Authors 
 pop_correspondence Correspondence author Bodmer 
 pop_email E-mail corresponding author E-mail 
 pop_journal Journal of the publication Journal name 
 pop_year Year of publication 2002 
 pop_volume Volume of Journal 69 
 pop_issue Issue of Journal 2 
 pop_pages Pages of the publication 12-17 
 pop_doi Digital object identifier  Identifier 
 pop_pubmed Pubmed reference  Reference 
 pop_file_name Path for electronic version \\path_file 
 pop_method Method used SSOP, SSP, … 
 pop_ssp Typed by SSP? Y, N 
 pop_ssop Typed by SSOP? Y, N 
 pop_sscp Typed by SSCP? Y, N 
 pop_sbt Typed by SBT? Y, N 
 pop_seq Typed by Sequencing? Y, N 
 pop_rsca Typed by RSCA? Y, N 
 pop_rflp Typed by RFLP? Y, N 
 pop_oth Typed by other method? Y, N 
 pop_country_lab Country in which the 
individuals were typed 
  
 pop_dna_origin Source of DNA   
 pop_kit Kit used for typing   
 pop_certify Population certification (Y/N) Y, N 
 pop_reference4 Population reference 4   
 pop_has_alleles Flag to indicate if pop has 
alleles 
Y, N 
 pop_has_haplotypes Flag to indicate if pop has 
haplotypes 
Y, N 
 pop_has_cytokines Flag to indicate if pop has 
cytokines 
Y, N 
programs prg_code Program code  hla0001a 
 prg_desc Program description  HLA allele catalogue 
 prg_desc2 Large program description  Program to add… 
 prg_desc3 Program keywords  HLA, allele, … 
 prg_desc4 Program description  … 
 prg_desc5 Program description  … 
 prg_type Program type  CAT 
 prg_module Program module  HLA                  
 prg_status Program status  A=Active, I=Inactive 
 prg_author Program author  Username 
 prg_created Program start date  07/01/2008 
 prg_last_update Program last update  07/01/2008 
 prg_user_update Last modification user  Username 
 prg_version Program version  1.0.0 
 prg_display Program display flag  Y 
 prg_web Program display in website 
flag 
U=User, S=Super 
administrator 
rareall rar_allele Allele name  A*01:01:01:02N 
 rar_release Release  2.22.0 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
rareall rar_web Total number of alleles in 
website 
 0 
 rar_nmdp Total number of alleles in 
nmdp 
 0 
 rar_labs Total number of alleles in 
laboratories 
 0 
 rar_status Status  A=Active, I=Inactive 
releases rel_code Release code  IMGT/HLA 
 rel_name Release name  2.19.0 
 rel_date Release date  01/10/2007 
 rel_ftp Release ftp path source  ftp://alleles.org 
 rel_file Release file source  confirmations_2190.txt 
 rel_http Release http path source  http://www.ebi.ac.uk 
 rel_desc Release description  HLA Alleles 
 rel_total_rows Release total rows updated  3041 
 rel_status Release status   A=Active, I=Inactive 
resolut res_parent Allele parent  A*01:01:01:01 
 res_child Allele child  A*01:01:01 
 res_parent_size Allele parent size  4 
 res_child_size Allele child size  3 
securacc sec_user User login  Username 
 sec_program Program code  hla2001a 
 sec_password User password in program  Password 
 sec_master_ins Access to insert in master  Y/N 
 sec_master_del Access to delete in master  Y/N 
 sec_master_mod Access to modify in master  Y/N 
 sec_detail_ins Access to insert in detail  Y/N 
 sec_detail_del Access to delete in detail  Y/N 
 sec_detail_mod Access to modify in detail  Y/N 
 sec_print Access to print  Y/N 
 sec_apply Access to apply updates  Y/N 
 sec_undo Access to undo changes  Y/N 
 sec_open Access to open data  Y/N 
 sec_cancel Access to cancel data  Y/N 
 sec_lock Access to lock record  Y/N 
 sec_unlock Access to unlock record  Y/N 
 sec_export Access to export information  Y/N 
 sec_page1 Access to page 1  Y/N 
 sec_page2 Access to page 2  Y/N 
 sec_page3 Access to page 3  Y/N 
 sec_page4 Access to page 4  Y/N 
 sec_page5 Access to page 5  Y/N 
 sec_page6 Access to page 6  Y/N 
 sec_page7 Access to page 7  Y/N 
 sec_page8 Access to page 8  Y/N 
 sec_page9 Access to page 9  Y/N 
 sec_page10 Access to page 10  Y/N 
statshla shla_locus Locus name  A 
 shla_imgt Total alleles in IMGT/HLA 
database 
 1518 
 shla_website Total alleles in Website  193 
 shla_entries Total entries in Website  7498 
statskir skir_locus Locus name  2DL1 
 skir_ipd Total alleles in IPD-KIR 
database 
 37 
 skir_website Total alleles in Website  21 
 skir_entries Total entries in Website  214 
statsmic smic_locus Locus name  MICA 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
statsmic smic_imgt Total alleles in IMGT/HLA 
database 
 72 
 smic_website Total alleles in Website  38 
 smic_entries Total entries in Website  516 
statspop spop_polyreg Polymorphic region  HLA 
 spop_pops Total populations  843 
 spop_alleles Populations with alleles  709 
 spop_haplotypes Populations with haplotypes  361 
 spop_genotypes Populations with genotypes  0 
 spop_family Populations at family level  503 
 spop_both Populations with both data  828 
tblallele tall_popid Population id 1980, 1981, … 
 tall_polyreg Polymorphic region HLA, KIR, … 
 tall_locus Locus name A, B, C, DRB1, … 
 tall_allele Allele name A*01:01:01:01 
 tall_line Record identifier 1, 2, 3, … 
 tall_gene_freq Gene frequency 0.001 
 tall_status Status A 
 tall_user Username … 
 tall_pheno_freq Phenotype frequency 100.0 
 tall_added Date added 01/01/2010 
 tall_updated Last update 01/01/2010 
 tall_gene_has_data Flag to identify gene frequency 
data 
Y, N 
 tall_gene_freq_num Gene frequency 0.001 
 tall_freq_has_data Flag to identify pheno 
frequency data 
Y, N 
 tall_pheno_freq_num Phenotype frequency 100.0 
 tall_has_data Flag to identify if has data Y, N 
 tall_indiv Number of individuals who 
carry the allele 
10 
 tall_chrom Number of chromosomes 
with the allele 
20 
 tall_samplesize Sample size of the population 100 
 tall_notes Notes in the record any note 
tblcytokines tcyt_popid Population id  2485 
 tcyt_gene Name of the gene  IL-4/ 
 tcyt_cytokine Cytokine name  IL-4/ - 590 TT 
 tcyt_line Record identifier  3782 
 tcyt_genotype Genotype combination  TT   
 tcyt_order Order  1045.3000 
 tcyt_freq Frequency in the population  3.6 
 tcyt_added Date added  25/11/2008 
 tcyt_update Last update  25/11/2008 
 tcyt_status Status  A=Active, I=Inactive 
 tcyt_user Username  … 
 tcyt_indiv Number of individuals who 
carry this cytokine 
 5 
 tcyt_sample_size Sample size of the population  140 
tblhaplotypes thap_popid Population id  1216 
 thap_region Polymorphic region  HLA 
 thap_haplotype Haplotype  A*02:01-B*15:01 
 thap_line Record identifier  2450 
 thap_haplotype2 Haplotype last nomenclature  A*0201-B*1501 
 thap_frequency Frequency in the population  1.4 
 thap_status Status  A 
 thap_loci Number of loci included in the 
haplotype 
 2 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
tmpmatrix tmp_user User login  … 
 tmp_allele Allele name  DPA1*02:01:03 
 tmp_pos Position of difference in 
amino acid 
 42 
 tmp_letter Amino acid  A 
 tmp_freq Frequency in the population  0.3 
tmpmatrix2 tmp2_user User login  … 
 tmp2_value Allele name  A*01:01 
 tmp2_position Order  1 
tmpmatrix3 tmp3_user User login  … 
 tmp3_value Value  2699 
 tmp3_position Order  1 
tmptab02 tmp2_popid Population id  1450 
 tmp2_allele Allele name  C*12:04:01 
 tmp2_pfreq Phenotype frequency  4.20 
 tmp2_afreq Allele frequency  0.021 
 tmp2_notes Additional notes  Additional notes 
tsession ses_user Session user  … 
 ses_last_event Session last event  main     
 ses_status Session status  A 
 ses_date Session date  28/11/2008 
 ses_time Session time  153420 
typehla thla_user User login  … 
 thla_indiv Individual id  000001 
 thla_locus Locus name  B 
 thla_copy Copy of the allele  1 
 thla_allele Allele variant  1301 
 thla_code Allele name  B*1301 
 thla_mark Type of record   
 thla_status Status  T= Temporary 
users usr_login User login  … 
 usr_password User password  Password 
 usr_lastname User last name  - 
 usr_firstname User first name  - 
 usr_title User title  - 
 usr_sex User sex  M/F 
 usr_date_of_birth User date of birth  - 
 usr_email User email  - 
 usr_status User status  - 
 usr_profile User profile  - 
 usr_add1 User address  - 
 usr_add2 User address  - 
 usr_city User city  - 
 usr_county User county or state  - 
 usr_country User country  - 
 usr_postcode User postcode  - 
 usr_tel1 User telephone 1  - 
 usr_tel2 User telephone 2  - 
 usr_fax User fax  - 
 usr_mobile User mobile  - 
 usr_url User url  - 
 usr_association User association or university  - 
 usr_interests User interests  - 
 usr_notify User notifications via email  - 
 usr_date_added User date added  - 
usrconf ucfg_user Configuration user  … 
 ucfg_program Configuration program  hla2001a 
 ucfg_event Configuration event  Login 
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Table B.2: Data dictionary of the AFND (Continued) 
Table Attribute Description Example 
usrconf ucfg_value Configuration value  1 
websetup web_name Website name AFND 
 web_name2 Website name  - 
 web_add1 Website address  - 
 web_add2 Website address  - 
 web_city Website city  - 
 web_county Website country  - 
 web_country Website country  - 
 web_postcode Website postcode  - 
 web_tel1 Website telephone (1)  - 
 web_tel2 Website telephone (2)  - 
 web_fax Website fax  - 
 web_mobile Website mobile   - 
 web_server Website server address  - 
 web_alias_db Website database alias  - 
 web_image Website image reference  - 
 web_icon Website icon reference  - 
 web_domain Website domain  - 
 web_library Website library  - 
 web_release Website HLA last release  - 
 web_email Website email contact  - 
 web_header Website page header  - 
 web_footer Website page footer  - 
 web_homepage Website homepage  - 
 web_path Website path  - 
 
